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Abstract 
Repetitive transcranial magnetic stimulation (rTMS) has become a popular neuromodulation 
technique, increasingly employed to manage several neurological and psychological conditions. 
Despite its popular use, the underlying mechanisms of rTMS remain largely unknown, 
particularly at the visual cortex. Moreover, the application of rTMS to modulate visual-related 
disorders is under-investigated. The goal of the present research was to address these issues. I 
employ a multitude of neuroimaging techniques to gain further insight into neural mechanisms 
underlying low-frequency (1 Hz) rTMS to the visual cortex. In addition, I begin to develop and 
refine clinical low-frequency rTMS protocols applicable to visual disorders as an alternative 
therapy where other treatment options are unsuccessful or where there are simply no existing 
therapies. One such visual disorder that can benefit from rTMS treatment is the perception of 
visual hallucinations that can occur following visual pathway damage in otherwise cognitively 
healthy individuals. In Chapters 2–3, I investigate the potential of multiday low-frequency rTMS 
to the visual cortex to alleviate continuous and disruptive visual hallucinations consequent to 
occipital injury. Combining rTMS with magnetic resonance imaging techniques reveals 
functional and structural cortical changes that lead to the perception of visual hallucinations; and 
rTMS successfully attenuates these anomalous visual perceptions. In Chapters 4–5, I compare 
the effects of alternative doses of low-frequency rTMS to the visual cortex on neurotransmitter 
levels and intrinsic functional connectivity to gain insight into rTMS mechanisms and establish 
the most effective protocol. Differential dose-dependent effects are observed on neurotransmitter 
levels and functional connectivity that suggest the choice of protocol critically depends on the 
neurophysiological target. Collectively, this work provides a basic framework for the use of low-
frequency rTMS and neuroimaging in clinical application for visual disorders.  
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CHAPTER 1  
 
GENERAL INTRODUCTION 
  
 2 
Methods of noninvasive human brain stimulation are increasingly used to study neural 
function/processes, pathophysiology, and as treatment alternatives or adjunct neuromodulatory 
therapy in a number of psychological and neurological conditions (for reviews, see Dayan, 
Censor, Buch, Sandrini, & Cohen, 2013; Fregni & Pascual-Leone, 2007). Transcranial magnetic 
stimulation (TMS) and transcranial direct stimulation (tDCS) are popular examples of 
noninvasive brain stimulation techniques. Different neuromodulatory stimulation techniques do 
not however induce the same physiological or behavioural effects. Repetitive TMS (rTMS) is 
capable of producing long-lasting plasticity, thus, it has important clinical applications in 
treatment-resistant conditions. Specifically, low-frequency rTMS is widely used as an inhibitory 
(suppressive) intervention to regulate neural activity, e.g., in stroke, and schizophrenia (Chen et 
al., 1997; Lee et al., 2005; Mansur et al., 2005). Despite its popular use, the underlying neural 
mechanisms of noninvasive brain stimulation remain largely unknown, and its application to 
manage visual-related disorders has received considerably less interest. The advancement of 
neuroimaging techniques permits noninvasive investigation of stimulation on a variety of neural 
mechanisms in humans. This dissertation explores the application of low-frequency rTMS to the 
visual cortex as a therapeutic alternative in visual-related disorders for which there are currently 
no effective interventions. I combine low-frequency rTMS investigation with neuroimaging 
techniques to gain understanding of local rTMS effects at the visual cortex and distal effects 
across the brain.  
Transcranial Magnetic Stimulation 
TMS is an effective neuroscientific stimulation tool to modulate cortical activity and 
plasticity, evaluate connectivity, map brain function, and assess the impact of pharmacological or 
other interventions in healthy control individuals and clinical populations. TMS was first 
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introduced by Barker, Jalinous, and Freeston (1985) as a noninvasive and painless 
neuromodulatory technique based on Faraday’s law of electromagnetic induction (Faraday, 
1832). A rapid pulse of electric current is sent through a conductive TMS wire coil that generates 
a fluctuating magnetic field. Short, rapidly changing magnetic field pulses pass through the coil 
on an individual’s scalp to induce secondary electrical currents in underlying neural tissue 
perpendicular to the current passing through the coil. The rate of change of the magnetic field 
determines the induction of the secondary current in nearby conductors (neural tissue). 
Electromagnetic induction adheres to the inverse cube law—the power of the magnetic field 
decreases exponentially as the distance from the original current increases. Accordingly, the 
induced current in the brain also decreases rapidly with distance from the coil. Because of this, 
the majority of direct TMS stimulation is restricted to superficial layers on the surface of the 
brain, e.g.,  1–2 cm deep with a figure-of-eight coil (Zangen, Roth, Voller, & Hallett, 2005). 
However, single TMS pulses induce the perception of phosphenes (visual sensations of 
unformed lights) by activating the visual cortex (V1) approximately 4 cm deep to the scalp with 
a figure-of-eight coil (Marg & Rudiak, 1994), therefore, direct stimulation of the visual cortex 
may be deeper. TMS coils exist that allow for deeper stimulation (4–6 cm), such as the H and 
double cone coil; however, these coils produce greater diffuse disruption in underlying tissue 
compared with a figure-of-eight coil that has much more focussed stimulation, and they are 
generally less tolerated as they are more painful with deeper stimulation. In addition, coils 
allowing for deeper and more widespread stimulation have potential for a greater range of side 
effects, and their safety or efficacy in high doses of TMS in clinical applications is not well 
studied compared with the figure-of-eight coil. Regardless, superficial areas of the brain closer to 
the plane of the coil will always be exposed to greater induced currents than deeper brain regions 
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(Roth, Amir, Levkovitz, & Zangen, 2007). Effects are local to the area of stimulation and reach 
distal regions from the site of stimulation through axonal projections to functionally and/or 
anatomically connected regions (Lee et al., 2003; Rafique, Solomon-Harris, & Steeves, 2015; 
Reithler, Peters, & Sack, 2011). Thus, the area of the brain stimulated by TMS will affect 
activity in specific brain networks in which the stimulated area is involved and potentially 
between functionally connected networks (Fox et al., 2014).  
Precise neural mechanisms of TMS are yet to be determined. Numerous studies suggest 
that TMS exerts its effect in the gyrus, lip of the gyrus, or in the wall of a sulcus because of their 
proximity to the coil (Day et al., 1989, 1987; Fox et al., 2004; Silva, Basser, & Miranda, 2008). 
The magnetic field strength is found to be largest at the gyral crown; while in white matter, field 
strength has been found to be largest in deeper fibres and is positively related to white matter 
anisotropy (degree of directionality) (Opitz, Windhoff, Heidemann, Turner, & Thielscher, 2011). 
However, since neurons in the gyral crown are perpendicular to the cortical surface, it has been 
suggested that the activation of cortical columns must be achieved indirectly via synaptic inputs 
through an initial activation of horizontally oriented excitatory interneurons (Day et al., 1989, 
1987). The induced electrical current activates a mixture of inhibitory and excitatory neurons 
beneath the coil (for reviews, see Hallett, 2007; Kobayashi & Pascual-Leone, 2003; Wagner, 
Valero-Cabre, & Pascual-Leone 2007). TMS may also actively initiate action potentials in the 
axons of neurons in the cortex and subcortical white matter rather than the cell bodies of cortical 
neurons (which have a much higher threshold). Changes in action potentials may occur via 
changes in membrane resting potentials and thresholds, channel properties with subsequent 
modifications in spontaneous activity through changes in synaptic connectivity, and timing 
dynamics of cellular gating components (Wagner, Rushmore, Eden, & Valero-Cabre, 2009). 
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Modification of cell membranes by TMS leads to depolarisation or hyperpolarisation of neurons 
(Amassian, Eberle, Maccabee, & Cracco, 1992; Nagarajan, Durand, & Warman, 1993). Sites 
where current amplitudes are highest (Wagner et al., 2009) and neuronal thresholds are lowest 
(Ridding & Rothwell, 2007) within the fastest conducting fibres, typically pyramidal tracts 
(Corthout, Barker, & Cowey, 2001; Day et al., 1989, 1987), are considered more susceptible to 
TMS effects. Due to the uncertainty of precise underlying cellular mechanisms, TMS has been 
proposed as exerting its effects by altering noise amongst neurons via the introduction of random 
neural events. Random neural events will bring about a reduction in the strength of the relevant 
neural signal relative to irrelevant background neural noise (Allen et al., 2007). In addition, TMS 
alters the level of neural excitability during (online) and after (offline) stimulation. More 
specifically, with regards to offline TMS, effects are thought to arise from an alteration of 
longer-term excitability of neural cells and networks following stimulation (Thickbroom, 2007). 
Longer-term effects are considered a form of facilitated synaptic plasticity (i.e., long-term 
potentiation [LTP] or long-term depression [LTD] like effects) depending on the stimulation 
parameters (Hallett, 2007; Hoogendam, Ramakers, & Di Lazzaro, 2010; Pell, Roth, & Zangen, 
2010).  
A variety of TMS paradigms are currently available that explore causal relations between 
brain activity and behaviour that are briefly worth mentioning due to their distinguishable 
effects. TMS can be administered in isolated pulses (single-pulse TMS), in pairs of pulses a few 
milliseconds apart (paired-pulse TMS), or repeatedly in a sequence lasting seconds to minutes 
(rTMS). In addition, online TMS protocols refer to cognitive tasks undertaken while TMS is 
being administered. For instance, generating pulses during a language task to disrupt speech 
production (Stewart, Walsh, Frith, & Rothwell, 2001a). Offline TMS protocols refer to studies 
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with or without a task undertaken after TMS has been administered. For instance, assessing 
visual processing after rTMS at rest is an “offline” paradigm (Mullin & Steeves, 2013; Rafique 
et al., 2015; Solomon-Harris, Rafique, & Steeves, 2016).  
Single- and paired-pulse paradigms. Single-pulse paradigms can be used to briefly 
disrupt or excite underlying neural tissue, and are useful for diagnostic and exploratory 
measurements of cortical response (for a review, see Chen et al., 1998) or to determine cortical 
excitability to each pulse, e.g., motor threshold (MT; excitability measure of the motor cortex) 
and phosphene threshold (PT; excitability measure of the visual cortex) (Ray, Meador, Epstein, 
Loring, & Day, 1998; Rossini et al., 1994). Paired-pulse paradigms utilise two isolated pulses 
delivered in close succession and have been used to induce a form of Hebbian learning, where 
the first pulse has a conditioning effect and the effect of the second pulse is dependent on the 
intensity and inter-pulse interval duration. Paired-pulse TMS is therefore useful for examining 
cortical excitation/inhibition ratios and functional connectivity in healthy subjects and in patients 
(for reviews, see Rotenberg, Horvath, & Pascual-Leone, 2014; Udupa & Chen, 2010).  
Repetitive transcranial magnetic stimulation paradigms. rTMS paradigms utilise 
repeated trains of pulses lasting seconds to minutes to induce neural effects that outlast 
stimulation duration. With offline rTMS, we can assess underlying neural mechanisms of longer-
lasting rTMS effects with a variety of neurotechniques, e.g., behavioural tasks, magnetic 
resonance imaging (MRI) (Ridding & Rothwell, 2007; Rossi & Rossini, 2004; Thut & Pascual-
Leone, 2010). rTMS is widely used to transiently disrupt neural activity, enabling researchers to 
modify cortical function during task performance that can reveal causal relations between brain 
regions/activity and behaviour in neurologically intact subjects (e.g., Ganaden, Mullin, & 
Steeves, 2013; Mullin & Steeves, 2011; Pascual-Leone et al., 1998; Wagner et al., 2007). Due to 
 7 
its longer-term effects, rTMS also has valuable therapeutic potential in higher doses in clinical 
applications and will be the protocol of focus in this dissertation. rTMS has important 
implications as a safe and effective means to treat and manage a number of disorders where 
pharmaceutical intervention is ineffective, as well as to evaluate effects on neuroplasticity, for 
example in Parkinson’s disease, mood disorders, schizophrenia, and stoke rehabilitation (e.g., 
Cassidy, Gillick, & Carey, 2014; Freitas, Fregni, & Pascual-Leone, 2009). The effects of rTMS 
and desired manipulation of neural mechanisms are highly dependent on the brain region of 
stimulation, state of neurons prior to stimulation (e.g., potentiated, depotentiated), and rTMS 
parameters.  
Parameters. The magnitude and direction of rTMS effects depends on a variety of 
parameters including the inter-pulse interval, total number of pulses delivered in the stimulation 
session (train length), frequency, and stimulation intensity of pulses. Safety guidelines on 
recommended values of stimulus parameters are provided in a number of reports (Rossi, Hallett, 
Rossini, Pascual-Leone, & The Safety of TMS Consensus Group, 2009; Wassermann, 1998). 
Moreover, the coil configuration, current direction, pulse waveform, and position of the coil with 
respect to the cortex influence rTMS effects (Kozel et al., 2000).  
In rTMS protocols, stimulation pulses are delivered in trains separated by time intervals 
termed the inter-pulse interval. The effect of rTMS pulses is cumulative in the brain as it shows 
dose-dependent effects (Hallett, 2007; Ridding & Rothwell, 2007; Rossi & Rossini, 2004). The 
number of sessions of rTMS used in clinical applications is considerably variable, ranging from 
5–10 sessions (e.g., Manes et al., 2001; Miniussi et al., 2005) to more than 30 sessions (e.g., 
Fitzgerald et al., 2003; O'Reardon et al., 2007; Rumi et al., 2005). Greater cumulative effects are 
associated with a greater number of sessions. A greater number of sessions (> 10) is therefore 
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associated with greater therapeutic effect and continuing improvement in symptoms 
(Goldsworthy, Müller-Dahlhaus, Ridding, & Ziemann, 2014; Holtzheimer et al., 2010; Spronk, 
Arns, & Fitzgerald, 2011). Further, rTMS effects vary with the choice of interval time between 
multiple stimulations (Goldsworthy, Pitcher, & Ridding, 2015; Monte-Silva, Kuo, Liebetanz, 
Paulus, & Nitsche, 2010).  
The stimulation frequency refers to the number of pulses delivered per second and are 
usually between 1 hertz (Hz) (one pulse per second) and 50 Hz (50 pulses per second). Low-
frequency refers to protocols employing < 5 Hz, while high-frequency refers to protocols  5 Hz. 
Lower frequencies are usually applied continuously for periods up to 30 min. Higher frequency 
paradigms are typically applied in a patterned fashion (bursts interrupted by pauses, e.g., 1 s 
stimulation with 20 s inter-pulse interval) for seconds to a few minutes. Traditionally, low-
frequency rTMS is considered “inhibitory” in its effects, whereas high-frequency stimulation is 
viewed as “excitatory”. This traditional view largely arises from animal studies and human 
electrophysiology recordings from motor and frontal cortices (for reviews, see Hallett, 2007; 
Thut & Pascual-Leone, 2010), and from behavioural aftereffects (e.g., Rafique et al., 2016; Rumi 
et al., 2005). Neurophysiological measures (e.g., changes in motor evoked potentials) suggest 
that low-frequency rTMS suppresses excitability of the motor cortico-spinal tract (e.g., Chen et 
al., 1997; Gerschlager, Siebner, & Rothwell, 2001; Houdayer et al., 2008; Touge, Gerschlager, 
Brown, & Rothwell, 2001), while higher frequency stimulation facilitates excitability (e.g., 
Huang, Edwards, Rounis, Bhatia, & Rothwell, 2005; Pascual-Leone, Valls-Solé, Wassermann, & 
Hallett, 1994; Peinemann et al., 2004). However, these frequency-dependent effects are far too 
simplistic and have become a misinformed generalisation for aftereffect predictability (Allen, 
Pasley, Duong, & Freeman, 2007). Both low- and high-frequency rTMS are observed to produce 
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an elevating antidepressant effect in medication-resistant major depression (Fitzgerald et al., 
2003). Similarly, both high- and low-frequency paradigms have been used to disrupt cognitive 
function (Brückner, Kiefer, & Kammer, 2013; Ko et al., 2008; Mullin & Steeves, 2011; Rafique 
et al., 2015). Several studies have demonstrated that the inter-pulse interval also plays a role in 
the direction of rTMS effects. For example, theta burst stimulation (TBS), a variant of high-
frequency rTMS, applied intermittently (e.g., 2 s of stimulation every 10 s) leads to facilitated 
excitability; and when it is applied continuously (e.g., 40 s), it leads to a suppression in 
excitability (Huang et al., 2005). The influence these inter-pulse intervals exert is likely a result 
of metaplasticity (i.e., ability of the synapse to undergo a secondary plastic change following the 
recent induction of plasticity). Moreover, findings on rTMS aftereffects from animal studies have 
been relatively inconsistent with those in human studies because of differences in techniques 
(e.g., invasive methods used in animals compared to noninvasive methods in humans) and 
heterogeneity among species (for a review, see Goldsworthy et al., 2015). Further, TMS effects 
are considered to be activity dependent (state-dependency), suppressing the most active neurons 
and changing the balance between excitation and inhibition (Pasley, Allen, & Freeman, 2009; 
Perini, Cattaneo, Carrasco, & Schwarzbach, 2012). 
For TMS to be effective, the stimulation intensity determines the potential of the 
magnetic field that induces electrical currents in neurons of underlying neural tissue. This 
intensity is expressed as a percentage of the maximal output percentage, and the choice of 
intensity depends on the stimulation site. For most cortical regions (excluding the visual cortex), 
the MT is commonly used (Pridmore, Filho, Nahas, Liberatos, & George, 1998; Rossini et al., 
1994). The MT is obtained by applying single-pulses to the motor cortex in a stepwise variation 
of the output intensity of the device and is defined as the minimal output intensity which yields a 
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motor response (e.g., produce muscle contraction in small muscles of the hand) in at least half of 
the applied trials. Stimulation intensity for the visual cortex is largely based on the PT. Pulses are 
applied to the visual cortex in a similar manner to the motor cortex until phosphenes are 
perceived. The PT is the minimum intensity of TMS to the visual cortex that elicits the 
perception of phosphenes (transient perception of unformed lights) in at least half of delivered 
pulses (Elkin-Frankston, Fried, Pascual-Leone, Rushmore III, & Valero-Cabré, 2010). Both MT 
and PT provide indirect measures of neural excitability, and are considered established methods 
to calibrate and normalise TMS coil output for individual neurophysiological variability. These 
threshold measures determine dose and safety limits with regards to adverse effects and its 
efficacy in stimulating neurons (Rossi et al., 2009; Wassermann, 1998). Lower intensities of 
low-frequency may induce inhibition and higher intensities may produce facilitation (Classen & 
Stefan, 2008; Fox et al., 1997; Nahas et al., 2001), whereas lower intensities of high-frequency 
rTMS reduce excitability (Paus et al., 1998; Siebner, Rossmeier, Mentschel, Peinemann, & 
Conrad, 2000b). 
Neurobiochemical effects. Ultimately, parameter-dependent TMS effects arise via 
neurobiochemical responses to the pulse(s). Neurobiochemical responses to stimulation drive the 
overall effect to form the basis of therapeutic intervention (for a review, see Hoogendam et al., 
2010). Much of our knowledge of biochemical effects of low- and high-frequency rTMS stem 
from invasive animal studies, thereby limiting translation of results. In general, high-frequency 
protocols have received greater attention due to their desired aftereffects in a variety of 
neurological and psychological disorders (e.g., stroke, schizophrenia) and approved application 
in mood disorders (e.g., depression). A brief overview of known high- and low-frequency 
biochemical aftereffects is provided here.  
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In vitro rat and cat studies show high-frequency rTMS to the hippocampus and visual 
neocortex induces N-methyl-D-aspartate (NMDA) glutamate receptor-mediated LTP (long-
lasting strengthening of synaptic efficiency), while low-frequency protocols induce LTD (long-
lasting decrease in the strength of synapses) (Dudek & Bear, 1992; Kirkwood, Dudek, Gold, 
Aizenman, & Bear, 1993). Long trains of low-frequency stimulation are capable of inducing 
LTD lasting for hours (Dudek & Bear, 1992; Mulkey & Malenka, 1992). Long-lasting effects are 
also observed in human studies, where stimulation to the prefrontal cortex and motor cortex is 
shown to induce effects lasting up to a year (e.g., Dunner et al., 2014; Liepert, Bauder, Miltner, 
Taub, & Weiller, 2000). However, the effects are not consistent across cortical/subcortical sites 
or even in subregions, e.g., in layers of the cat visual cortex (Bear & Kirkwood, 1993; Komatsu, 
Fujii, Maeda, Sakaguchi, Toyama, 1988). Similar inconsistent effects are observed between 
different low-frequency protocols in the rat and cat hippocampus and visual neocortex (e.g., 1 Hz 
versus 3 Hz; Kirkwood et al., 1993). The amino acid neurotransmitters glutamate and γ-
Aminobutyric acid (GABA) modify the membrane potential of the receptive neuron. Glutamate 
and GABA have opposing excitatory and inhibitory effects, respectively, and modulate the 
induction of LTP and LTD (for a review, see Lüscher & Malenka, 2012). Electrical stimulation 
can exert excitatory or inhibitory cortical effects at the stimulated area via glutamate (NMDA) 
and GABA receptor activity (for a review, see Bear & Malenka, 1994). These effects on 
GABAergic and glutamatergic systems are additionally relatively inconsistent between high- and 
low-frequency protocols, and duration of stimulation. However, human and rat studies of the 
subcortex, motor and prefrontal cortices suggest that low-frequency is thought to act on 
GABAergic mechanisms and high-frequency on glutamate systems (Michael et al., 2003; Stagg 
et al., 2009b; Yue, Xiao-Lin, & Tao, 2009).  
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High-frequency rTMS protocols (e.g., 25 Hz versus 15 Hz) to frontal brain regions also 
have variable effects on monoamines (e.g., serotonin, norepinephrine, dopamine, and associated 
metabolites) in the rat brain (Ben-Shachar et al., 1997, 1999; Keck et al., 2002) and humans 
(Strafella et al., 2001), as well as on messenger ribonucleic acid (mRNA) expression of 
monoamine transporter genes (Ikeda, Kurosawa, Uchikawa, Kitayama, & Nukina 2005). The 
rTMS-induced modulation of dopamine in humans may be a consequence of direct stimulation 
via glutamate (Strafella, Paus, Fraraccio, & Dagher, 2003), or indirectly via GABA-mediated 
activity (for a review, see Pascual-Leone et al., 1998). An increase in dopaminergic 
neurotransmission with high-frequency rTMS is in line with the therapeutic effects of rTMS in 
the treatment of conditions implicating dopamine including affective disorders (e.g., Schutter & 
van Honk, 2005) and Parkinson’s disease (e.g., Lomarev et al., 2006).  
Chronic high-frequency rTMS in the rat brain is observed to increase brain-derived 
neurotrophic factor (BDNF) mRNA and BDNF-like immunoreactivity across the brain, as well 
as protect against oxidative stressors (e.g., high glutamate concentrations) that cause neuronal 
damage and neurotoxic effects (Müller, Toschi, Kresse, Post, & Keck, 2000; Post, Müller, 
Engelmann, & Keck, 1999). High-frequency rTMS demonstrates gene expression of glial 
fibrillary acidic protein in the murine central nervous system in mice (Fujiki & Steward, 1997) 
that is associated with recovery such as synaptic reorganisation (Steward, Torre, Phillips, & 
Trimmer, 1990). In contrast, low-frequency rTMS to the rat motor cortex and hippocampus 
demonstrates no significant differences in glial fibrillary acidic protein (Liebetanz et al., 2003).  
Associations between regional cerebral blood flow and local cerebral glucose metabolism 
are well established. Increased glucose levels correlate with greater energy consumption and 
accordingly greater neuronal (mainly synaptic) activity (for reviews, see Heeger & Ress, 2002; 
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Jueptner & Weiller, 1995). During high- and low-frequency rTMS to the visuoparietal cortex in 
anaesthetised cats, (14C)2-deoxyglucose uptake is significantly reduced in the stimulated cortex 
and in remote cortical and subcortical networks compared with the contralateral hemisphere 
(Valero-Cabré, Payne, & Pascual-Leone, 2007). (14C)2-deoxyglucose is considered a close 
correlate of neuronal presynaptic activity (Kennedy et al., 1975). A greater effect is observed for 
high- than low-frequency rTMS. However, immediately following cessation of high-frequency 
rTMS, (14C )2-deoxyglucose uptake is increased in the stimulated cortex only. Conversely, 
(14C)2-deoxyglucose uptake remains attenuated following cessation of low-frequency rTMS in 
the stimulated cortex with mild effects in subcortical regions compared with the contralateral 
hemisphere. These findings suggest that during rTMS (high- and low-frequency) neuronal firing 
may be suppressed, with a greater suppressive effect with high-frequency rTMS. Yet, local and 
distal effects are highly dependent on the stimulation parameters in that suppression versus 
facilitation of neuronal firing is frequency-dependent (1 Hz versus 20 Hz, respectively). 
Magnetic resonance spectroscopy (MRS) measures of glucose however show no change in 
glucose at the stimulation site following 1 Hz low-frequency rTMS in rats (Liebetanz et al., 
2003). In human subjects, 18fluoro-deoxyglucose positron emission tomography (PET) provides 
a noninvasive alternative and shows an increase in normalised regional cerebral metabolic rate 
for glucose following 2 Hz low-frequency rTMS to the sensorimotor cortex (Siebner et al., 
2001).  
In summary, rTMS can induce changes in neuromodulator (neurotransmitters and 
metabolites) release, synaptic efficiency, signalling pathways, and in gene transcription. Effects 
of rTMS are specific to brain regions and/or networks and stimulation parameters. Variability 
between study methods including rTMS parameters, stimulation schedules, stimulation sites, 
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stimulation coils, differences in technique sensitivity of rTMS effects, and the use of different 
animal models limits comparability of rTMS effects. Moreover, a larger proportion of studies 
investigate high-frequency rTMS to frontal and motor cortices for therapeutic treatment in 
several psychological and neurological disorders. Further research is needed on low-frequency 
rTMS across the bran in human studies. Noninvasive in vivo investigation of neurobiochemical 
effects in humans has also been limited post-rTMS. However, with advancing noninvasive 
neuroimaging techniques in humans and a growing number of studies, a greater variety of rTMS 
parameters have been exploited with more detailed probing of effects, revealing complex effects 
that are not simply predicted by frequency of stimulation. This increasing number of techniques 
and parameter choices have also added to the variety of inconsistent effects that vary across brain 
regions within humans. rTMS effects on the visual cortex are even less investigated, and thus the 
application of TMS in visual disorders has received little attention. Knowledge of biochemical 
mechanisms of rTMS has important implications for predicting effects in humans, predominantly 
for validating causal inferences of brain function/regions and developing therapeutic 
applications. Depending on the disorder in question and its associated altered mechanisms, the 
desired neurobiochemical response will be highly dependent on the rTMS protocol. 
Magnetic Resonance Imaging 
MRI provides a method of noninvasive investigation of cortical and subcortical structure 
and activity. Brain regions form a complex integrative network in which information is 
continuously processed and transported between structurally and/or functionally linked brain 
regions. Due to the complexity, a number of neuroimaging techniques sensitive to a variety of 
measures are necessary to gain better overall understanding of neuroarchitecture. Identifying 
group differences between healthy control subjects and those with impairments using MRI can 
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segregate functional and structural abnormalities underlying different disease states from which 
we can infer changes. This knowledge could in turn lead to identification of 
diagnostic/prognostic markers, new treatments, or drug targets. For instance, a lesion will not 
only affect the implicated region and nearby regions, but it will also affect the functional and 
structural network architecture of areas in both hemispheres distant from the lesion (Hummel et 
al., 2005; Murase, Duque, Mazzocchio, & Cohen, 2004; Nomura et al., 2010; Rafique, Richards, 
& Steeves, 2016, 2018). The combination of noninvasive brain stimulation with neuroimaging 
offers a valuable means to explore how rTMS impacts the human brain, providing new insights 
into the changeability of functional and structural brain networks, and efficacy of rTMS as a 
therapeutic tool in clinical populations. Neuroimaging highlights the neurophysiological 
response to stimulation at the targeted cortex, whether it be disruptive or facilitative. For 
instance, functional MRI (fMRI) demonstrates that stimulation to a given brain region typically 
induces significant inhibitory or excitatory changes in the activity of regions distal from the coil, 
but which are anatomically and/or functionally connected to the targeted stimulation region (e.g., 
Lee et al., 2003; Rafique et al., 2015; Solomon-Harris et al., 2016). In this dissertation, I use a 
number of neuroimaging techniques (fMRI, MRS, diffusion imaging) to identify neural 
mechanisms of low-frequency rTMS to the visual cortex and determine its efficacy for 
development of therapeutic protocols in visual-related disorders. The techniques employed are 
also well suited to longitudinal studies and for monitoring treatment effects. For example, we can 
examine the effect of clinical intervention (e.g., rTMS) by comparing pre- and post-treatment 
data (e.g., Inzitari et al., 2009; Kunimatsu et al., 2003).  
Functional magnetic resonance imaging. fMRI is a noninvasive technique for 
measuring brain activity and understanding function of brain regions. fMRI assesses changes in 
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blood oxygen level-dependent (BOLD) signal to identify areas of increased or decreased 
neuronal activity (Logothetis, 2003; Raichle & Mintun, 2006). BOLD signal arises from the 
magnetic properties of haemoglobin that are dependent on brain metabolism, blood flow, and 
essential changes in neuronal excitability (Logothetis & Wandell, 2004; Raichle & Mintun, 
2006). Regional changes in brain activity can be inferred throughout the brain by assessing 
changes in the BOLD signal that indicate the direction (increase or decrease) of neuronal 
activity, and allowing the researcher to make inferences about the contribution of a cortical area 
or its interconnected region to a distinct brain function. As the brain consists of functionally 
interconnected nodes within a network, fMRI offers insights into the overall organisation of 
functional communication in the brain network and how regions with different functions 
communicate. 
Task-based functional magnetic resonance imaging. Typical fMRI research focusses on 
the change in BOLD signal caused by the neural response to an externally controlled stimulus 
(i.e., neural response to a task). The fMRI signal during processing of a task is contrasted with 
fMRI acquisition during a baseline or control condition, resulting in the relative signal change 
because of the specific process being studied. Task-based fMRI provides information about 
regions that are engaged/disengaged in different functions (i.e., tasks), for example, visual 
processing of scenes compared to objects. 
Resting-state functional magnetic resonance imaging. At rest, in the absence of explicit 
input or output demands (i.e., task engagement), the brain remains functionally and metabolically 
active. One index of this intrinsic activity is the spontaneous fluctuations of low-frequency 
oscillations (∼0.01–0.1 Hz; Biswal et al., 1995, 1997) in the BOLD signal of fMRI (for reviews, 
see Fox & Raichle, 2007; van den Heuvel & Hulshoff Pol, 2010). Identification and correlation 
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of patterns in these spontaneous fluctuations between functionally and/or anatomically distinct 
regions is termed resting-state functional connectivity (rsFC). rsFC therefore highlights intrinsic 
functional connectivity among cortical and subcortical networks (Aertsen, Gerstein, Habib, & 
Palm, 1989; Friston, Frith, Liddle, & Frackoqiak, 1993; Friston, Jezzard, & Turner, 1994). 
Support for the neural basis of resting-state fMRI (rsfMRI) comes from the observation that most 
resting-state patterns occur between brain regions that overlap in both function and 
neuroanatomy, for example, regions of the motor, visual, and auditory networks (Biswal et al., 
1995; Damoiseaux et al., 2006; Lowe, Dzemidzic, Lurito, Mathews, & Phillips, 2000; van den 
Heuvel, Mandl, & Hulshoff Pol, 2008).  
rsfMRI holds tremendous potential to greatly increase the translation of fMRI into 
clinical care and improve the clinical applicability of fMRI (Fox & Greicius, 2010; Fox & 
Raichle, 2007). During resting conditions, the brain consumes ~20% of the body’s energy, of 
which a considerable amount supports ongoing neuronal signalling (Ames III, 2000; Attwell & 
Laughlin, 2001; Shulman, Rothman, Behar, & Hyder, 2004). Task-related increases in neuronal 
metabolism are considerably small (< 5%) compared to the larger resting-state energy 
consumption (Raichle & Mintun, 2006). Fox and Greicius (2010) report that differences in task-
related changes between normal and pathological populations are even smaller (< 1%). 
Therefore, studying resting-state conditions to investigate pathophysiology can be much more 
valuable as focus is on a greater proportion of neural brain activity than studying task-related 
changes (Fox & Greicius, 2010).  
Although task-based fMRI remains extremely valuable to determine function of brain 
regions, rsfMRI also minimises limitations associated with task-based fMRI. We undertake a 
wide array of tasks on a daily basis incorporating multiple interchanging brain networks that 
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would be extremely difficult to fully assess and account for in pathophysiology given that it 
would require a countless number of diverse task manipulations. The incorporation of numerous 
task-based fMRI experiments is additionally time consuming and a considerable expense due to 
high MRI costs. Further difficulties arise in interpreting results between different task data sets 
and after treatment due to a number of confounds (Fox & Greicius, 2010). For example, a single 
task involves a variety of cognitive processes and it can be difficult to discern changes between 
different brain regions with overlapping function if task demands are not precisely controlled for. 
rsfMRI also avoids task performance confounds between individuals and groups because there is 
a reduced need for participant compliance (e.g., task engagement and responsiveness). In 
cognitive dysfunction, physical, or visual impairment, many patients cannot accurately perform 
tasks in the MRI scanner. Resting-state removes task performance confounds that may occur in 
these patients if undertaking a task and places only minimal demands on the patient (Fox & 
Greicius, 2010). Specifically, in the case of visual disorders, for example visual pathway 
damage, there is potential for extensive visual loss which may reduce accuracy of fixation and 
impair simple viewing. As intrinsic neural activity provides insight into neural processing that 
encompasses the majority of the brain’s resources, it not only provides a richer source of disease-
related signal changes but also a means of studying multiple cortical systems at once.  
Diffusion tensor imaging. White matter tracts enable connectivity between spatially 
separate regions. Diffusion imaging is currently the only noninvasive technique available to 
reconstruct, visualise, and characterise the architecture of white matter fibre tracts. Diffusion 
tensor imaging (DTI) measures the diffusion profile of water molecules through fibres that are 
influenced by underlying microstructure rather than directly capturing anatomical structures of 
axons. DTI relies on the principle that water molecules diffuse differently along tissues 
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depending on their type, integrity, architecture, and barriers (e.g., cell membranes, myelin 
sheaths, and microtubules), providing information about their orientation and quantitative 
anisotropy (Beaulieu, 2002; Chenevert, Brunberg, & Pipe, 1990; Moseley et al., 1990). A 
number of images, each sensitised to diffusion in a different direction, are used to determine the 
rate and orientation of water diffusion in a given voxel that is summarised in a diffusion tensor 
model (Mori & Zhang, 2006). Faster diffusion will occur along a fibre tract rather than 
perpendicular to it, giving rise to diffusion anisotropy (directionally-dependent). The particular 
orientation of axons leads to the segregation of specific fibre tracts in order to map axonal 
orientations, thereby enabling measurement of white matter properties and microstructure in 
vivo. Accordingly, anisotropy in cerebral organisation for white matter tracts corresponds to the 
main axonal fibres connecting cortical areas. Direct association is determined between functional 
and structural connectivity in the human brain by combining fMRI with DTI (e.g., Hagmann et 
al., 2008; Koch, Norris, & Hund-Georgiadis, 2002). Microstructural organisation of white matter 
tracts is found to be directly related to the level of functional connectivity between regions (van 
den Heuvel et al., 2008). Regions with a higher level of structural connectivity show a higher 
level of functional connectivity (Hagmann et al., 2008; Honey et al., 2008). Pathological 
processes can alter structural organisation either by injury, regeneration of cell membranes, or 
via change in cellularity (e.g., scarring, inflammation, cell infiltration) that impact diffusivity 
(Bammer, 2003). DTI can therefore provide insight in damaged nerve fibres that connect an area 
of the brain affected by injury and regions that are distant from it. Moreover, DTI can provide 
information on the presence of abnormal or new aberrant connections resulting from damage 
(e.g., Arfanakis et al., 2002; Rafique et al., 2018; Wong et al., 2018).  
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Identified pathways can be interpreted quantitatively using indices inferring diffusion 
properties in each voxel. Diffusion tensor indices combine contributions from the different sub-
compartments of white matter into a single metric that characterises different aspects of diffusion 
and is useful in making implications regarding white matter connectivity and structure (Jones, 
Knösche, & Turner, 2013). Fractional anisotropy (FA) represents the directional preference of 
diffusion and describes the degree of directionality (anisotropy) of diffusion using a scalar value 
between zero and one. FA values close to zero represent isotropic regions, that is, unrestricted 
water movement that will diffuse in all directions. FA values approaching one represent 
anisotropy, that is, restricted water diffusion in one direction (Mori & Zhang, 2006). Mean 
diffusivity (MD) is a measure of the average rate of diffusion per voxel or the molecular 
diffusion rate. Axial diffusivity (AD) represents the degree of diffusion parallel to the main axis 
of diffusion. Lastly, radial diffusivity (RD) is a measure of diffusion perpendicular to the axon 
(Mori & Zhang, 2006). Diffusion in white matter is more restricted along the axon and tends to 
be anisotropic, whereas in grey matter diffusion is less anisotropic, and in cerebrospinal fluid 
diffusion is unrestricted in all directions and is therefore isotropic (Hagmann et al., 2006; 
Pierpaoli & Basser, 1996; Pierpaoli, Jezzard, Basser, Barnett, & Di Chiro, 1996).  
Diffusion pathways can also be interpreted qualitatively to infer the extent and the 
general course of certain fibre bundles. Tractography is a three-dimensional (3D) modelling 
technique that enables qualitative visualisation and quantification of fibre tracts based on 
statistical inferences as true anatomy of nerve fibres cannot be directly reconstructed. Computed 
trajectories or pathways in tractography are determined by following from voxel to voxel the 
direction of maximum diffusion coherence. Tractography results are considered to run 
reasonably parallel to a large portion of the nerve fibres (for a review, see Soares, Marques, 
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Alves, & Sousa, 2013) and correspond well with post-mortem dissection studies (Lawes et al., 
2008). 
Magnetic resonance spectroscopy. Proton (1H) MRS enables noninvasive in vivo 
quantification of neurotransmitter concentrations and of other neurometabolites (molecules 
involved in a neuronal metabolic process) within a localised region (voxel). 1H MRS measures 
the magnetic properties and energies of protons in nuclei of various chemical compounds (e.g., 
metabolites). MRI pulse sequences consist of a combination of radiofrequency and gradient 
pulses arranged in a specific order to excite, detect, and encode resonance signals. Nuclei found 
in matter (e.g., brain tissue) in a magnetic field (e.g., MRI) absorb the executed MR pulse and 
emit electromagnetic radiation in the radiofrequency range. Nuclei from the same chemical 
compound will absorb and emit radiofrequency energy at different frequencies depending on the 
chemical environment surrounding the nuclei (Dickinson, 1950a, 1950b; Protor & Yu, 1950). 
Therefore, metabolites will emit signals of a chemically specific frequency based on their 
molecular structure. 1H MRS detects the radiofrequency signals that arise from tissue metabolites 
within the localised region of interest. Resonance signals are then processed into images or 
spectra that reflect properties of the metabolite of interest (Puts & Edden, 2012). MRS identifies 
a number of metabolites by their discrete peak or a set of peaks in the frequency spectrum 
(Pfeuffer, Tkáč, Provencher, & Gruetter, 1999). Change in neurotransmitter and neurometabolite 
concentrations provides insight into neurobiochemical processes underlying pathological 
processes or following treatment (e.g., neuromodulation with noninvasive brain stimulation). 
Clinical Application of Noninvasive Brain Stimulation  
Noninvasive brain stimulation induces plasticity allowing modification of cortical 
networks. Thus, noninvasive brain stimulation provides a valuable tool to investigate and 
 22 
manipulate neural mechanisms to promote recovery of brain function in neurological and 
psychological disorders. In higher doses for therapeutic application, it can elicit significant 
neurophysiological and behavioural aftereffects outlasting stimulation itself (for a review, see 
Wassermann & Lisanby, 2001). Plasticity is retained throughout life and enables modification of 
function and structure in response to environmental demands via strengthening, weakening, 
pruning, recruitment of synaptic connections, and by promoting neurogenesis (for a review, see 
Pascual-Leone, Amedi, Fregni, & Merabet, 2005). Plasticity is essential to forming and 
maintaining brain circuitry in the absence of pathophysiology, yet it is also necessary to enable 
acquisition of new skills and adaptation after injury via compensatory recruitment of healthy 
circuitry and networks (e.g., Carmichael, 2003; Cramer, 2008). However, maladaptive plasticity 
processes can give rise to disability and symptoms of pathophysiology. Local pathophysiological 
changes cause maladaptive network dynamics through interconnected regions leading to 
widespread dysfunction in networks and remote regions (for a review, see Fox & Greicius, 
2010). Noninvasive brain stimulation can manipulate mechanisms involved in deficits and 
promote recovery of brain functionality. Clinical therapeutic protocols of targeted stimulation to 
a brain region typically fall under three distinct categories (Horvath, Najib, & Press, 2014): (1) 
directly target the specific area of dysfunction that is considered to be a critical functional node 
in a network driving the dysfunctional behaviour of interest. The aim is to modulate cortical 
excitability and normalise aberrant activity by either up-regulating pathologically under-excited 
tissue (e.g., Avery et al., 2006; Ward & Cohen, 2004) or down-regulating pathologically over-
excited tissue (e.g., Hummel & Cohen, 2006; Fregni & Pascual-Leone, 2007; Rafique et al., 
2016). (2) Target a distal area functionally connected to the area of dysfunction and normalise 
aberrant activity via excitation or inhibition, for instance, if the dysfunctional region is too deep 
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to reach directly with noninvasive brain stimulation. (3) Modulate distributed brain activity via 
network-specific release of neurotransmitters to normalise aberrant activity. 
 The number and type of neurological and psychological conditions being treated with 
noninvasive brain stimulation, particularly rTMS, is ever increasing. rTMS is accepted as a safe 
and effective method with minimal adverse effects, if used within safety limits (Rossi et al., 
2009; Wassermann, 1998), for rehabilitation and therapeutic intent long-term in a number of 
disorders where pharmaceutical intervention is ineffective (e.g., Hallet, 2007; Kobayashi & 
Pascual-Leone, 2003; Ridding & Rothwell, 2007; Rossi & Rossini, 2004). In addition, 
stimulation parameters employed to treat these conditions are continuously evolving. In cases 
where rTMS is applied for therapeutic purposes, the classic approach involves a stimulation 
session provided daily over consecutive days usually for a period of 2–6 weeks. Aftereffects of 
these longer doses of stimulation have been reported to last months (Bortolomasi et al., 2007; 
Liepert et al., 2000a; Triggs et al., 1999) and even up to one year (Dunner et al., 2014). Repeated 
daily applications of stimulation have cumulative effects on the induction/maintenance of 
neuroplastic changes (e.g., Bäumer et al., 2003; Dunner et al., 2014). More recently, accelerated 
(or within-session) stimulation has been proposed as an alternative to the classical approach, 
where multiple spaced stimulation sessions are provided in a single day over consecutive days, 
but for fewer days/weeks than the classical approach. The interval at which spaced stimulation is 
applied critically influences the neuroplastic response (Monte-Silva et al., 2013, 2010). Spaced 
intervals of stimulation produce more long-lasting effects than simply extending the length of 
stimulation protocols (Gamboa, Antal, Moliadze, & Paulus, 2010; Monte-Silva et al., 2013, 
2010). Increasing the number of spaced stimulation sessions disproportionately extends the 
duration of induced neuroplastic changes. Additionally, spaced noninvasive brain stimulation 
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aftereffects in human studies are found to be more stable, possibly owing to a consolidation of 
longer-term plasticity effects (e.g., Cazzoli et al., 2012; Nyffeler, Cazzoli, Hess, & Müri, 2009).  
The application of noninvasive brain stimulation in disorders with known disease 
mechanisms has advanced our understanding by measuring biochemical and behavioural changes 
that occur following stimulation. However, despite established protocols and effects, 
mechanisms and evidence of efficacy are lacking, mainly due to the inconsistency of stimulation 
parameters and absence of long-term follow-up with neuroimaging. As mentioned previously, 
different stimulation paradigms have substantially different effects on plasticity. This is of 
considerable importance in clinical contexts as the choice of paradigm will depend on its 
underlying effect and the pathological mechanism one intends to modulate.  
Non-visual disorders. TMS devices and protocols have received United States Food and 
Drug Administration, and European Union approval for the treatment of medication-resistant 
depression, and presurgical motor and speech mapping. In Europe, several devices have been 
awarded European CE Mark approval and are increasingly used for diagnostic and therapeutic 
indications in clinical practice. Clinical trials of TMS are currently underway in a number of 
countries exploring the effects in diverse conditions including autism, epilepsy, migraine, 
tinnitus, stroke recovery, schizophrenia, obsessive compulsive disorder, Parkinson’s and 
Alzheimer’s disease (Cassidy et al., 2014; Freitas et al., 2009; George, Lisanby, & Sackeim, 
1999; Ridding & Rothwell, 2007; Wassermann & Lisanby, 2001).  
For instance, in stroke, neuroimaging studies demonstrate hyperactivity in the 
contralesional motor cortex and interhemispheric inhibition between motor cortices that is 
greater in those with a poorer prognosis (Murase et al., 2004; Ward, Brown, Thompson, & 
Frackowiak, 2003). rTMS restores imbalanced cortical activity across hemispheres leading to 
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functional improvement in the paretic limb either by facilitating the lesioned hemisphere using 
high-frequency protocols (10 Hz rTMS or intermittent TBS; Kim et al., 2006; Talelli, 
Greenwood, & Rothwell, 2007), or by down-regulating the contralesional hemisphere using low-
frequency protocols (1 Hz rTMS; Fregni et al., 2006; Mansur et al., 2005; Takeuchi et al., 2008). 
Most rTMS studies in depression to date have been performed by means of applying high-
frequency (5–20 Hz) stimulation to the left prefrontal cortex to produce an 
antidepressant/elevating effect by exciting the depressed activity (e.g., Avery et al., 2006; 
O'Reardon et al., 2007). However, low-frequency (1 Hz) rTMS to the right prefrontal cortex 
elicits a similar reduction in depressive symptoms (Fitzgerald et al., 2003). Both treatment 
modalities in depression appear to be equally efficacious (Fitzgerald, Hoy, Daskalakis, & 
Kulkarni, 2009). Based on a meta-analysis of randomised controlled rTMS studies in depression, 
it is suggested that low-frequency rTMS might even be more beneficial than high-frequency 
rTMS as low-frequency is better tolerated, e.g., patients reported fewer headaches. Low-
frequency protocols may also minimise the risk of inducing adverse events like seizures 
(Schutter, 2010). 
Visual disorders. The visual system comprises the most complex circuitry of all the 
sensory systems and possesses the ability to undergo induced and spontaneous neuroplastic 
changes. Numerous distinct unimodal areas are involved in visual processing in the macaque and 
human brain (Felleman & Van Essen, 1991; Tootel, Dale, Sereno, & Malach, 1996). Different 
levels of visual processing are coded in different regions—such as oriented lines and edges, 
colour, to more complex movement and form—and each visual processing region presents with 
distinct anatomical properties and functional connectivity patterns. Very few studies so far have 
investigated the effects of noninvasive brain stimulation in visual disorders.  
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In amblyopia, low- and high-frequency rTMS to the visual cortex significantly improves 
contrast sensitivity (Clavagnier, Thompson, & Hess, 2013; Thompson, Mansouri, Koski, & Hess, 
2008) with long-lasting effects > 2 months (Clavagnier et al., 2013). Similarly, tDCS to the 
visual cortex also shows improvement in contrast sensitivity in amblyopia, but this effect is only 
transient (Spiegel, Byblow, Hess, & Thompson, 2013). tDCS has been explored as potential 
treatment in visual field loss related to cerebral stroke. tDCS applied over the visual cortex in 
combination with vision restoration training is shown to facilitate regaining parts of the visual 
field and accelerating recovery time following stroke (Gall et al., 2015; Plow et al., 2011). These 
results are consistent with findings from stroke-related motor and speech rehabilitation 
demonstrating improved performance with adjunct therapies of noninvasive brain stimulation 
(e.g., Seniów et al., 2013; Takeuchi et al., 2008). Similarly, tDCS to parieto-occipital cortex 
combined with blindsight rehabilitation in homonymous hemianopia shows better functional 
outcome than rehabilitation on its own (Alber, Moser, Gall, & Sabel, 2017; Halko et al., 2011; 
Matteo et al., 2017). 
Aftereffects of tDCS are thought to be relatively short-lasting compared to rTMS, and 
more so in visual areas compared to the motor cortex using equivalent stimulation parameters 
(Antal, Paulus, & Nitsche, 2011). Visual and motor cortices vary in factors influencing 
neuroplasticity and excitatory/inhibitory systems. There are differences in cortical connections 
and neuronal membrane properties (e.g., receptor expression), and these may account for the 
dissimilar responses of tDCS in the motor and visual cortices (Creutzfeldt, Fromm, & Kapp, 
1962). Moreover, rTMS allows for more focal and therefore targeted stimulation compared to 
tDCS (Woods et al., 2016). Therefore, rTMS may provide a better neuromodulatory tool for 
clinical applications, particularly in visual-related disorders. 
 27 
Visual hallucinations. A secondary consequence of vision loss that has received limited 
investigation into therapeutic intervention, and would benefit from noninvasive brain 
stimulation, is visual hallucinations that occur in otherwise cognitively healthy individuals 
(Kölmel, 1985; Lepore, 1990). Visual hallucinations are involuntary visual perceptions in the 
absence of an external stimulus. This perception is considered to arise from widespread 
miscommunication within neural circuitry, for example, disturbance of input or processing 
(Adachi, Watanabe, Matsuda, & Onuma, 2000; Anderson & Rizzo, 1994; Behrendt, 2003; 
ffytche et al., 1998). Dysfunction of part of the network involved in processing visual 
information has downstream effects on perception and is considered to give rise to the visual 
hallucinations (ffytche & Howard, 1999). However, underlying mechanisms are yet to be 
confirmed as there is little evidence from neuroimaging in cases of hallucinations following 
visual pathway damage. Visual hallucinations can be differentiated into two main categories 
(Baier et al., 2010; Santhouse, Howard, & ffytche, 2000): simple hallucinations/phosphenes, and 
complex hallucinations otherwise referred to as Charles Bonnet syndrome. The type of 
hallucinatory image is related to the site of damage along the visual pathway, and/or the visual 
processing function of the implicated region(s). Phosphenes consist of unstructured lights—such 
as flashes and unformed images—and are thought to relate to pathology of the primary visual 
cortex and optic radiations (Anderson & Rizzo, 1994), but also arise in certain eye diseases (e.g., 
optic neuritis; Davis, Bergen, Schauf, McDonald, & Deutsch, 1976). Complex visual 
hallucinations are structured images—such as objects, scenes, people, and animals—and are 
thought to have underlying pathology in visual associative cortices and temporo-parieto-occipital 
regions, but can also occur following degenerative eye disease (e.g., glaucoma, age-related 
macular degeneration) (Manford & Andermann, 1998; Santhouse et al., 2000; Vaphiades, 
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Celesia, & Brigell, 1996). The type of hallucinatory image seen by an individual can be variable 
and change over time.  
Patients with hallucinations in the absence of hallucinogenic agents (e.g., alcohol, 
recreational drugs, antipsychotics) or underlying neuropsychiatric disease (e.g., Alzheimer’s 
disease, Parkinson’s disease, dementia with Lewy bodies, schizophrenia) are aware that the 
hallucinations are fictitious. Visual hallucinations associated with vision loss are more prevalent 
than commonly thought, with the most common occurrence among acute cases. Studies report a 
prevalence of 10–50% depending on the site of damage (e.g., Baier et al., 2010; Gordon, 2016). 
In many cases the phenomena dissipate with time (Kölmel, 1985; Manford & Andermann, 1998), 
but for others the hallucinations persist chronically and may worsen rather than improve over 
time. Persistent visual hallucinations lasting for more than five years are reported in 75% of 
patients with Charles Bonnet syndrome; and 32% report adverse outcomes including fear, 
negative impacts on daily activities, and contribution to the onset of psychological illness such as 
anxiety and depression (Cox & ffytche, 2014). In persistent hallucinations, the experience of the 
abnormal percept is both mentally and physically exhausting. For instance, patients have trouble 
discerning real stimuli from overlapping hallucinatory images despite being fully aware the 
hallucinatory images are not real. The presence of a hallucinatory image requires constant 
cognitive effort in continuously trying to ignore the hallucination resulting in exhaustion. In 
some cases, the hallucinations can be frightening for the individual and commonly include 
disturbing experiences such as seeing crawling insects or disfigured people. Ultimately, 
pervasive visual hallucinations lead to further psychological consequences that interfere with 
quality of life in addition to the vision loss, which in turn results in further social and economic 
burden (Cox & ffytche, 2014).  
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In general, reports of hallucinations following visual pathway damage are frequently 
dismissed by clinicians or simply not reported due to poor understanding of pathogenesis. 
Patients are often reassured that hallucinations will subside, or it may be incorrectly implied that 
these perceptions stem from a psychological basis. Patients may also not report the phenomena 
despite being very aware they are fictitious due to the misconceived associations made with 
psychological illness, or their own fear of these associations. Attention in vision loss primarily 
focusses on aetiology, prevention, and treatment, rather than secondary consequences such as 
visual hallucinations. As such, hallucinations following vision loss are typically deemed less 
significant due to poor understanding of the phenomenon and its implications, yet they are also 
an important factor to consider in rehabilitation due to their impact on psychological health.  
At present there are no standard pharmacological protocols or alternative therapies to 
alleviate visual hallucinations subsequent to vision loss. Pharmacological intervention in the 
absence of neurological or psychological disorders (e.g., schizophrenia, Parkinson’s disease) 
have generally been ineffective long-term and show inconsistency in responsiveness across 
patients (e.g., Hughes, 2013; Paulig & Mentrup, 2001). However, there is one previous published 
case study of a patient with Charles Bonnet syndrome following bilateral ischaemic damage to 
occipital cortex in which a single 30 min application of low-frequency (1 Hz) rTMS was 
sufficient to cease visual hallucinations for two weeks (Merabet, Kobayashi, Barton, & Pascual-
Leone, 2003). Unfortunately, there was no long-term follow-up or neuroimaging measures post-
rTMS. Multiday low-frequency rTMS to the temporoparietal cortex is also observed to 
significantly decrease auditory hallucinations in schizophrenia (Lee et al., 2005; Vercammen, 
Knegtering, Liemburg, den Boer, & Aleman, 2010). A complex array of processes occur giving 
rise to hallucinations that will not be consistent among cases depending on underlying disease 
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processes and site of damage. However, the potential for low-frequency rTMS to modulate 
hallucinations requires further investigation. It has been suggested that the content of the visual 
hallucinations likely reflects the functional specialisation of the region(s) involved (ffytche et al., 
2008) that can help in identifying stimulation target regions. Regions can be targeted directly 
with rTMS or indirectly via remote interconnected nodes. 
Purpose of the Current Work 
In the present work, I begin to develop and refine low-frequency (1 Hz) rTMS protocols 
applicable to visual-related disorders. To effectively translate this work to therapeutic protocols, 
I investigate underlying neural mechanisms of 1 Hz rTMS at the stimulation site (visual cortex) 
as well as local and distal rTMS effects using MRI. The choice of 1 Hz rTMS paradigm is based 
on work described previously demonstrating that it may have an overall suppressive effect on 
symptoms and neural activity. The chosen neuromodulation regime was further based on 
evidence that 1 Hz rTMS to the visual cortex induces dishabituation of electrophysiological 
responses (visual evoked potentials), whereas 10 Hz (high-frequency) rTMS of comparable 
pulses has no significant effect (Bohotin et al., 2002; Fumal et al., 2003). Moreover, multiday 
sessions of 1 Hz rTMS to the visual cortex produce a cumulative effect in dishabituation (Fumal 
et al., 2006).  
A focal point of the research was to develop rTMS treatment for disruptive chronic visual 
hallucinations, a frequent and dismissed consequence of visual pathway damage. In Chapter 2–3, 
I begin by investigating the efficacy of 1 Hz rTMS in mitigating these visual hallucinations. As 
mechanisms of both rTMS to the visual cortex and visual hallucinations in cases of visual 
pathway damage are still relatively unknown, I address this by investigating functional and 
structural correlates of visual hallucinations and rTMS effects using task-based fMRI and DTI. 
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For rTMS paradigms to be effective, it was necessary to not only understand the neural 
mechanisms of therapy but also the pathophysiology as this provides insight into the pathological 
mechanisms to target. Investigation of these aspects can provide valuable information in 
determining the appropriate therapeutic tool, prognosis, as well as longer-term post-treatment 
efficacy.  
A major problem when applying rTMS in clinical populations is that pre-existing 
abnormalities in function and excitability can alter the responsiveness of the targeted area to 
rTMS (e.g., Bohotin et al., 2002; Siebner et al., 1999a, 1999b). Inevitable heterogeneity in 
patient groups due to pathological processes also makes interpretation and generalisability of 
results more difficult. Because of limited combined MRI and TMS studies of the visual cortex, it 
was difficult to determine whether the rTMS findings in Chapter 2 were because of aberrant 
functional and structural processes following visual cortical damage. It became clear that it was 
crucial to take a step back and begin to investigate rTMS effects using consecutive MRI in 
healthy control participants to guide development of therapeutic interventions that would be 
relevant to visual disorders and not just cases of visual hallucinations. Investigating rTMS effects 
in healthy individuals would determine neural substrates and aid predictability of effects. It was 
desirable to determine underlying neurochemical mechanisms of rTMS prior to translation to 
clinical protocols targeted at altering plasticity and to minimise adverse effects. Moreover, 
typical rTMS effects in controls and deviations from the expected response in clinical 
populations can provide more information regarding underlying pathophysiology and which 
mechanisms to target. In Chapter 4, I investigate the potential of 1 Hz rTMS to the visual cortex 
on altering GABA and glutamate neurotransmitters that are key in plasticity. In addition, in 
pathophysiology, network communication becomes destabilised from disturbances; therefore, an 
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effective protocol must sufficiently target networks in the appropriate direction. In Chapter 5, I 
address this by investigating the effects of rTMS to the visual cortex on global functional 
connectivity across brain regions. Chapter 5 investigates which nodes, and correspondingly 
which networks become altered following 1 Hz rTMS to the visual cortex, as well as the 
magnitude of rTMS effects on network communication.  
Further, before rTMS can be considered as a therapeutic tool in visual disorders, it was 
necessary to refine parameters that would induce sufficiently long plasticity to modify neuronal 
activity in visual and associated cortices with minimal stimulation application. The current 
combination of stimulation parameters used in experimental research involving visual cortices 
would not provide optimal clinical effects due to insufficient aftereffect duration (for a review, 
see Thut & Pascual-Leone, 2010). Therefore, the effects of prolonged and/or repeated exposures 
to noninvasive brain stimulation, as well as dose-dependent effects needed to be explored in the 
visual cortex. Longer-term follow-up of rTMS effects and its potential for adverse effects is also 
lacking, particularly within the domain of neuroimaging studies. In Chapters 4–5, I additionally 
address these unknown aspects using two different regimes of 1 Hz rTMS and investigate their 
differential effects on GABA and glutamate concentrations, global functional connectivity, and 
their potential for adverse effects to determine the most efficient protocol. Constant stimulation 
is less than ideal; thus, it was important to develop methodologies of optimal stimulation 
parameters and performance to transition brain stimulation technologies into operational clinical 
practice. Ultimately the suitability of 1 Hz rTMS in visual disorders depends on its 
neurophysiological aftereffects.  
In summary, this novel research aims to develop and refine 1 Hz rTMS protocols for 
widespread clinical use in visual-related disorders that are non-responsive to alternative 
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treatment modalities or for which there is currently no treatment. Due to the investigation of 
different 1 Hz rTMS regimes in healthy control participants, this research also advances non-
clinical investigations of rTMS to determine function and processes associated with the visual 
cortex. Overall, this work aims to carry out more detailed studies to better characterise low-
frequency rTMS effects on the visual cortex that would inform therapeutic protocols. 
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CHAPTER 2 
 
MITIGATING VISUAL HALLUCINATIONS  
ASSOCIATED WITH OCCIPITAL STROKE  
USING LOW-FREQUENCY REPETITIVE  
TRANSCRANIAL MAGNETIC STIMULATION1 
 
 
 
 
 
 
 
                                                 
1Adapted version published as: Rafique, S. A., Richards, J. R., & Steeves, J. K. E. (2016). Neurology, 87(14), 1493–
1500. 
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Preface 
We investigated the efficacy of multiday rTMS to the visual cortex in mitigating chronic and 
continuous phosphene hallucinations in a patient who suffered occipital stroke. Low-frequency 
(1 Hz) rTMS was applied to the lesion site for 30 min daily over five consecutive days. fMRI 
was performed before and after rTMS treatment. Pre-rTMS fMRI revealed focal excitatory 
discharges at the border of the lesion highlighting the origin of phosphenes, and an imbalance of 
functional activity across hemispheres. Increased application of rTMS resulted in a cumulative 
reduction in intensity of phosphene hallucinations that was reflected in altered BOLD signal. 
rTMS did not simply suppress the disorganised activity at the lesion site in the patient, but rather, 
it redistributed the previously imbalanced cortical activity at the lesion site and remote regions so 
that it more closely resembled the balanced functional activity across hemispheres observed in 
controls. This case is rare in its presentation of continuous visual hallucinations. We provide 
neuroimaging insight into neural mechanisms of visual hallucinations following occipital injury; 
and demonstrate that multiday 1 Hz rTMS to the visual cortex provides a valuable therapeutic 
intervention for mitigating visual hallucinations. 
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Posterior circulation stroke involving the posterior and middle cerebral arteries accounts 
for 17–40% of ischaemic strokes (87% of all strokes; Benjamin et al., 2017). Posterior and 
middle cerebral artery stroke affects cortical regions involving the visual pathway (occipital, 
temporal, parietal, and frontal cortices; Marinković, Milisavljević, Lolić-Draganić, & Kovacević, 
1987). It is estimated that 30–70% of stroke patients have deficits in vision or visual perception 
(Brandt, Thie, Caplan, & Hacke 1995; Pambakian & Kennard, 1997). Injury to these visual 
pathway cortical regions following stroke can cause a variety of visual and perceptual deficits 
including visual agnosia, visual field loss, and achromatopsia (Damasio et al., 1982, 1980; 
Marinković et al., 1987). In addition, visual hallucinations are frequently reported subsequent to 
stroke injury to the occipital cortex, and are attributed with the more frequent consequence of 
hemianopia (Anderson & Rizzo, 1994; De Haan, Nys, van Zandvoort, & Ramsey, 2007; Kishi, 
Ishino, & Naganuma, 1998; Kölmel, 1985; Lance, 1976; Vaphiades et al., 1996). Visual 
hallucinations following stroke are frequently localised to the affected part of the visual field 
(Kölmel, 1985; Manford, & Andermann, 1998). Visual field defects in themselves have 
significant implications on functional prognosis of daily activities such as driving, reading, and 
navigating within an environment. The presence of abnormal visual experiences in addition to 
the visual field loss causes further psychological distress (Cox & ffytche, 2014; De Haan et al., 
2007). Depending on the location and severity of the occipital stroke lesion, many patients 
demonstrate partial functional recovery over time. Prognosis is worse with primary visual cortex 
(V1) involvement and greater extent of damage (Çelebisoy, Çelebisoy, Bayam, & Köse, 2010; 
Tiel And & Kölmel, 1991). Recovery in visual field loss following stroke is dependent on the 
return of V1 activity and is unlikely beyond 3–6 months (Ajina & Kennard, 2012; Sabel, 1997; 
Zhang, Kedar, Lynn, Newman, & Biousse, 2006). While much focus is paid to stroke prevention 
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and treatment/rehabilitation of motor, speech, and visual field deficits, little work has been done 
to alleviate visual hallucinations despite historical reports in patients with occipital lobe stroke 
(De Haan et al., 2007).  
Typically following stroke, the interhemispheric balance of neural activity becomes 
modified between ipsilesional and contralesional hemispheres that normalise over time. 
Hyperexcitability is observed in the contralesional hemisphere as result of decreased 
interhemispheric inhibition and hypoexcitability is observed in the lesioned hemisphere (Liepert 
et al., 2000a). Interhemispheric inhibition induces diaschisis following stroke in brain areas that 
are spatially distinct but functionally related to the stroke site (Feeney & Baron, 1986). This 
process is correlated with functional progress and reflects brain plasticity induced by 
spontaneous recovery and rehabilitation (Traversa et al., 2000). Neurons with absolute damage 
from stroke are not salvageable, but those affected as a result of diaschisis remain viable 
(Cassidy et al., 2014). With greater alteration in interhemispheric inhibition after stroke, the 
prognosis for recovery is poorer (Murase et al., 2004). TMS has been popularly applied to 
promote motor recovery in stroke and is shown to disinhibit interhemispheric transcallosal 
interactions that are essential for rehabilitation (Bäumer et al., 2006; Meyer, Röricht, Von 
Einsiedel, Kruggel, & Weindl, 1995). Therefore, TMS may also have valuable application to 
visual deficits subsequent to stroke. 
Occipital lesions from stroke causing hemianopia with visual hallucinations are 
significantly smaller than those that cause hemianopia without hallucinations, suggesting that 
involved regions with intact visual processing are required to yield hallucinations (Manford & 
Andermann, 1998). However, visual hallucinations do not only occur following stroke but are 
frequently observed in other causes of vision loss (retinal, subcortical, or cortical damage), e.g., 
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age-related macular degeneration, and optic neuropathy (Baier et al., 2010; Gordon, 2016). 
Several theories are posited as to why visual hallucinations occur following visual pathway 
damage. In short, (1) the “irritative” process is described as spontaneous excitatory discharges at 
the border of the ischaemic area, or an imbalance of resting potentials within the lesion that 
stimulate neighbouring associative cortical areas, which are falsely interpreted as sensory input 
(Cogan, 1973; Seguin, 1886). (2) The “perceptual release” phenomenon is described as the 
withdrawal of inhibition within the lesioned area that normally inhibits irrelevant impulses from 
conscious perception. The interference of normal inhibitory circuitry results in abnormal cortical 
excitation and processing. Disinhibition of previously subconscious perceptions or memories is 
consequently viewed as visual hallucinations (Cogan, 1973; Manford & Andermann, 1998; 
Santhouse et al., 2000). (3) The “deafferentation” theory argues that surviving neurons within the 
lesion continue to receive input from intact cortical visual areas and remaining visual processing 
capacity is expressed as hallucinations. Hallucinatory phenomena arise from pathological 
feedback of neuronal clusters in regions bordering the lesion that presumably contain records of 
“visual feature fragments” (Anderson & Rizzo, 1994; Manford & Andermann, 1998). However, 
there is little evidence from neuroimaging studies to confirm that these neural mechanisms 
underlie visual hallucinations in visual pathway damage. In addition, mechanisms that 
differentiate acute and chronic visual hallucinations have not been investigated. Visual 
hallucinations in the absence of dementia, delusions, or confusion, e.g., dementia with Lewy 
bodies, schizophrenia, Parkinson’s disease (Aarsland et al., 2009; Oishi et al., 2005; Yoon et al., 
2010), provide isolated evidence for underlying neural substrates and cognitive mechanisms. 
fMRI can reveal injury-induced neural processes and plasticity within localised and remote 
regions principal to visual hallucinations in order to ascertain treatment modalities.  
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We describe the case of a 31-year-old patient presenting with continuous and disruptive 
phosphene hallucinations within an incomplete left homonymous hemianopia following right 
occipital stroke that remained unchanged for over two years. Although visual hallucinations can 
occur long-term in large number of patients with visual pathway damage (Cox & ffytche, 2014), 
the experience is intermittent, and cases of continuous hallucinations are extremely rare. The 
patient was treated with rTMS to the visual cortex for 30 min daily over five consecutive days. 
We demonstrate that rTMS can be successfully applied to mitigate these abnormal percepts 
following occipital lobe damage. Combining rTMS with fMRI, we assess the underlying neural 
correlates of hallucinations secondary to occipital injury, as well as rTMS-modulated alterations 
in functional activity. We performed fMRI on an age-matched healthy controls to enable 
statistical comparison of the patient to a neurologically intact group. This study presents the first 
case of multiday rTMS to the visual cortex to mitigate visual hallucinations subsequent to visual 
pathway damage.  
Methods 
This study was approved by York University’s Office of Research Ethics. All individuals 
gave informed written consent.  
Participants 
Patient. We evaluated a 31-year-old female experiencing continuous phosphene 
hallucinations within an incomplete congruous left homonymous hemianopia for 2.5 years after 
the onset of right subacute occipital lobe stroke. Symptoms initially began as a severe right 
occipital headache followed by an incomplete left homonymous hemianopia (Figure 2.1a). Her 
visual deficit initially appeared as a dark grey scotoma with irregular borders and within two 
hours evolved into phosphene hallucinations. Her past medical history was notable only for 
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migraine headache with visual aura since age 18 years occurring 1–2 times per week. MRI 
revealed a right subacute ischaemic occipital lobe stroke within the calcarine artery distribution 
(Figure 2.1b) and a benign subarachnoid cyst. Possible vasospasm of the calcarine artery was 
noted on computed tomography (CT) angiogram performed immediately after MRI. Other initial 
investigations included an echocardiogram with bubble study that revealed a patent foramen 
ovale. Electroencephalogram (EEG) recordings were normal, ruling out epileptiform excitatory 
activity as a cause of the hallucinations. After two weeks, her headache resolved but the 
phosphene hallucinations remained unchanged and were present all times of the day and night. 
Several pharmacological approaches were attempted during this period to eliminate or suppress 
the phosphene hallucinations. Initially, intravenous (IV) infusion of magnesium sulfate was 
administered and had no effect. Subsequent trials of IV diazepam (Valium®), IV phenobarbital 
(Luminal®), and IV levetiracetam (Keppra®) were also ineffective. Oral levetiracetam was 
taken for one week without effect. Oral topiramate (Topamax®) was then attempted but also 
failed to mitigate the phosphene hallucinations. She was then started on daily aspirin for future 
stroke prevention and verapamil for migraine prophylaxis. Her patent foramen ovale was closed 
endovascularly with an Amplatzer™ septal occluder. Visual field rehabilitation was attempted 
next over a period of six months with Vision Restoration Therapy (NovaVision, Boca Raton, 
Florida) and had no significant improvement in visual field loss nor the perception of phosphene 
hallucinations. Lastly, noninvasive brain stimulation in the form of tDCS was attempted with no 
noticeable effect. Over the next two years, the phosphene hallucinations persisted, but with a 
slight overall decrease in intensity. The phosphene hallucinations were described as moving 
white/grey vibrating images of shattered glass and small–medium circular lights within the 
scotoma. Occasional high-frequency lightning bolts and irregular zigzag shapes were perceived 
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migrating inferolateral within the scotoma into the normal visual field. Phosphenes were more 
intense at the relative (incomplete damage) field defect, accompanied with macropsia and 
general distortion. The hallucinations were perceived at all times; however, intensity increased 
with stress, lack of sleep or increasing light intensity, and intensity decreased in the dark or with 
eyes closed. The patient found the constant need to differentiate real percepts and phosphene 
hallucinations confusing and exhausting despite full awareness the hallucinations were not real. 
The hallucinations were debilitating, interfering with sleep, vision, and quality of life. At the 
time of our investigation, the calcarine artery vasospasm and occipital ischaemia had resolved. 
The patient had normal foveal vision (> 0.2 logMAR; stereoacuity ≥ 50”; previous Lasik 
refractive surgery) and all other ophthalmic findings were unremarkable. The patient was right-
handed and there were no known contraindications to MRI and TMS. 
Healthy controls. Eight healthy female controls (Mage ± SEM = 29 ± 0.79 years) were 
recruited with no history of neurological disorders and no known contraindications to MRI. All 
controls were right-handed, had normal or corrected-to-normal vision (> 0.2 logMAR; 
stereoacuity ≥ 50”) and otherwise normal visual assessment findings.  
Vision Assessments 
Standard clinical vision testing was performed to ensure otherwise normal visual status in 
the patient and controls. Monocular and binocular visual acuity and contrast sensitivity were 
measured using the standardised early treatment diabetic retinopathy study (ETDRS) vision chart 
(Precision Vision, La Salle, IL). Stereoacuity was measured using the Titmus circles test (Stereo 
Optical Company Inc., Chicago, IL), and colour vision was assessed using the Ishihara test 
(Kanehara Trading Inc., Tokyo, Japan). Ocular muscle status involved assessment with the cover 
test (distance and near), near point of convergence, and ocular motility. Visual field perimetry 
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was performed using the Octopus 900 (Haag-Streit, Mason, OH). Vision testing was repeated in 
the patient following cessation of rTMS to determine any adverse effects on basic visual status. 
Experimental Design Overview 
The patient underwent the following: (1) pre-rTMS (baseline) clinical vision testing and 
MRI, (2) sham and vertex rTMS, (3) five consecutive days of rTMS, and (4) post-rTMS MRI 
and vision testing. Healthy controls underwent (1) only. 
Magnetic Resonance Imaging 
Stimuli and procedure. We performed two fMRI experiments. The patient self-reported 
increases in phosphene hallucinations with increasing brightness of visual input and a 
corresponding decrease in phosphene hallucinations under reduced or dark visual environments. 
Based on these reports, a phosphene localiser was used to delineate cortical and subcortical 
origins of the hallucinations. The phosphene localiser consisted of five full screen 30 s blocks of 
a bright white stimulus interleaved with five full screen 30 s blocks of black stimulus, with a 
continuous central fixation (Figure 2.2a). A grey screen with central fixation appeared for 30 s at 
the start and finish of the run. Each run lasted 6 min and was repeated twice. During the 
phosphene localiser, the patient was asked to indicate a change in intensity (increase or decrease) 
of perceived phosphene hallucinations using a MRI compatible response button box. Control 
participants were also given the same button response instructions when undergoing the 
phosphene localiser to minimise cognitive differences, although visual hallucinations were not 
expected. The phosphene localiser was performed first in the patient to prevent any confounding 
manipulations in phosphene hallucinations from viewing previous experimental visual stimuli 
and to ensure maximal effect. For consistency, the phosphene localiser was also performed first 
in control participants. 
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Since the lesion was located in the occipital cortex (involving the parahippocampal and 
lingual gyri, cuneus, and sub-lobar regions), we expected network changes in visual processing 
regions connected to the lesion site and peri-infarct regions. Much of this network contributes to 
the processing of specialised visual stimuli, mainly faces, scenes, and objects, that are also 
implicated in complex visual hallucinations (ffytche et al., 1998). A face-scene-object localiser 
was therefore performed to delineate regions involved in processing these visual stimuli, and to 
measure alterations in activity induced by the lesion and/or with rTMS in the patient. The face-
scene-object localiser consisted of three different blocks (Figure 2.2b), each with sixteen images: 
(1) faces (males and females of different ethnicities), (2) scenes (natural and non-natural scenes), 
(3) objects (natural and man-made). Digitised colour images of objects were obtained from a 
bank of standardised stimuli (Brodeur, Dionne-Dostie, Montreuil, & Lepage, 2010), and 
coloured images of faces and scenes were obtained from a compact disc photo image library. 
Epochs containing three blocks of the three categories of stimuli were repeated 6 times in a 
counterbalanced order to minimise first-order carry over effects. Each image was presented for 
900 ms with a 100 ms inter-stimulus interval, and images were presented without repetition. A 
central fixation cross appeared for 16 s at the start and finish of the run and between epochs. 
Each run lasted 6 min 52 s and was repeated twice.  
Localisers were performed prior to and immediately after rTMS treatment ceased in the 
patient to assess stimulation-induced changes. Control participants underwent both localisers to 
enable comparison that would highlight deviations of functional activity in the patient, and hence 
determine contributions to the perception of hallucinations. Stimuli were viewed in a dark room. 
Apparatus. Stimuli were presented with VPixx software (VPixx Technologies Inc., 
Montreal, QC, Canada; www.vpixx.com). Images were viewed on a screen (resolution: 1024 x 
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768) ~40 cm from the participant’s eyes via a rear-projector system of the same resolution 
(Avotec SV6011; Avotec Inc., Stuart, FL, USA) while in the scanner. Refractive errors were 
corrected where necessary during acquisition using fMRI compatible goggles. 
Image acquisition. Functional and anatomical images were acquired with a 3 Tesla (3T) 
Siemens Magnetom® Tim Trio magnetic resonance scanner (Siemens, Erlanger, Germany) using 
BOLD fMRI imaging. Head motion was minimised with the placement of soft pads holding the 
participant's head in place. Functional volumes were acquired using a Siemens 32-channel high-
resolution brain array coil and echo-planar imaging with a T1-weighted sequence (number of 
contiguous axial slices = 32; in-plane resolution = 2.5 x 2.5 mm; slice thickness = 3 mm; 
imaging matrix = 96 x 96; repetition time (TR) = 2000 ms; echo time (TE) = 30 ms; flip angle = 
90°; field of view (FoV) = 240 mm). Anatomical images were acquired after functional scans 
with a T1 magnetisation-prepared rapid gradient echo (MPRAGE) imaging sequence (number of 
slices = 192; in-plane resolution = 1 x 1 mm; slice thickness = 1 mm; imaging matrix = 256 x 
256; TR = 1900 ms; TE = 2.5 ms; TI = 900 ms; flip angle = 9°; FoV = 256 mm).  
Repetitive Transcranial Magnetic Stimulation  
Only the patient underwent rTMS treatment. The demarcation between the absolute 
(complete) and relative (incomplete) visual field defect (Figure 2.1a) is a functional 
representation of intact or partially intact neurons with residual recovery of function. This 
suggested disorganised activity from surviving or partially damaged neurons within or around 
the lesion and was confirmed from the restricted disorganisation of hyperexcitability at the lesion 
border evident from fMRI analysis compared with controls. Therefore, we chose the lesion as the 
target site for rTMS in order to reach the partially damaged neurons considered responsible for 
the perception of visual hallucinations. The lesion was mapped onto the patient’s anatomical MR 
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images that were reconstructed to 3D cortical surfaces in Brainsight software (Rogue Research, 
Montreal, QC, Canada). Reference points were mapped onto the patient’s head (tip of nose, 
nasion, right and left tragus) using infrared tracking balls. The spatial relationship between 
reference points from the lesion site (MR images) and those on the patient’s head were co-
registered using a Polaris infrared tracking system (Northern Digital Instruments, Kitchener, ON, 
Canada) to enable targeted rTMS to the disorganised activity at the border of the lesion. The 
image-guided stereotaxic system enables accurate coil position over the target stimulation site 
and tracking of the coil with respect to the patient’s head during stimulation that can be 
continuously monitored and corrected in real time.  
A Magstim Rapid2 Stimulator and a 70 mm diameter figure-of-eight coil (Magstim, 
Whitland, Wales, UK) were used to deliver the stimulation pulses to the targeted stimulation site. 
The figure-of-eight coil provides more focal stimulation and allows detailed mapping of cortical 
representation (Kobayashi & Pascual-Leone, 2003). The patient was seated in a comfortable 
position with an adjustable chin rest to limit head movement and provided with earplugs to 
prevent changes in auditory thresholds during rTMS (Rossi et al., 2009). The TMS coil was held 
tangential to the surface of the skull to minimise coil-to-cortex distance, and to maximise the 
TMS effect (Ulmer & Jansen, 2010). A low-frequency pulse (1 Hz) was delivered at 85% of 
maximum stimulator output (110% visible twitch MT; Bohotin et al., 2002; Pridmore et al., 
1998) for 30 min (1800 pulses) at rest. Due to the continuous and variable perception of 
phosphene hallucinations, MT instead of PT was chosen. We chose a low-frequency rTMS 
protocol since is typically considered to be suppressive (for a review, see Hallet, 2007) in an 
attempt to reduce disorganised activity. Prior to stimulation of the target site, two separate 
placebo control conditions were performed in a single day: rTMS to vertex and sham rTMS (coil 
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held orthogonal to the skull and no pulses enter the brain), during which the patient reported no 
effect on hallucinations. rTMS treatment was then performed daily over five consecutive days to 
the target stimulation site at the posterior tip of the lesion (Talairach coordinates: x = 14, y = -75, 
z = 9; ~14 mm deep), which was within TMS penetration limits of the figure-of-eight coil (1–2 
cm; Zangen et al., 2005).  
A subjective log of rTMS effects on intensity of phosphene hallucinations was recorded 
during and after vertex and sham rTMS, and for each active rTMS session. We recorded the 
length of time the effects persisted and any changes in perception throughout the day. Subjective 
changes were reported as a percentage decrease in the self-reported average baseline intensity of 
phosphene hallucinations that were perceived prior to beginning rTMS treatment. The patient 
reported this daily average baseline intensity to be 70% (relative to worst intensity previously 
experienced).  
Data Analyses 
MRI analyses were performed using BrainVoyager QX (v2.8; Brain Innovation, 
Maastricht, The Netherlands).  
Preprocessing. Functional data underwent a series of preprocessing steps to minimise 
noise in the data, including temporal high-pass filtering to remove temporal frequencies (lower 
than 3 cycles/run), and linear trend removal to exclude scanner-related signal drift. The 3D 
motion correction algorithm using linear and sinc interpolation was applied to evaluate and 
correct small inter-scan head movements. Outputs from the motion correction algorithm were 
assessed to ensure motion did not exceed the recommended 1–2 voxels (Huettal, Song, & 
McCarthy, 2004). Functional data were not subjected to spatial smoothing. Undesirable effects 
of smoothing include shifting of activation and merging of adjacent peaks of activation (Mikl et 
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al., 2008). The precise localisation of activation and any shifts in location were important to the 
study because of changes with rTMS. Each participant’s functional images were analysed using a 
multiple regression general linear model (GLM) in order to determine the magnitude of activity 
in each scan. Z-transformation was applied to normalise time courses. All brains were skull-
stripped and standardised with Talairach standard space transformation (Talairach & Tournoux, 
1988). Functional images were then co-registered with their anatomical images. 
Phosphene localiser. A whole-brain fixed effects analysis was performed using a linear 
balanced contrast (white < > black stimuli), cluster threshold of 6 voxels, false discovery rate 
(FDR) multiple comparison corrected single-voxel threshold of q < .05, to compare: (1) patient 
(pre- and post-rTMS, separately) and control activation for white and black event predictors. 
Further, subtraction analysis (beta-difference maps) was performed for the following 
comparisons (2) patient’s pre- versus post-rTMS phosphene localiser activity, (3) patient (pre- 
and post-rTMS, separately) versus control phosphene localiser activity. Subtraction of maps was 
performed for white and black event predictors independently for voxels above selected beta 
thresholds of b > 0.5, where beta values quantify the level of cortical activity.  
The patient’s subjective button responses (indicating an increase or decrease in 
perception of phosphene hallucinations) were compared with event (white and black stimuli) 
predictors to assess any differences between subjective and neuronal processes. A reported 
intensity increase in phosphene hallucinations during the localiser corresponded with the onset of 
white stimuli, while a decrease in phosphene hallucinations intensity corresponded with the onset 
of black stimuli (i.e., no significant differences between comparisons). No button responses were 
pressed by control participants. Therefore, only event predictor activity was used to compare 
patient and control data. This ensured more comparable perceptual or cognitive processes across 
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individuals, and that a perceptual delay in the patient while discerning an increase/decrease in 
hallucinations for button responses did not result in added confounds between comparisons. 
Face-scene-object localiser. A priori regions known to be involved in the processing of 
faces, scenes, and objects were defined in all individuals independently. The a priori face 
preferential regions included the fusiform and occipital face areas. The scene preferential regions 
included the transverse occipital sulcus (also known as the occipital place area), 
parahippocampal place area, and lingual gyrus. The object preferential region involved the lateral 
occipital area. A priori regions were defined using a linear balanced contrast and were identified 
by determining the peak selective activation for the region in question, using a cluster threshold 
of 6, and FDR corrected single-voxel threshold of q < .05. The scene preferential regions were 
defined as the set of voxels in the transverse occipital sulcus and collateral sulcus/posterior 
parahippocampal gyrus that responded more strongly to scenes than to objects and faces 
(contrast: scenes > objects + faces). The lingual gyrus also showed preferential activation to 
scenes and was defined as the region between the calcarine sulcus and the posterior part of the 
collateral sulcus in the visual cortex using the same contrast (scenes > objects + faces). The 
object preferential lateral occipital area was defined as the region of lateral/dorsal 
occipitotemporal cortex that responded more strongly to objects than to faces and scenes 
(contrast: objects > scenes + faces). The face preferential regions were defined as regions 
maximally responsive to faces compared to objects and scenes in the fusiform gyrus (fusiform 
face area) and inferior occipital gyrus (occipital face area) (contrasts: faces > scenes + objects). 
Locations were consistent with those identified previously (Ewbank, Schluppeck, & Andrews, 
2005; Grill-Spector et al., 1999). Activity within a priori regions was quantified from the event-
related time course as beta-weights. We used the modified t-test (two-tailed tests) developed for 
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single-case studies (Crawford & Garthwaite, 2002; Crawford, Garthwaite, Azzalini, Howell, & 
Laws, 2006) to compare the patient’s level of functional activation to controls. We report 
significant differences at p < .05, and results trending significance are reported at p < .1. 
Results 
Subjective Perception of Phosphene Hallucinations and Visual Testing 
The patient reported a gradual reduction in phosphene hallucinations with increased 
application of rTMS. Effects summated with increased time of rTMS application during each 
session. With each new day of rTMS treatment, hallucinations were mitigated faster and effects 
continued to summate and last longer. As a result, with each new day, the patient also reported 
an overall improvement in well-being described as being less mentally and physically exhausted. 
Effects of rTMS were maintained for a few days after discontinuation of stimulation with a 
gradual linear return to baseline intensity by 1-week (Figure 2.3). The perception of phosphene 
hallucinations did not completely cease during the treatment, however, they were reduced to less 
than 15% subjective intensity (Figure 2.3). In addition, the patient reported minimal distortion 
and macropsia after rTMS treatment, however, this reduction was not quantified. There was no 
change in visual status measured using clinical vision testing during or after rTMS cessation, and 
no adverse effects of rTMS were reported.  
Phosphene Localiser 
 The anatomical regions with significant differences in activation between bright (white > 
black stimuli) and dark (black > white stimuli) viewing conditions for the patient (pre- and post-
rTMS) and controls are detailed in Tables 2.1–2.2, respectively.  
Figure 2.4 highlights the most notable difference in patterns of functional cortical activity 
at the lingual gyrus and cuneus, not only between the patient and controls, but a remarkable 
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difference is seen between the patient pre- and post-rTMS. Pre-rTMS, a greater concentration of 
diffuse activity is observed in the contralesional hemisphere at the lingual gyrus and cuneus, 
while ipsilesional activity was focal to the calcarine sulcus and anterior to the lesion in the 
patient in both bright (white > black stimuli) and dark (black > white stimuli) viewing 
conditions. Post-rTMS cortical activity appeared balanced across hemispheres resembling that of 
controls. Unlike the patient, controls did not show greater activation at the lingual gyrus in dark 
viewing conditions (Table 2.2). 
Subtraction analysis of the phosphene localiser providing beta-difference maps for the 
patient pre-rTMS and controls, and for the patient post-rTMS and controls are shown in Tables 
2.3–2.4, respectively. Beta-difference maps for the patient pre- and post-rTMS showed greater 
activation pre-rTMS in the left superior frontal gyrus (Brodmann area 9; Talairach coordinates: x 
= -24, y = 57, z = 28) and greater activation post-rTMS in the left lingual gyrus (Brodmann area 
17, Talairach coordinates: x = -7, y = -93, z = -7). 
Face-Scene-Object Localiser  
Results of the a priori analysis and significant differences between the patient and 
controls (using modified t-tests) are shown in Figure 2.5. Differences are observed in processing 
resources allocated within regions for preferential and non-preferential task-specific processing 
between the patient and controls. Compared with controls, pre-rTMS, the patient displayed 
greater selectivity to scenes (and minimal object and face processing) in the left scene 
preferential region transverse occipital sulcus, but reduced scene selectivity (i.e., greater non-
preferential processing) in the right transverse occipital sulcus and right lingual gyrus. Within the 
left lateral occipital area, typically an object preferential region, the patient showed greater non-
preferential processing of faces and reduced non-preferential processing of scenes pre-rTMS 
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compared with controls. Greater face selectivity (and minimal object and scene processing) was 
observed in the bilateral face preferential occipital face area pre-rTMS compared with controls.  
Post-rTMS, in some cases, there was redistribution of activity in preferential and non-
preferential processing towards a similar level of activation to that of controls. For example, 
post-rTMS in the left parahippocampal place area, the patient showed reduced selectivity to faces 
and scenes, and increased selectivity to objects, similar to control selectivity. However, post-
rTMS in the right parahippocampal place area, the patient showed reduced face, object, and 
scene selectivity (as opposed to increased selectivity pre-rTMS) compared with controls.   
Discussion 
Using low-frequency (1 Hz) rTMS, we greatly reduced the perception of continuous 
phosphene hallucinations following occipital stroke in our patient who had been unresponsive to 
alternative therapies (e.g., tDCS, pharmacological approaches). These rTMS effects summated 
daily and outlasted stimulation. rTMS did not simply reduce activity in regions with previously 
disorganised functional activity contributing to the perception of phosphene hallucinations, but 
rather, it redistributed imbalanced activity throughout the brain to a level similar to that of 
controls. The reorganisation of imbalanced functional activity presumably occurs through 
disinhibition of intra- and interhemispheric interactions via rTMS mechanisms.  
Regions Associated with Visual Hallucinations 
Several differences in functional activity were observed between the patient pre-rTMS 
and controls (Tables 2.1–2.3; Figure 2.4) that implicate these regions in the patient’s perception 
of phosphene hallucinations. MRI studies in occipital ischaemic stroke with phosphene 
hallucinations demonstrate a common involvement of visual association areas, e.g., lingual gyrus 
and cuneus (Baier et al., 2010; Missimer, Seitz, & Kleiser, 2010; Vaphiades et al., 1996), as in 
 52 
our patient. Electrical stimulation to V1, the calcarine fissure, and the visual association 
Brodmann area 18 induces the perception of phosphenes (Foerester, 1931; Lance, 1976), which 
further supports the involvement of these regions in the genesis of phosphene hallucinations. 
Whereas, stimulation of Brodmann area 19 instead induces complex organised images 
(Foerester, 1931; Lance, 1976). 
The patient showed greater activation in regions of the middle occipital gyrus in both 
bright and dark viewing conditions pre-rTMS, and only in bright viewing conditions post-rTMS. 
Conversely, controls showed greater activation at the middle occipital gyrus under darker 
viewing conditions (Tables 2.1–2.2). The middle occipital gyrus is involved in shape analysis 
operations (Gauthier, Tarr, Anderson, Skudlarski, & Gore, 1999; Sergent, Ohta, & MacDonald, 
1992). Differences between the patient and controls in the middle occipital gyrus may therefore 
be attributed to the perceptual processing of phosphene hallucinations consisting of unformed 
shapes. In addition, differences of activation were observed in the middle temporal gyrus 
between the patient pre-rTMS and controls (Tables 2.1–2.2). A possible theory that has been put 
forward to explain visual hallucinations is that areas involved in memory retrieval (including 
category-specific visual areas) may release percepts from memory when sensory impulses that 
are excluded from consciousness are no longer inhibited following damage (Lance, 1976; 
Weinberger & Grant, 1940). Both the middle occipital and middle temporal gyri demonstrate 
involvement in object memory (Yonelinas, Hopfinger, Buonocore, Kroll, & Baynes, 2001), and 
their involvement may contribute to the validity of this theory. Consistent with the notion that 
inappropriate functional recruitment of these regions may contribute to the perception of visual 
hallucinations, lesions in the middle temporal gyrus instead produce the extreme opposite and 
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cause visual agnosia (Chao, Haxby, & Martin, 1999; Gross, 1994; Puce, Allison, Asgari, Gore, & 
McCarthy, 1996).  
Only the patient showed activation in the anterior vermis of the cerebellum (pre-rTMS 
only; Table 2.1). The anterior vermis is frequently reported in studies of visual and even auditory 
hallucinations (Caparelli et al., 2010; Kenny, Blamire, Firbank, & O'Brien, 2012; van Lutterveld, 
Diederen, Koops, Begemann, & Sommer, 2013). While the precise function of the anterior 
vermis remains unknown, the cerebellum plays a significant role in mental imagery (Grealy & 
Lee, 2011). Greater vivid imagery and a weak ability to distinguish real perception from mental 
imagery has been linked to hallucinations (Mintz & Alpert, 1972). The cerebellum also shows 
connectivity to the dorsal visual stream, visual cortices, and is involved in visual attention to 
moving stimuli (Kellermann et al., 2012). Further, the cerebellum, together with extensive 
cortical networks, yields higher activation when receiving incongruent sensory information 
presumably to cope with increasing cortical computational demands (Shih et al., 2009). 
Therefore, the functional recruitment of the cerebellum in the absence of task-specific 
engagement is also consistent with the irregular afferent sensory input of moving and 
consistently changing perception of phosphenes in the patient. 
The claustrum regulates communication across the brain via cholinergic mechanisms. 
Acetylcholine is concentrated in both visual thalamic and visual cortex regions (Fitzpatrick, 
Diamond, & Raczkowski, 1989; Smith, Pare, Deschenes, Parent, & Steriade, 1988). Cholinergic 
input inhibits GABAergic inhibitory input from the reticular nucleus (Wilson, 1993). Release of 
visual association cortex with loss of cortico-cortical inputs after stroke (Jones & Powell, 1970) 
alters cortical activity via the reticular activating system by decreasing cholinergic input that is 
linked to hallucinations (Manford & Andermann, 1998). The involvement of the claustrum in the 
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patient pre-rTMS (Table 2.3) is consistent with evidence of its involvement in visual 
hallucinations.  
The face-scene-object localiser enables assessment of category-specific visual processing 
regions connected to the lesion and peri-infarct regions. In the patient, prior to rTMS, a 
redistribution of category-specific responses was observed from the impaired attenuation of non-
preferential processing within these regions. Analysis following rTMS revealed reconfiguration 
of preferential and non-preferential selectivity of regions to some level matching that of controls. 
The a priori regions investigated in this study (e.g., lingual, parahippocampal, and fusiform gyri) 
are key structures for object representation in the ventral stream of visual information processing 
(Haxby et al., 2001; Kanwisher, 2000). Damage to these regions leads to the disruption in normal 
flow of shape and contour information processing and results in visual form agnosia (Karnath, 
Rüter, Mandler, & Himmelbach, 2009). Conversely, hyperexcitability or imbalanced activity of 
these regions, as in the present study, has been linked to the onset of visual hallucinations 
(ffytche et al., 1998). Although controls did not undergo rTMS in this study, our previous studies 
show no change to stimulus category selectivity in the same regions following rTMS to the 
visual cortex in healthy controls (Mullin & Steeves, 2013; Rafique et al., 2015). 
Mechanisms of Visual Hallucinations 
The regions discussed may be directly involved in the origin of hallucinations (the cause) 
or are connected to the primary origin through direct or indirect connections. Alternatively, the 
regions might be recruited as a function-specific response to the continuous perception or 
subjective interpretation of recurrent phosphene hallucinations (the effect). The occurrence of 
hallucinations with a visual field defect implies that the visual association cortex is more likely 
to discharge spontaneously once deprived of normal afferent inflow from the calcarine cortex or 
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once its afferent connections with V1 are severed (Lance, 1976). Moreover, given that the 
phosphenes were mainly constrained to the area of visual field loss in our patient, in line with 
retinotopic organisation, this suggests that the primary origin of hallucinations arises close to the 
lesion site. The concept of spontaneous discharge of neuronal circuits in ischaemic regions is 
attractive in this patient since hallucinations were reported to continue (less distinctly) in dark 
viewing conditions or with eyes closed, and therefore were not triggered by external visual 
stimuli. When the majority of the calcarine fissure is intact, suggesting V1 and visual association 
area V2 are mostly intact, pathways between preserved portions provide a means for continued 
relay of signals (Kölmel, 1984). Partially damaged neurons retain the ability to process but relay 
dysfunctional signals to nearby lesioned or intact regions (Kasten, Wüst, Behrens-Baumann, & 
Sabel, 1998). Alternatively, neural signals that cannot be relayed beyond lesioned borders may 
result in a build-up of signal (excitatory discharges), and an overall disruption in flow of 
communication. Relatively consistent activation at the posterior rim of a lesion, as observed in 
this case, is observed in other non-visual cortical regions following stroke damage (Rijntjes et 
al., 1994), and this activation poses a popular theory for neural mechanisms of hallucinations 
(Anderson & Rizzo, 1994; De Haan et al., 2007). Neural systems surrounding the lesion that 
receive input from the now lesioned area will have altered activity and deficiencies in 
modulating activity through feedback connections (Braun, Dumont, Duval, Hamel-Hébert, & 
Godbout, 2003; Manford & Andermann, 1998).   
Changes in Functional Activity with Repetitive Transcranial Magnetic Stimulation 
Following five consecutive days of rTMS application to the visual cortex in the patient, 
some rebalance of previously aberrant functional activation was observed inter- and 
intrahemispherically post-rTMS (Figures 2.4–2.5). This included deactivation of regions 
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observed in the patient pre-rTMS that were not observed in controls, or conversely activation of 
regions that were observed in controls but not in the patient pre-rTMS (Tables 2.1–2.4). Thus, 
post-rTMS activation in the patient became similar to neural processes in controls within these 
regions. The redistribution of activation across the brain with rTMS demonstrates that rTMS was 
not restricted in its effects to the targeted region in the occipital lobe, but rather, it led to a more 
global redistribution of activity in remotely interconnected regions. Nonetheless, the patient 
continued to demonstrate some differences post-rTMS compared with controls (Table 2.4). The 
ipsilesional lingual gyrus continued to demonstrate greater activation at the posterior border of 
the lesion post-TMS compared with controls. This residual activity, particularly at the border of 
the lesion, demonstrates persistent neuronal firing, which corresponds to the continued, yet 
greatly reduced, perception of phosphene hallucinations after rTMS treatment. Notably, we did 
not observe a typical response to 1 Hz rTMS in the patient, in that we do not see the typical 
“inhibition” of activity at the stimulation site following low-frequency rTMS as is observed in 
healthy controls (Caparelli et al., 2010; Rafique et al., 2015). In the deafferented cortex, there is 
an increase of membrane resistance that can cause excitability of involved regions (Prince & 
Tseng, 1993), therefore, reducing the susceptibility to inhibition. It is likely that remote 
stimulation effects and restoration to normal function were limited due to impaired inhibitory 
mechanisms in the patient. Underlying mechanisms of rTMS remain largely unknown, and 
effects are less predictable in pathophysiology (e.g., Siebner et al., 1999a, 199b). Despite the 
absence of predicted suppression in functional activity at the target stimulation site, 1 Hz rTMS 
instead, to an extent, normalised the previous aberrant activity that had suppressive effects on the 
patient’s symptoms. 
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Limitations 
In order to overcome limitations of a single-case study, future work requires a larger 
patient sample size, refinement of rTMS parameters, and further neuroimaging to probe a variety 
of neural mechanisms (e.g., rsfMRI, MRS). It is our experience during patient recruitment that 
complex hallucinations following visual pathway damage (i.e., Charles Bonnet syndrome) are 
more common. Charles Bonnet syndrome more frequently occurs following age-related retinal 
disease (e.g., age-related macular degeneration, glaucoma, diabetic retinopathy). A frequent 
problem we encountered with these patients due to age-related consequences is that they co-
occur with underlying systemic or psychological conditions that present contraindications to 
TMS or MRI (e.g., pace makers, drug interactions; Najib & Horvarth, 2014). As the effects of 
chronic low-frequency rTMS on the visual cortex are still relatively unknown, we cannot predict 
adverse effects in patients taking medications such as those altering seizure-thresholds. We were 
correct to exert caution as we saw an increase in neural activity at the rTMS target site with an 
“inhibitory” 1 Hz protocol. Unfortunately, due to our limited time with this patient, we were 
unable to further refine stimulation parameters (e.g., intensity and duration) in order to achieve 
maximal phosphene suppression. Our future work will refine these stimulation parameters. 
Conclusion 
This study provides the first report of therapy-induced multiday rTMS to the visual 
cortex to mitigate abnormal visual percepts following cortical injury. We demonstrate that a 
therapeutic intervention with 1 Hz rTMS interferes with abnormal cortical and subcortical 
activity that give rise to visual hallucinations. rTMS alters deficient functional activity at the 
stimulation site and remote nodes of interconnected networks to greatly reduce the perception of 
hallucinations. These effects were maintained and outlasted the stimulation itself. A number of 
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neurodegenerative conditions present with secondary visual hallucinations, e.g., Parkinson’s 
disease (Manford & Anderson, 1998), schizophrenia (Yoon et al., 2010), and Alzheimer’s 
disease (Palop & Mucke, 2010), as well as degenerative eye disease leading to Charles Bonnet 
syndrome (Burke, 2002; ffytche et al., 1998). These conditions share analogous mechanisms of 
dysfunction involving mutually implicated neurotransmitters and brain regions, and 
interhemispheric imbalance of neural activity. Neuromodulation with rTMS could provide a 
valuable tool for effective treatment of visual hallucinations in these populations.  
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Figure 2.1. Images of the patient’s visual field plot and ischaemic occipital stroke lesion. (a) 
Patient’s visual field plots show an incomplete contralateral (left) congruent homonymous 
hemianopia. (b) T2-weighted MRI images taken at the time of stroke showing the location of the 
ischaemic occipital lesion in the right hemisphere at different slices. L = left; R = right. 
 
 
 
 
 60 
 
Figure 2.2. Schematic images of the localisers. (a) Phosphene localiser—each epoch contained a 
block of white and black stimuli (each shown for 30 s). (b) Face-scene-object localiser showing one 
epoch with sample stimuli—each epoch contained three blocks of each stimulus category with 16 
images (each image shown for 900 ms with a 100 ms inter-stimulus interval) in each block.  
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Figure 2.3. Patient subjective changes in perception of phosphene hallucinations with rTMS. (a) Daily subjective reduction in phosphenes 
assessed at 15 min intervals. (b) Average daily subjective reduction in phosphenes. Improvement is reported as a reduction in severity of 
hallucinations compared with average baseline intensity of phosphene hallucinations (~70%) experienced prior to commencing rTMS 
treatment.  
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Figure 2.4. Phosphene localiser (white < > black stimuli) activity for the patient and control average. 
(a) Cortical activity at the lingual gyrus. ‘X’ marks the approximate location of the rTMS target site. 
A benign subarachnoid cyst is visible under the ‘X’ and is not to be confused with the lesion. (b) 
Cortical activity at the cuneus. Activation to white stimuli is indicated in orange/yellow and 
activation to black stimuli is indicated in blue/green; q < .05. L = left (contralesional in the patient); 
R = right (ipsilesional in the patient). 
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Figure 2.5. A priori analysis of the face-scene-object localiser. Right lateral occipital activation was 
not observed for the patient. Data are presented as mean ± SEM for controls. Significant differences 
in cortical activation for preferential and non-preferential processing are observed between the 
patient and controls. at = -2.654, p = .033, effect size (Zcase-controls [cc]) = -2.815; 
bt = 2.095, p = .074, 
ZCC = 2.222; 
ct = 2.386, p = .048, ZCC = 2.531;
 dt = -2.183, p = .065, ZCC = -2.315;
 et = -2.525, p = 
.039, ZCC = -2.678. Scene processing preferential regions: parahippocampal place area, transverse 
occipital sulcus, lingual gyrus. Object processing preferential region: lateral occipital area. Face 
processing preferential regions: fusiform face area, occipital face area.  
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Table 2.1. 
Phosphene Localiser Results for the Patient 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) the anatomical regions showing significant differences in 
functional activation between white and black stimuli (q < .05) for the patient in pre- and post-rTMS 
conditions, the Brodmann area, and (mean) Talairach coordinates of the cluster for the associated 
contrast. R = right (ipsilesional); L = left (contralesional). 
 
  
   Talairach coordinates 
  
Brodmann 
 White > black 
stimuli 
 Black > white 
stimuli 
Region area  x y z  x y z 
Patient pre-rTMS          
    R lingual gyrus 17      23 -82 3 
    R lingual gyrus 18  12 -76 4     
    L lingual gyrus 17  -7 -89 4     
    L lingual gyrus 18  -21 -71 -9     
    R cuneus 18  1 -80 16     
    L cuneus 18  -6 -87 12     
    L middle occipital gyrus 18      -27 -82 -8 
    R middle temporal gyrus 19  35 -80 22     
    L fusiform gyrus 19      -25 -84 -13 
    R anterior vermis (culmen)   16 -55 -10     
    L anterior vermis (culmen)       35 -51 -15 
Patient post-rTMS          
    R lingual gyrus 18  13 -68 1     
    L lingual gyrus   -17 -76 3     
    R middle occipital gyrus 19  27 -83 14     
    R cuneus 19  10 -83 26     
    L cuneus 18  -8 -86 14     
    R sub-gyral 37  49 -48 -5     
    R superior parietal lobule 7  19 -66 52     
    L superior parietal lobule 7  19 -66 54     
    L inferior parietal lobule 40  -37 -43 45     
    R precentral gyrus 6  51 -12 28     
    L precentral gyrus 6  -55 -4 34     
    L postcentral gyrus 3  -49 -15 50     
    R posterior lobe   28 -52 -13     
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Table 2.2. 
Phosphene Localiser Results for Controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) the anatomical regions showing significant differences in 
functional activation between white and black stimuli (q < .05) for age-matched controls, the Brodmann 
area, and (mean) Talairach coordinates of the cluster for the associated contrast. R = right; L = left.  
 
  
   Talairach coordinates 
  
Brodmann 
 White > black 
stimuli 
 Black > white 
stimuli 
Region area  x y z  x y z 
R lingual gyrus 17  14 -92 -2     
R lingual gyrus 18  13 -71 -3     
L lingual gyrus 17  -7 -87 -2     
L lingual gyrus 18  -3 -68 -2     
R cuneus 18  4 -85 22     
L cuneus 19  -4 -87 26     
R middle occipital gyrus 18      32 -79 2 
L middle occipital gyrus 19      -44 -71 4 
R inferior occipital gyrus 18      34 -80 -1 
L inferior occipital gyrus 18      -28 -88 -12 
R middle temporal gyrus 22      60 -45 5 
R fusiform gyrus 19      34 -78 -12 
R fusiform gyrus 37      42 -59 -7 
L superior parietal lobule 7  -33 -70 43     
R inferior parietal lobule 7  40 -60 44     
R inferior parietal lobule 39  40 -64 42     
R precentral gyrus 6  43 -8 52     
L precentral gyrus 6  -40 -12 36     
L precentral gyrus 4  -43 -11 45     
L postcentral gyrus 3  -51 -15 45     
R superior frontal gyrus 10  26 55 18     
R middle frontal gyrus 8  41 26 46     
R middle frontal gyrus 9  47 34 32     
L middle frontal gyrus 10  -37 54 9     
R inferior frontal gyrus 44  50 13 19     
R posterior lobe   15 -79 -17  28 -79 -20 
L posterior lobe   -12 -75 -20     
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Table 2.3. 
Subtraction Analysis of the Phosphene Localiser Between the Patient Pre-rTMS and Controls 
 
 
  
   Talairach coordinates  
 Brodmann  White stimuli  Black stimuli  
Region area  x y z  x y z  
Patient pre-rTMS         
    R lingual gyrus 17      24 -78 -1  
    R lingual gyrus 18      27 -83 4  
    R precuneus 31      19 -62 22  
    R cuneus 18  5 -71 21      
    L cuneus 19      -25 -78 24  
    L cuneus  18  -4 -71 18  -25 -78 23  
    L middle occipital gyrus 18      -23 -86 0  
    R inferior occipital gyrus 19      32 -75 0  
    L inferior occipital gyrus 18      -25 -86 -7  
    L sub-gyral 20  -47 -18 -16      
    R middle temporal gyrus 38  -48 5 -20      
    R middle temporal gyrus 21  58 -18 -10      
    L middle temporal gyrus 21  -50 -14 -16      
    R inferior parietal lobule 40  35 -38 44  50 -37 35  
    R precentral gyrus 9  -34 12 39      
    R superior frontal gyrus 10  33 51 19  16 61 24  
    R superior frontal gyrus 8  15 26 44      
    R middle frontal gyrus 46  49 37 14      
    R middle frontal gyrus 10      24 56 21  
    R middle frontal gyrus 9  43 20 32      
    R middle frontal gyrus 8      37 29 45  
    R middle frontal gyrus 6  36 3 44      
    L middle frontal gyrus 46  -47 19 20      
    L middle frontal gyrus 9  -36 18 28      
    L medial frontal gyrus 32  -17 12 47      
    R inferior frontal gyrus 47  30 29 -3      
    R inferior frontal gyrus 45  63 22 12      
    R inferior frontal gyrus 10  43 49 3      
    L inferior frontal gyrus 47  -34 30 -6      
    L inferior frontal gyrus 46  -45 41 10  -43 43 9  
    L inferior frontal gyrus 9      -54 14 27  
    L anterior cingulate 32  -8 33 20      
    R posterior cingulate 30  5 -58 6      
    L posterior cingulate 30  -23 -65 5      
    L anterior lobe (culmen)   -32 -38 -23      
    L posterior lobe   -40 -67 -25  -30 -82 -20  
    R claustrum   31 6 -3      
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 Table 2.3. (continued) 
   Talairach coordinates  
 Brodmann  White stimuli  Black stimuli  
Region area  x y z  x y z  
Controls        
    R lingual gyrus 17  13 -93 -2      
    R lingual gyrus 18  2 -80 -5      
    R precuneus 18  4 -90 15      
    R cuneus 23      1 -72 11  
    R cuneus 18      22 -89 16  
    R cuneus 17  13 -93 3  15 -90 8  
    L cuneus 18      -4 -82 22  
    L cuneus  19  -6 -84 30      
    L middle occipital gyrus 18      -20 -90 12  
    L superior temporal gyrus 13  -47 -20 7      
    R middle temporal gyrus 19      38 -78 20  
    L middle temporal gyrus 21  -50 -41 11      
    R inferior temporal gyrus 37      -47 -50 0  
    L precentral gyrus 6  -56 1 38      
    R superior frontal gyrus 6      12 13 60  
    L superior frontal gyrus 9  -31 48 34      
    R middle frontal gyrus 46  46 44 27      
    R middle frontal gyrus 6  32 23 54      
    R medial frontal gyrus 10  15 57 12      
    L anterior cingulate 32  -21 41 2      
    R posterior lobe   1 -81 -16      
    L posterior lobe   -7 -83 -20      
 
Note. Beta-difference maps (b > 0.5) between the patient pre-rTMS and age-matched controls. The 
columns list (from left to right) the anatomical regions showing differences in functional activation for the 
patient and controls, the Brodmann area, and (mean) Talairach coordinates of the cluster for the 
associated stimuli. R = right (ipsilesional in the patient); L = left (contralesional in the patient). 
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Table 2.4. 
Subtraction Analysis of the Phosphene Localiser Between the Patient Post-rTMS and Controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Beta-difference maps (b > 0.5) between the patient post-rTMS and age-matched controls. The 
columns list (from left to right) the anatomical regions showing differences in functional activation for the 
patient and controls, the Brodmann area, and (mean) Talairach coordinates of the cluster for the 
associated stimuli. No clusters of activity were observed to be greater in controls for both white and black 
stimuli (b < 0.5). R = right (ipsilesional); L = left (contralesional). 
 
   Talairach coordinates  
 Brodmann  White stimuli  Black stimuli  
Region area  x y z  x y z  
Patient post-rTMS         
    R lingual gyrus 18  13 -75 4  3 -87 -13  
    R lingual gyrus 17      12 -93 -4  
    L lingual gyrus 18      -9 -90 -10  
    L lingual gyrus 17  -11 -85 4      
    R precuneus 19  32 -74 31      
    R precuneus 7  15 -63 47      
    L precuneus 31  -1 -74 27      
    L precuneus 19  -28 -75 31      
    L precuneus 7  -24 -55 47      
    R cuneus 18  9 -80 20      
    R cuneus 17  11 -78 12      
    L cuneus  23  -1 -72 11      
    L cuneus 18  -4 -87 11      
    R middle occipital gyrus 19  32 -79 10      
    L middle occipital gyrus 19  -33 -82 10      
    L fusiform gyrus 18      -26 -86 -17  
    R middle temporal gyrus 37  52 -58 -8      
    L middle temporal gyrus 37  -58 -50 -6      
    L precentral gyrus 6  -50 2 28      
    R inferior frontal gyrus 9  48 8 30      
    R posterior cingulate 30  26 -55 13      
    R posterior lobe   27 -58 -13      
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CHAPTER 3 
 
ALTERED WHITE MATTER CONNECTIVITY  
ASSOCIATED WITH VISUAL HALLUCINATIONS  
FOLLOWING OCCIPITAL STROKE2 
 
 
  
                                                 
2Adapted version published as: Rafique, S. A., Richards, J. R., & Steeves, J. K. E. (2018). Brain and Behaviour, 
e01010. 
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Preface 
We sought to determine if structural changes in white matter connectivity play a role in the 
aberrant functional activity that is observed in cases of chronic visual hallucinations associated 
with visual pathway damage. We performed DTI and probabilistic fibre tractography to assess 
white matter connectivity in a patient suffering from continuous and disruptive phosphene 
hallucinations for more than two years following right occipital stroke. Data were compared to 
that of healthy age-matched controls. Probabilistic tractography to reconstruct white matter tracts 
suggested regeneration of terminal fibres of the ipsilesional optic radiations in the patient. 
However, arrangement of the converse reconstruction of these tracts, which were seeded from 
the ipsilesional visual cortex to the intrahemispheric lateral geniculate body, remained disrupted. 
We further observed compromised structural characteristics and changes in diffusion (measured 
using diffusion tensor indices) of white matter tracts in the patient connecting the visual cortex 
with frontal, parietal, and temporal regions, and also in interhemispheric connectivity between 
visual cortices. Cortical remapping and the disruption of connectivity between visual cortices 
and remote regions are consistent with our previous fMRI data showing imbalanced functional 
activity in the same regions in this patient (Chapter 2; Rafique et al., 2016). Long-term adaptive 
and disruptive changes in white matter connectivity may account for cases presenting with 
chronic visual hallucinations, particularly in the rare nature of continuous hallucinations. 
Investigation of structural white matter connectivity can be valuable for providing prognostic 
information and resistance to therapeutic interventions (e.g., neuromodulation).  
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Previous fMRI studies have shown that visual hallucinations following vision loss are 
associated with disorganised functional activity in visual cortices across both hemispheres, and 
in interconnected cortical and subcortical networks (ffytche et al., 1998; Rafique et al., 2016). 
We sought to determine if structural changes in white matter connectivity are also present in 
cases of chronic visual hallucinations following visual pathway damage. Cortical injury induces 
a process of remapping and reconnection within the adult brain through changes in neuronal 
activity. Lesions can induce axonal sprouting within local intra- and interhemispheric projections 
to establish substantially new patterns of cortical connections with deafferented or partially 
damaged brain areas (for a review, see Carmichael, 2003; Darian-Smith & Gilbert, 1995). 
Investigation of structural connectivity can provide valuable information for determining the 
appropriate therapeutic protocol and prognosis, as well as longer-term post-treatment efficacy 
(Inzitari et al., 2009; Kunimatsu et al., 2003). We employed DTI and probabilistic fibre 
tractography to enable noninvasive investigation of white matter structure. To gain information 
about the integrity of white matter, the diffusion of water in white matter tracts that is influenced 
by underlying microstructure and orientation of axonal fibres was characterised using diffusion 
tensor indices: FA (directionality of diffusion parallel to fibre tracts), MD (directionally averaged 
measure of diffusion), AD (measure of diffusion parallel to axonal fibres), and RD (measure of 
diffusion perpendicular to axonal fibres). Probabilistic fibre tracking algorithms use directions of 
greatest diffusion to estimate white matter fibre orientation and employ Bayesian modelling to 
infer these fibre directions and generate 3D depictions of white matter tracts (Behrens, Berg, 
Jbabdi, Rushworth, & Woolworth, 2003; Ciccarelli, Catani, Johansen-Berg, Clark, & Thompson, 
2008). 
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We investigated a patient experiencing chronic and continuous phosphene hallucinations 
following occipital stroke. In a previous study (Chapter 2; Rafique et al., 2016), the patient 
underwent fMRI and therapeutic treatment with rTMS to the lesion site to provide relief from 
hallucinations that were interfering with quality of life. fMRI showed aberrant functional activity 
in visual cortices, and an imbalance of activity across frontal, parietal, temporal, and cerebellar 
regions prior to rTMS treatment. In the present study, we investigated whether the previously 
documented aberrant functional activity and persistent nature of hallucinations in the patient 
(Chapter 2; Rafique et al., 2016) were a reflection of compromised structural characteristics in 
white matter connectivity. We used DTI and probabilistic tractography to examine white matter 
connectivity between cortical regions implicated in our previous fMRI study. Moreover, in our 
previous fMRI study, we observed some restoration of functional activity in the patient following 
treatment with rTMS. However, this redistribution of functional activity post-rTMS in the patient 
did not completely match that of controls; and despite a significant reduction in intensity of 
visual hallucination with rTMS treatment, the hallucinations persisted, albeit to a lesser extent 
(Chapter 2; Rafique et al., 2016). We further expected that this incomplete functional restoration 
and failure to fully suppress the hallucinations with rTMS would in part, if not wholly, be due to 
white matter connectivity changes. There are presently no cases in the literature that have 
investigated white matter in cases of visual hallucinations following visual pathway damage.  
Methods 
This study was approved by York University’s Office of Research Ethics. All individuals 
gave informed written consent. 
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Participants 
We evaluated a 31-year-old female experiencing persistent and disruptive phosphene 
hallucinations within an incomplete congruous left homonymous hemianopia for 2.5 years 
following right subacute occipital stroke. A detailed patient history and description of visual 
hallucinations is provided in Chapter 2 (see Methods: Participants, pp. 39–41). 
 Seven age-matched healthy female control participants (Mage ± SEM = 29 ± 0.79 years) 
with no history of neurological disorders, and normal or corrected-to-normal vision (> 0.2 
logMAR; stereoacuity ≥ 50”) were recruited. All participants (patient included) had taken part in 
a previous fMRI study (Chapter 2; Rafique et al., 2016).  
Magnetic Resonance Imaging  
Whole-brain imaging was acquired with a 3T Siemens Magnetom® Tim Trio magnetic 
resonance scanner and a Siemens 32-channel high-resolution brain array coil (Siemens, Erlanger, 
Germany). Head motion was minimised with the placement of soft pads holding the participant's 
head in place. DTI was obtained with diffusion-weighted scanning using two-dimensional (2D) 
gradient echo echo-planar sequencing (number of contiguous axial slices = 56; in-plane 
resolution = 1.5 x 1.5 mm; slice thickness = 2 mm with no interslice gap; imaging matrix = 128 x 
128; TR = 6900 ms; TE = 86 ms; FoV = 192 mm) with 64 isotropically distributed orientations 
for the diffusion-sensitising gradients at a b-value of 1000 s/mm2, and b = 0 s/mm2 for T2-
weighted images. Anatomical images were acquired with a T1-weighted sequence using 3D 
MPRAGE (number of slices = 192; in-plane resolution = 1 x 1 mm; slice thickness = 1 mm; 
imaging matrix = 256 x 256; TR = 1900 ms; TE = 2.5 ms; inversion time (TI) = 900 ms; flip 
angle = 9°; FoV = 256 mm). A T2-weighted turbo spin echo fluid attenuated inversion recovery 
(FLAIR) imaging sequence was obtained in the patient to localise the lesion site (number of 
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slices = 25; in-plane resolution = 0.9 x 0.9 mm; slice thickness = 4 mm; imaging matrix = 256 x 
256; TR = 900 ms; TE = 93 ms; TI = 2500 ms; flip angle = 130°; FoV = 220 mm). 
Data Analyses 
All DTI analyses were performed using FSL’s DTI processing pipeline (FMRIB, Oxford, 
UK; www.fmrib.ox.ac.uk/fsl).  
Image processing and normalisation. Diffusion images underwent preprocessing. 
Diffusion images were corrected for eddy current-induced spatial distortions and head motion 
using affine registration to the reference (b0) volume (Andersson & Sotiropoulos, 2016) within 
FSL’s diffusion toolbox (FDT), and brain-extracted using the brain extraction tool (BET) to 
remove skull and head tissue (Smith, 2002). T1-weighted images also underwent brain-
extraction using BET. Diffusion tensor models were fitted at each voxel of the eddy current 
corrected diffusion data using standard linear regression with the diffusion tensor fitting program 
(DTIFIT) of the FDT toolbox. The brain-extracted T1-weighted images underwent linear 
registration to diffusion space and also to standardised Montreal Neurological Institute (MNI) 
space (MNI152, 1 x 1 x 1 mm) using the linear image registration tool (FLIRT; Jenkinson, 
Bannister, Brady, & Smith, 2002) with default parameters (affine 12 degrees of freedom; 
correlation ratio cost function; tri-linear interpolation). Diffusion images were non-linearly 
registered to T1-weighted anatomical and standard MNI spaces (MNI152, 1 x 1 x 1 mm) to 
derive transformation matrices using the non-linear image registration tool (FNIRT) of FDT 
(Andersson, Jenkinson, & Smith, 2007) with default parameters (normal search; correlation ratio 
cost function; 6 and 12 degrees of freedom for anatomical and standard space, respectively). T1-
weighted images were also registered to standard MNI space (MNI152, 1 x 1 x 1 mm). 
 75 
Diffusion tensor indices. The diffusion tensor indices FA, MD, AD, and RD were 
extracted from 11 major white matter tracts of John Hopkins University (JHU) white-matter 
tractography atlas provided with FSL (Wakana et al., 2007). Accordingly, diffusion tensor 
indices were extracted from the following bilateral tracts: anterior thalamic radiations, 
corticospinal tracts, cingulum (cingulate gyrus and hippocampus), inferior fronto-occipital 
fasciculi, inferior longitudinal fasciculi, superior longitudinal fasciculi, temporal aspects of 
superior longitudinal fasciculi, and uncinate fasciculi. Diffusion tensor indices were also 
extracted from the forceps major and minor. Indices were extracted using tract-based spatial 
statistics (TBSS; Smith et al., 2006). Using the diffusion-weighted brain images computed from 
DTIFIT, each participant’s FA image underwent preprocessing to remove outliers from the 
diffusion tensor fitting. The FA image was then aligned to standard MNI space using affine non-
linear registration, and thinned to create a binary skeleton image using a threshold of FA > 0.2. 
Tracts from the JHU atlas were thresholded at a 15% probability to allow for inter-subject 
variation and binarised. Each binarised tract was then co-registered (masked) to each 
participant’s binary skeleton diffusion image using fslmaths. The fit of the white matters tracts 
was manually assessed to ensure accurate overlap with skeleton images. White matter tract 
values were then extracted from skeletonised diffusion images for each participant and each tract 
separately using fslmeants. To obtain the non-FA diffusion indices, the FA-derived non-linear 
transformations were applied to the MD, AD, and RD images, and projected onto the FA binary 
skeleton to estimate projection vectors from the same voxels as in the FA analysis. AD was 
defined as the principal diffusion eigenvalue (λ1), and RD as the mean of the second and third 
eigenvalues (λ2 + λ3/2). The extracted diffusion tensor indices underwent statistical analyses to 
compare the patient with controls using the modified independent t-test (one-tailed) for single-
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case studies (Crawford & Garthwaite, 2002). We report significant differences in diffusion tensor 
indices at p < .05, and trending significance at p < .1. 
Probabilistic fibre tractography. Our main interests were tracts connected with the 
visual cortex (primary and association cortices) consistent with the location of the patient’s 
lesion site. Tracts of interest were generated to cortical regions of interest based on our previous 
fMRI findings, which showed functional differences in BOLD signal between the patient (prior 
to rTMS, consistent with visual system status at time of DTI acquisition) and controls (Chapter 
2; Rafique et al., 2016). To reconstruct tracts of interest, we used FDT’s Bayesian estimation of 
diffusion parameters obtained using sampling techniques for modelling crossing fibres 
(BEDPOSTX), which uses Markov Chain Monte Carlo sampling to estimate diffusion 
parameters at each voxel and model crossing fibres within each voxel of the corrected diffusion 
data (Behrens et al., 2007). We then used FDT’s probabilistic tracking with crossing fibres 
(PROBTRACKX) to generate fibre tractography in MNI space (Behrens et al., 2007). A two-
region of interest approach was used to isolate streamlines (tracts). A seed mask was placed at 
the visual cortex (to include primary and association cortices, i.e., Brodmann areas 17, 18, 19) to 
waypoint (identifies tracts passing through this point only) and terminate (end point) in 
intrahemispheric sub-regions of frontal lobe gyri (superior, middle, and inferior), temporal lobe 
gyri (superior, and middle temporo-occipital), parietal lobules (superior and inferior), and 
precentral and postcentral gyri, independently. We further reconstructed the optic radiations by 
placing a seed mask at the lateral geniculate body, and waypoint and termination masks at the 
ipsilateral primary visual cortex. A converse intrahemispheric reconstruction was generated from 
the primary visual cortex (seed mask) to the lateral geniculate body (waypoint and termination 
masks) as these are shown to differ from feedforward connections (Shipp, 2007; Sillito, Cudeiro, 
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& Jones, 2006). A cerebral white matter exclusion mask of the opposite hemisphere was used to 
limit tracts within the ipsilateral hemisphere and minimise false positive tracts. Tracts were 
reconstructed for all participants and both hemispheres. To investigate interhemispheric 
connectivity between the visual cortices, a seed mask was placed at one hemisphere of the visual 
cortex with waypoint and termination masks placed at the contralateral visual cortex (with no 
exclusion mask). This was reversed to generate interhemispheric connections between the visual 
cortices for the opposite direction. Interhemispheric visual cortex connectivity was also 
reconstructed for all participants separately. Fibre tracking involved 5000 streamlines drawn 
from each voxel in the seed mask through the probability distribution in the principle fibre 
direction. Streamlines ended at a pathway curvature threshold of 0.2 (~80°) and a maximum 
number of 2000 steps (step length of 0.5 mm) (default parameters). Reference to seed and 
termination points does not imply tract directionality, but strictly refers to the generation of tracts 
from every point in the seed to only enter and end at the target termination point. Tracts were 
visually inspected for changes in size and orientation compared with the contralateral 
hemisphere, and comparing the patient with controls. 
Results 
Diffusion Tensor Indices 
A T2-weighted image and colour-coded FA map for the patient indicating the lesion site 
are shown in Figure 3.1. Table 3.1 contains values for diffusion tensor indices obtained from the 
11 major white matter tracts and demonstrates significant differences in diffusivity between the 
patient and controls. 
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Probabilistic Fibre Tractography 
Reconstruction of intrahemispheric tracts seeded from the visual cortex to the inferior 
frontal gyrus showed greater tracts for the patient within the ipsilesional visual cortex compared 
with the contralesional hemisphere and controls (Figure 3.2a). Similarly, for intrahemispheric 
tracts seeded from the ipsilesional visual cortex to the precentral gyrus, the patient showed 
greater tracts close to the precentral gyrus relative to the contralesional hemisphere and controls 
(Figure 3.2b).  
 Probabilistic tractography for the patient further showed incomplete intrahemispheric 
tracts seeded from the ipsilesional visual cortex to superior temporal and middle temporo-
occipital gyri, and the lateral geniculate body, compared with the contralesional hemisphere and 
controls (Figure 3.3a-c, respectively). This is observed from the absence of intrahemispheric 
tracts within the ipsilesional visual cortex in the patient—instead the tracts originate further 
anteriorly, closer to anterior temporo-occipital regions.  
 Reconstruction of the optic radiations in the patient shows a marked displacement of 
ipsilesional optic radiations relative to the contralesional hemisphere and controls. The terminal 
fibres of the patient’s ipsilesional optic radiations are seen to deviate anterior to the lesion site 
(Figure 3.4). 
Altered interhemispheric connectivity between visual cortices is observed in the patient. 
Tracts seeded from the ipsilesional visual cortex fail to terminate in the contralesional visual 
cortex, and instead discontinue at the midline. However, the converse is spared as tracts seeded 
from the contralesional visual cortex continue past the midline and terminate in the ipsilesional 
visual cortex (Figure 3.5). In comparison, control participants demonstrate overlapping 
interhemispheric connections (Figure 3.5). 
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Given that directionality cannot be inferred from probabilistic tractography, it is 
important to note that tracts seeded from the lateral geniculate body to the visual cortex are 
intermingled with and cannot be differentiated from the converse reconstruction of these tracts 
(i.e., seeded from the visual cortex to the lateral geniculate body) using this method. The same 
applies to interhemispheric visual cortex tracts. 
 For ease of comparison of probabilistic fibre tractography between the patient and 
controls, we only present data of one control example in Figures 3.2–3.5. The results of 
probabilistic tractography for all other controls are presented in Appendix A (Figures A1–A7). 
Despite inter-individual variation in tracts, the patient consistently showed these differences 
compared with all control participants.  
 No differences were observed between the patient and controls for intrahemispheric tracts 
seeded from the visual cortex to superior and middle frontal gyri, and postcentral gyrus. 
Probabilistic tractography did not reveal tracts from the visual cortex to the middle temporal 
gyrus or parietal lobules in the patient or controls based on our seed and termination masks.  
Discussion 
Diffusion imaging highlights changes in diffusion indices of major white matter tracts 
associated with the patient’s lesion site compared with controls. Moreover, probabilistic fibre 
tractography demonstrates changes in white matter tracts between the visual cortex and remote 
regions in the patient that are consistent with previously observed alterations in functional 
activity between the patient and controls. Overall, these results suggest that altered global 
structural connectivity contributes to chronic cases of visual hallucinations in visual pathway 
damage. 
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White Matter Changes with Occipital Stroke and Associated Vision Loss 
In the patient, we observed incomplete intrahemispheric tracts from the ipsilesional visual 
cortex to superior temporal and middle temporo-occipital gyri (Figure 3.3a-b, respectively). This 
finding is consistent with observed differences in functional activation within these regions 
between the patient and controls during a basic visual task (Chapter 2, Tables 2.1–2.3). Although 
we only observed greater intrahemispheric tracts from the ipsilesional visual cortex to the 
inferior frontal gyrus (Figure 3.2a), the patient has shown significantly greater functional 
activation in bilateral inferior frontal gyri compared with controls (Chapter 2, Table 2.3). These 
regions are connected via the major white matter tracts superior longitudinal and inferior fronto-
occipital fasciculi. The superior longitudinal fasciculus connects frontal, parietal, temporal, and 
occipital lobes (Catani, Howard, Pajevic, & Jones, 2002), while the inferior fronto-occipital 
fasciculus connects the frontal lobe with posterior aspects of parietal, temporal, and occipital 
lobes (Martino, Brogna, Robles, Vergani, & Duffau, 2010). The inferior fronto-occipital 
fasciculus further passes through the lateral geniculate body and claustrum (Kier, Staib, Davis, & 
Bronen, 2004). Not only did the patient show incomplete tracts from the ipsilesional visual 
cortex to the intrahemispheric lateral geniculate body (Figure 3.3c), our previous fMRI findings 
implicate the ipsilesional claustrum in the genesis of visual hallucinations in this patient (Chapter 
2, Table 2.3).  
The inferior longitudinal fasciculus connects anterior temporal and posterior occipito-
temporal regions of the occipital lobe, including visual association areas, fusiform and 
parahippocampal gyri (Catani, Jones, & Donato, 2003; Wakana, Jiang, Nagae-Poetscher, van 
Zijl, & Mori, 2004). Given that the lesion site involved the right visual association areas (Chapter 
2, Figure 2.1b), it did indeed compromise the structural integrity of the right inferior longitudinal 
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fasciculus (Figure 3.1b; Table 3.1). Additionally, the visual association areas (e.g., lingual gyrus 
and cuneus) showed the most obvious alterations in functional activity in our patient and were 
considered the primary regions contributing to the perception of visual hallucinations (Chapter 2, 
Figure 2.4).  
 Changes in FA and/or AD of the superior (including temporal aspects) and inferior 
longitudinal fasciculi in the patient (Table 3.1) are therefore not surprising given the disruption 
to diffusivity at the stroke site (Figure 3.1), and consequent changes in tractography between 
regions concerned with these fasciculi (Figures 3.2–3.3). Altered FA suggests changes to white 
matter microstructure (Jones et al., 1999) indicative of change in aspects of connectivity (Jones, 
Simmons, Williams, & Horsefield, 2013). AD measures are considered variable in white matter 
changes and pathology; however, a decrease is observed in axonal injury/damage (Song et al., 
2002). Despite involvement of intrahemispheric ipsilesional tracts in the patient (Figures 3.2a, 
3.3b-c) implicating the ipsilesional inferior fronto-occipital fasciculus, it was the contralesional 
inferior fronto-occipital fasciculus that showed significantly lower AD (Table 3.1). A possible 
explanation for contralesional inferior fronto-occipital fasciculus involvement may be from 
sharing of axons with the ipsilesional fasciculus or axons originating from the lesion site. 
Alterations in interhemispheric white matter connectivity between visual cortices in the 
patient (Figure 3.5) offer further explanation to the disorganised and imbalanced functional 
activity in visual processing regions previously observed across both hemispheres, for example, 
greater functional activity in the contralesional hemisphere (Chapter 2, Figure 2.4).  
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Compensatory White Matter Changes with Occipital Stroke and Associated Vision 
Loss  
The marked displacement of the ipsilesional optic radiations in the patient (Figure 3.4) 
suggests recovery of function with new connections via recruitment of peri-infarct regions that 
adapt to new roles after stroke (Carmichael, 2003; Cramer, 2008). The optic radiations carry 
visual information from the retina via the lateral geniculate body to the primary visual cortex. 
Damage to the optic radiation pathway is consistent with the presence of hemianopia in the 
patient (Chapter 2, Figure 2.1a). Quite notably, the location of terminal fibres of the ipsilesional 
optic radiations is consistent with the location of disorganised functional activity anterior to the 
patient’s lesion at the lingual gyrus (Chapter 2, Figure 2.4). In this patient, it appears that input 
from the retina to ipsilesional visual cortex, via remapping of optic radiations, produces 
sustained sensory responses in new structural circuits in peri-infarct regions; and this aberrant 
neuronal firing may produce the perception of phosphene hallucinations in the area of 
hemianopia. Indeed, in vivo cortical recordings of mice show an effect of prolonged 
depolarisation at remapped peri-infarct regions and in regions with greater connectivity post-
stroke (Brown, Aminoltejari, Erb, Winship, & Murphy, 2009). A DTI study in an infant with 
perinatal temporo-parieto-occipital stroke shows the same pattern of regeneration of ipsilesional 
optic radiations (Seghier et al., 2005) as in our patient. In both cases, the location of terminal 
fibres of the regenerated optic radiations are consistent with the location of disorganised 
ipsilesional functional activity. Moreover, ipsilesional functional activation in the infant was 
localised anterior to the lesion at the lingual gyrus in the same manner as our patient. No follow-
up was reported in the infant past 20 months of age; therefore, we cannot ascertain whether 
visual hallucinations manifested in the infant.  
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Despite the pattern of regeneration of ipsilesional optic radiations, we do not see such a 
recovery in the converse reconstruction of these tracts (seeded from the visual cortex to the 
lateral geniculate body) that remain disrupted in the patient (Figure 3.3c) and may suggest 
retrograde degeneration. Post-mortem studies of occipital lobotomies in primates have shown 
retrograde degeneration persists back to the retina corresponding to the visual field 
representation of the damaged occipital cortex (Cowey, 1974; Johnson & Cowey, 2000). 
Lower FA and increased RD were observed in the contralesional corticospinal tract of the 
patient (Table 3.1). An increase in RD suggests white matter pathology (Song et al., 2002) in this 
motor pathway. Although motor deficits were not a consequence of stroke in our patient, 
corticospinal tract plasticity following early vision loss is thought to arise from overcoming 
difficulty with eye-hand coordination from loss of vision (Yu et al., 2007). Many corticospinal 
neurons originate in the precentral gyrus (Dum & Strick, 1991), and accordingly, we observed 
greater tracts from the ipsilesional visual cortex to the intrahemispheric precentral gyrus (Figure 
3.2b). These combined findings may indicate compensation for the need for increased left eye-
hand coordination following left homonymous hemianopia in the patient. Consistent with these 
structural white matter changes, subtraction analysis of fMRI responses during a basic visual task 
between the patient and controls has shown greater patient activation in the ipsilesional (right) 
precentral gyrus, while controls showed greater activation in the left precentral gyrus (Chapter 2, 
Tables 2.2–2.3). 
Changes in white matter tracts in the patient at both ipsi- and contralesional hemispheres 
stem from altered intra- and interhemispheric communication, e.g., major forceps, or 
commissural tracts. Early studies of occipital lobe lesions in animals show retinotopic 
reorganisation and changes of neuronal response properties in the ipsilesional hemisphere, and 
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aberrant distribution of callosal connections in both ipsi- and contralesional hemispheres (Payne 
& Lomber, 2001; Restrepo, Manger, Spenger, & Innocenti, 2003). Greater ipsilesional tracts in 
the patient (Figure 3.2) suggest recruitment of redundant neurons/interneurons. Global over-
connectivity is observed in patients with hemianopia following occipital stroke, with greater 
node strength in ipsilesional temporal and orbitofrontal areas as well as the contralesional visual 
association cortex (Guo, Jin, Feng, & Tong, 2014). Reduced contralesional tracts (Figure 3.2) 
may occur to compensate for changes in ipsilesional tracts (e.g., greater tracts), or from pruning 
that occurs from loss of interhemispheric communication following stroke (Grefkes et al., 2008). 
White Matter Changes Associated with Persistent Visual Hallucinations  
Reduced FA of the contralesional anterior thalamic radiation in the patient (Table 3.1), 
which connects the anterior and dorsomedial thalamic nuclei with the prefrontal cortex (Wakana 
et al., 2004), suggests changes to white matter microstructure and connectivity of this tract 
(Jones et al., 2013, 1999). Thalamic degeneration is previously implicated in visual 
hallucinations (Manford & Andermann, 1998), consistent with its involvement in this patient. 
Additionally, reduced FA in the anterior thalamic radiation is observed in cases of auditory 
hallucinations in schizophrenia (Ćurčić-Blake et al., 2015). The uncoupling of processes 
underlying perception from sensory input are linked to the emergence of hallucinations via 
dysregulation of thalamic sensory transmission (Behrendt, 2006). 
 The inferior longitudinal and inferior fronto-occipital fasciculi are involved in visual 
perception (ffytche, 2008) and visual processing (Fox, Iaria, & Barton, 2008). As in our patient, 
visual hallucinations have been linked to lower FA in the inferior longitudinal fasciculus in 
individuals with schizophrenia (Ashtari et al., 2007) and dementia with Lewy bodies (Kantarci et 
al., 2010), suggesting an association of visual hallucinations with temporo-occipital projections. 
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Furthermore, frontal lesions can produce visual hallucinations in the temporal and occipital lobes 
thought to arise through the spread of increased activity from one area to another (Schneider, 
Crosby, Bagchi, & Calhoun, 1961). Consistent with this notion, direct electrical stimulation of 
the inferior frontal gyrus evokes visual hallucinations of faces considered to originate from 
activity propagated in the prefrontal cortex along white matter pathways to face processing 
regions (Vignal, Chauvel, & Halgren, 2000), for example, via the inferior longitudinal fasciculus. 
In addition to frontal stimulation, stimulation of the temporal lobe (Lee, Hong, Seo, Tae, & 
Hong, 2000; Penfield & Perot, 1963) and visual cortices (Lee et al., 2000) also evokes visual 
hallucinations. This suggests that it is not simply an increase and/or disorganisation of activity in 
visual associated cortices that produce visual hallucinations (ffytche et al., 1998; Rafique et al., 
2016), but rather, the additional involvement of these white matter tracts (and accordingly 
specific networks) that differentiates these patients from those with similar disorders who do not 
experience visual hallucinations.   
Limitations 
Given the single-case study approach of the present research, we appreciate that the data 
may be insufficient to generalise specific plasticity effects following occipital stroke associated 
with chronic visual hallucinations. In addition, due to the number of independent t-tests, and the 
less conservative threshold for trending results (p < .1), some differences in diffusion tensor 
indices between the patient and controls (Table 3.1) may reflect statistical noise. Further 
diffusion imaging studies in patients with visual pathway damage who perceive visual 
hallucinations and those who do not are necessary in order to isolate factors predisposing 
individuals to visual hallucinations. To our knowledge, other than the case of perinatal stroke 
(Seghier et al., 2005), there are no other studies reported in the literature investigating white 
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matter structure in visual pathway damage with or without visual hallucinations. Knowledge of 
white matter structure is pivotal in elucidating underlying mechanisms of brain function 
associated with chronic and disruptive visual hallucinations in these patients. Evaluation of white 
matter connectivity in other leading causes of vision loss associated with visual hallucinations 
(e.g., age-related macular degeneration) is also needed to confirm or refute our hypotheses 
implicating specific structural networks and remapping in visual hallucinations.  
The patient presents with a benign subarachnoid cyst at the occipital pole (Figure 3.1a). 
The cyst impinges on deeper occipital and cerebellar structures, and its location is sufficiently far 
removed that we would not expect it to directly affect the reconstruction of white matter tracts in 
this study. Therefore, the cyst would not account for the atypical anatomy of these tracts. Our 
results continue to show clear disturbance to white matter tracts in regions that are far from the 
cyst (e.g., Figure 3.2b).  
Our tractography findings in the patient may also be influenced by diffusion properties of 
the lesion, for example, diffusion values within the lesion may be outside of the probabilistic 
tractography thresholds. A greater number of streamlines (tracts) can occur in probabilistic 
tractography in cases of Wallerian degeneration, where intact pathways with higher anisotropy 
will show a greater number of streamlines than the damaged pathways (Jones, 2010). However, 
the probabilistic tractography approaches used in this study (multi-fibre and a priori regions of 
interest) are shown to track reliably (Behrens et al., 2007; Dyrby et al., 2007), are fairly accurate 
in cases of crossing fibres, and can track through areas of low FA (Jones, 2010) such as 
degeneration of microstructure following stroke and in artefacts (Behrens et al., 2003; Jones, 
Travis, Eden, Pierpaoli, & Basser, 2005). It is important to clarify that probabilistic tractography 
does not indicate the strength of connectivity but only estimates the probability (Jones, 2010). 
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Tractography results compared with post-mortem dissection show DTI based tractography to be 
reliable (Lawes et al., 2008). Further, changes in diffusion tensor indices in our patient cannot 
simply be interpreted as compromised microstructure of white matter, e.g., specific to axonal 
changes or neurodegeneration, etc. Interpretation of diffusion indices is uncertain when other 
factors such as glial cells or crossing fibres of similar density may contribute to water diffusion 
(Jbabdi, Behrens, & Smith, 2010). However, we can be more certain that axonal loss has 
occurred from known Wallerian degeneration in stroke, and accordingly the degeneration of 
neurons. 
Although we are cognisant that this is a single-case study and acknowledge that this case 
report using DTI is speculative, we have attempted to constrain the methods to the best of our 
ability by comparing to an age-matched healthy control group, as well as comparing intra-
individual tracts between contralesional and ipsilesional hemispheres, and previous fMRI data to 
strengthen the validity of the current findings. Further, as we are unable to acquire longitudinal 
data in the patient, we can only speculate as to the nature of the tracts with respect to 
regeneration and reorganisation. 
Conclusion 
In short, our results point towards interruption of specific white matter tracts (networks) 
and cortical remapping as the root of disorganised functional activity in the patient that leads to 
the continued perception of visual hallucinations. Cortical reorganisation may offer explanation 
for chronic visual hallucinations differentiating this case from the more common reports of acute 
visual hallucinations (Manford & Andermann, 1998; Vaphiades et al., 1996). The extent of 
structural reorganisation in our patient likely explains why rTMS did not produce a more 
sustained mitigatory response in that long-term aberrant connectivity persists and is not easily 
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overcome with temporary neuromodulation. Diffusion imaging and fibre tractography combined 
with fMRI in future studies will provide a more accurate visualisation of plasticity following 
visual pathway damage associated with visual hallucinations in order to ascertain treatment 
modalities directed at improving functional outcome. To maximise functional recovery and 
prevent continued abnormal neural processing, it is likely that neuromodulatory intervention 
(e.g., rTMS) needs to be applied much earlier post-injury within the plasticity window for 
recovery (Kasten et al., 1998; Pinter & Brainin, 2013) before more permanent aberrant white 
matter connectivity changes occur.  
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Figure 3.1. Diffusion images for the patient. (a) T2-weighted image shows no obvious lesion 2.5 
years after occipital stroke. ‘X’ marks the location of a benign subarachnoid cyst. (b) Diffusion 
tensor image of a colour-coded FA map for the patient. Reduced anisotropy is observed at the lesion 
site (yellow box) and shows disruption in diffusivity at the right inferior longitudinal fasciculus 
(ILF)/inferior fronto-occipital fasciculus (IFOF), which merge with the optic radiations (OR) that are 
also disrupted. Red represents fibres crossing left–right, green represents fibres in the posterior–
anterior direction, and blue represents fibres in the inferior–superior direction. Average MNI 
coordinates of lesion site: x = 15, y = -68, z = 5. L = left; R = right.  
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Figure 3.2. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex 
to: (a) inferior frontal gyrus (white mask), and (b) precentral gyrus (lime green mask). Only one 
control example is presented here, all other controls are presented in Appendix A (Figures A1–A2, 
respectively). See Figure 3.5 for an example of the visual cortex mask (red mask). L = left 
(contralesional in the patient); R = right (ipsilesional in the patient).  
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Figure 3.3. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex 
to: (a) superior temporal gyrus (yellow mask), (b) middle temporo-occipital gyrus (peach mask), and 
(c) lateral geniculate body (pink mask). Only one control example is presented here, all other controls 
are presented in Appendix A (Figures A3–A5). See Figure 3.5 for an example of the visual cortex 
mask (red mask). L = left (contralesional in the patient); R = right (ipsilesional in the patient). 
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Figure 3.4. Probabilistic fibre tractography of the optic radiations. Tracts were seeded from the 
lateral geniculate body to the visual cortex (red mask). Only one control example is presented here, 
all other controls are presented in Appendix A (Figure A6). See Figure 3.3c for an example of the 
lateral geniculate body mask (pink mask). L = left (contralesional in the patient); R = right 
(ipsilesional in the patient). 
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Figure 3.5. Probabilistic fibre tractography of interhemispheric connections between visual cortices. 
In the patient, tracts seeded from the ipsilesional (right) hemisphere (light green tracts) do not cross 
the midline to terminate in the contralesional (left) hemisphere, while contralesional to ipsilesional 
(dark green tracts) interhemispheric tracts do. In controls, tracts seeded from the right visual cortex 
(dark blue tracts) do cross the midline to connect with the left visual cortex, and vice versa (blue 
tracts), resulting in overlapping interhemispheric connections (light blue and pink tracts). Only one 
control example is presented here, all other controls are presented in Appendix A (Figure A7). L = 
left; R = right.
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Table 3.1.  
Diffusion Tensor Indices for Major White Matter Tracts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) the major white matter tracts and their associated diffusion tensor indices for controls and the patient. 
Data are presented as mean (± SEM) control and single patient values. R = right; L = left; ATR = anterior thalamic radiation; cCG = cingulum - 
cingulate gyrus; cH = cingulum - hippocampus; CT = corticospinal tract; FMa = forceps major; FMi = forceps minor; IFOF = inferior fronto-
occipital fasciculus; ILF = inferior longitudinal fasciculus; SLF = superior longitudinal fasciculus; tSLF = temporal part of superior longitudinal 
fasciculus; UF = uncinate fasciculus. Arrows indicate significant increase/decrease in patient’s diffusion tensor index relative to controls (black 
arrows represent p < .1; red arrows represent p < .05).
White matter 
tracts 
FA  MD (x10-3)  AD (x10-3)  RD (x10-3) 
Controls Patient  Controls Patient  Controls Patient  Controls Patient 
R ATR 0.508 ± 0.008 0.501  0.692 ± 0.007 0.693  1.102 ± 0.008 1.099  0.487 ± 0.008 0.490 
L ATR 0.513 ± 0.006 0.484   0.695 ± 0.008 0.689  1.108 ± 0.014 1.073  0.489 ± 0.006 0.497 
R cCG 0.574 ± 0.014 0.625  0.671 ± 0.012 0.676  1.136 ± 0.023 1.221  0.438 ± 0.014 0.403 
L cCG 0.607 ± 0.013 0.628  0.689 ± 0.011 0.688  1.221 ± 0.026 1.247  0.424 ± 0.012 0.409 
R cH 0.588 ± 0.026 0.551  0.558 ± 0.024 0.637  0.928 ± 0.032 1.049  0.373 ± 0.025 0.432 
L cH 0.588 ± 0.021 0.546  0.594 ± 0.021 0.593  1.014 ± 0.030 0.971  0.384 ± 0.022 0.404 
R CT 0.626 ± 0.006 0.608  0.664 ± 0.008 0.670  1.197 ± 0.012 1.179  0.397 ± 0.007 0.415 
L CT 0.633 ± 0.005 0.612   0.663 ± 0.009 0.673  1.202 ± 0.019 1.195  0.387 ± 0.004 0.412  
FMa 0.685 ± 0.009 0.675  0.718 ± 0.008 0.726  1.423 ± 0.010 1.410  0.366 ± 0.011 0.383 
FMi 0.570 ± 0.001 0.564  0.718 ± 0.008 0.729  1.249 ± 0.009 1.261  0.452 ± 0.010 0.463 
R IFOF 0.562 ± 0.012 0.530  0.726 ± 0.008 0.751  1.236 ± 0.008 1.240  0.471 ± 0.013 0.506 
L IFOF 0.561 ± 0.009 0.548  0.750 ± 0.007 0.735  1.280 ± 0.008 1.240   0.486 ± 0.010 0.482 
R ILF 0.562 ± 0.011 0.517   0.724 ± 0.007 0.737  1.229 ± 0.009 1.240   0.471 ± 0.011 0.509 
L ILF 0.549 ± 0.008 0.555  0.748 ± 0.008 0.727  1.265 ± 0.009 1.240  0.490 ± 0.009 0.471 
R SLF 0.535 ± 0.008 0.497   0.686 ± 0.008 0.689  1.118 ± 0.011 1.080  0.468 ± 0.007 0.494 
L SLF 0.516 ± 0.006 0.490   0.716 ± 0.007 0.714  1.146 ± 0.007 1.108   0.501 ± 0.008 0.518 
R tSLF 0.586 ± 0.010 0.539   0.672 ± 0.009 0.683  1.149 ± 0.013 1.116  0.433 ± 0.011 0.467 
L tSLF 0.557 ± 0.007 0.532  0.716 ± 0.007 0.719  1.193 ± 0.007 1.159   0.478 ± 0.009 0.499 
R UF 0.518 ± 0.015 0.498  0.736 ± 0.011 0.734  1.206 ± 0.018 1.165  0.502 ± 0.015 0.519 
L UF 0.514 ± 0.012 0.487  0.736 ± 0.008 0.730  1.192 ± 0.012 1.172  0.507 ± 0.011 0.508 
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CHAPTER 4 
 
MODULATING VISUAL CORTEX γ-AMINOBUTYRIC ACID AND 
GLUTAMATE USING LOW-FREQUENCY REPETITIVE 
TRANSCRANIAL MAGNETIC STIMULATION 
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Preface 
Neural plasticity is key in rehabilitation and recovery of function; thus, effective therapeutic 
strategies must be capable of modulating plasticity. Glutamate- and GABA-mediated changes in 
the balance between excitation and inhibition are prominent features in visual cortical plasticity. 
Particularly, reduced GABAergic inhibition facilitates synaptic plasticity. We investigated the 
effects of low-frequency (1 Hz) rTMS to the visual cortex on altering levels of neurotransmitters 
GABA and glutamate to determine the therapeutic potential of 1 Hz rTMS for visual-related 
disorders. Two rTMS regimes commonly used in clinical applications were investigated: 
participants received rTMS to the visual cortex either in a single 20 min session or five 
accelerated 20 min sessions. 1H MRS for in vivo quantification of GABA (assessed via GABA+) 
and glutamate (assessed via Glx) concentrations was performed pre- and post-rTMS. GABA+ 
and Glx concentrations were unaltered following a single session of rTMS to the visual cortex. 
One day of accelerated rTMS significantly reduced GABA+ concentration lasting for up to 24 
hr, with levels returning to baseline by 1-week post-rTMS. These findings demonstrate that 
accelerated rTMS to the visual cortex has greater potential for approaches targeting plasticity or 
in cases presenting with altered GABAergic responses with clinical translation for treatment in 
visual disorders. Notably, results provide preliminary insight into a critical window of plasticity 
with accelerated rTMS (e.g., 24 hr) in which adjunct therapies may offer better functional 
outcome.  
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 A valuable therapeutic application of low-frequency rTMS to the visual cortex is to 
modulate disruptive visual hallucinations that are prevalent following visual pathway damage 
(Chapter 2; Merabet et al., 2003). Other forms of noninvasive brain stimulation (e.g., tDCS) have 
been used to promote vision restoration in visual field loss (for a review, see Alber, Cardoso, & 
Nafee, 2015). The desired neuromodulatory effect will largely depend on the stimulation 
technique and its underlying neural mechanisms (e.g., rTMS versus tDCS), altered mechanisms 
associated with the pathophysiology, and responsiveness of the cortical/subcortical structure in 
question. Despite the popular use of rTMS as a research and therapeutic tool (for reviews, see 
Chen et al., 2008; Thut & Pasucual-Leone, 2010; Wasserman & Lisanby, 2001), its potential to 
modulate neurobiochemical responses in the visual cortex, and hence its value as a therapeutic 
neuromodulation technique in visual-related disorders, is under-investigated.  
 Glutamate and GABA, key excitatory and inhibitory neurotransmitters in the mammalian 
brain, respectively, modulate the induction of LTP and LTD (for a review, see Lüscher & 
Malenka, 2012). Additionally, glutamine acts an important precursor in the glutamate/GABA-
glutamine cycle (Bak, Schousboe, & Waagepetersen, 2006). rTMS can exert excitatory or 
inhibitory cortical effects at the stimulated area in non-visual cortical regions via glutamate and 
GABA receptor activity (Michael et al., 2003; Stagg et al., 2009b; Yue, Xiao-Lin, & Tao, 2009). 
Alterations in the delicate homeostatic balance between these neurotransmitters have significant 
implications in various disorders. For example, with relevance to visual disorders, a blockade of 
GABA and a resultant increase in neural firing is thought to underlie visual hallucinations 
(Manford & Andermann, 1998). Reduced GABA and unaffected glutamate levels have also been 
shown to promote visual cortical plasticity and improve visual function in amblyopia 
(Vetencourt et al., 2008). In order to advance the application of noninvasive brain stimulation to 
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target visual-related disorders, we sought to determine the ability of low-frequency (1 Hz) rTMS 
on altering visual cortical GABA (assessed via GABA+, the combined concentration of GABA 
and macromolecules) and glutamate (assessed via Glx, the combined concentration of glutamate 
and glutamine) levels in healthy control participants. Noninvasive in vivo quantification of visual 
cortex GABA+ and Glx concentrations were acquired using 1H MRS. Knowledge of effects in 
healthy controls is desirable to determine underlying neurochemical mechanisms prior to 
translation for visual-related therapeutic application targeted at GABAergic and glutamatergic 
activity.  
 In addition, the most efficient stimulation protocol for different stimulation techniques is 
under question. In clinical applications, two alternative rTMS regimes are established: a single 
session or accelerated sessions applied in a single day over consecutive days. Accelerated (also 
termed within-session) stimulation consists of multiple sessions within a day, and significantly 
reduces the number of days/weeks of stimulation compared with single session rTMS. We tested 
a shorter schedule of these two regimes on the visual cortex. The first protocol consisted of a 
single 20 min session of 1 Hz rTMS to the visual cortex. Single sessions of rTMS have been 
applied over consecutive days for therapeutic application in visual-related disorders (e.g., Fumal 
et al., 2006; Rafique et al., 2016) and non-visual disorders (e.g., Dunner et al., 2014; Liepert et 
al., 2000a; Speer et al., 2000). The second accelerated protocol consisted of five consecutive 20 
min sessions of 1 Hz rTMS separated by ~15 min in a single day. Intervals of 10–20 min in 
accelerated stimulation are considered to produce longer lasting effects (for a review, see 
Goldsworthy et al., 2015) compared with shorter intervals, e.g., 3 min (Monte-Silva et al., 2010) 
or 5 min (Bastani & Jaberzadeh, 2014). Advances in therapeutic use of rTMS in non-visual 
disorders demonstrate that accelerated rTMS produces more cumulative, stable, and longer-
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lasting effects than single daily sessions over consecutive days/weeks (Goldsworthy et al., 2014; 
Holtzheimer et al., 2010). The effect of accelerated rTMS in visual disorders remains unknown. 
Accelerated rTMS additionally has better compliance in clinical settings due to the considerably 
reduced number of visits, for example, five accelerated sessions in a single day is comparable to 
a single daily session applied over five consecutive days. We have previously obtained a 
cumulative effect in modulating visual hallucinations following occipital stroke with a 30 min 
session of 1 Hz rTMS to the visual cortex repeated for 5 consecutive days (Chapter 2; Rafique et 
al., 2016). We considered five consecutive 30 min sessions taxing on participants in the 
accelerated protocol, thus, in the present study we opted for a minimum of 20 min of stimulation 
since it is more effective than shorter application times and reduces inter-individual variability 
(Aydin-Abidin, Moliadze, Eysel, & Funke, 2006).  
 Our focus was also to continue and refine our previous work using rTMS to modulate 
disruptive visual hallucinations (Chapter 2; Rafique et al., 2016, 2018) that prevalently occur 
following visual pathway damage (Baier et al., 2010; Gordon, 2016). Visual hallucinations are 
associated with increased vividness of visual imagery and a weak ability to distinguish real 
perception from mental imagery (Böker, Hijman, Kahn, & Haan, 2000; Mintz & Alpert, 1972). 
The neural substrates of visual imagery are similar to those of visual perception (Ishai & Sagi, 
1995; Kosslyn, Thompson, & Alpert, 1997). Visual imagery critically depends on neural activity 
in V1 and is related to perception and memory that may facilitate cognitive performance 
(Kosslyn et al., 1999). Therefore, we also assessed the effects of the two alternative low-
frequency rTMS regimes on vividness of visual imagery and predisposition to visual 
hallucinations, and their relationship with visual cortical excitability. Knowledge of rTMS 
effects on these aspects provides crucial information to inform recommended therapy in 
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disorders presenting with visual hallucinations (e.g., visual pathway damage, schizophrenia, 
Parkinson’s disease; Burke, 2002; Manford & Anderson, 1998, Yoon et al., 2010). As far as we 
are aware, we are the first to investigate accelerated rTMS with a low-frequency protocol and its 
application to the visual cortex. To ensure safe and effective use of accelerated rTMS to the 
visual cortex, we also considered it necessary to assess adverse effects, including effects on basic 
cognitive function. 
Methods 
This study was approved by York University’s Office of Research Ethics. All individuals 
gave informed written consent. 
Participants 
Sixteen healthy participants were recruited for the study (Mage ± SEM = 25.15 ± 1.21 
years; 10 males/six females). All participants were right-handed, with normal or corrected-to-
normal vision (> 0.04 logMAR; stereoacuity ≥ 50”), and no known contraindications to TMS and 
MRI. We recruited participants with no known underlying medical conditions, and no history of 
neurological or psychological disorders. Further, due to interactions with metabolite receptors 
and/or TMS mechanisms, we recruited participants that were not currently taking any 
medications (Stell, Brickley, Tang, Farrant, & Mody, 2003) including hormonal contraceptives 
(Kaore et al., 2012; Smith, Adams, Schmidt, Rubinow, & Wassermann, 2002b), with no history 
of frequent or chronic migraines (Bohotin et al., 2002; Russo et al., 2005), no history of 
alcohol/substance dependence, and were non-smokers (Epperson et al., 2005). We additionally 
asked that participants did not consume alcohol within 48 hr prior to each visit due to 
interactions with metabolites (Lobo & Harris, 2008). Participants received monetary 
compensation for their participation ($10 CAD/hr).  
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Experimental Design Overview 
Participants underwent pre-rTMS (baseline) vision assessments and questionnaires, MRS, 
and PT measures. In a separate follow-up visit, participants received 1 Hz rTMS to the visual 
cortex (V1) at the individual PT, either in a (1) single 20 min session of rTMS, or (2) five 
accelerated 20 min sessions of rTMS (separated by intervals of ~15 min). MRS was repeated 
immediately following cessation of rTMS in both groups. MRS was further performed (1) 1 hr 
post-rTMS in the single rTMS group, and (2) 24 hr and 1-week post-rTMS in the accelerated 
rTMS group. Vision assessments and questionnaires were repeated at follow-up visits. 
Vision Assessments, Cognitive and Imagery Questionnaires, and Adverse Effects  
Standard visual testing was conducted to ensure normal visual status. Monocular and 
binocular visual acuities were measured using the standardised ETDRS vision chart (Precision 
Vision, La Salle, IL), stereoacuity was measured using the Titmus circles test (Stereo Optical 
Company Inc., Chicago, IL), and colour vision was assessed using the Ishihara test (Kanehara 
Trading Inc., Tokyo, Japan). Ocular muscle status involved assessment with the cover test 
(distance and near) and near point of convergence. 
 To ensure normal cognitive status, we administered the Montreal Cognitive Assessment 
(MoCA, v7.1–7.3; Appendix B), a brief 30-point cognitive screening test to detect mild cognitive 
impairment (Nasreddine et al., 2005). MoCA evaluates attention, concentration, working 
memory, short-term memory, delayed recall, language, visuospatial, orientation, and executive 
function. A different version of MoCA was administered at each follow-up visit. 
 Vividness of visual imagery was measured using the Vividness of Visual Imagery 
Questionnaire (VVIQ; Appendix C), a 15-item questionnaire (Marks, 1973). VVIQ was 
performed initially with eyes open and then repeated with eyes closed. We reversed the 5-point 
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rating scale, so that 1 = no image at all, you only know that you are thinking of an object, and 5 = 
perfectly clear and as vivid as normal vision, which provides a more intuitive scale.  
 Unusual positive perceptual experiences were assessed using a revised Launay-Slade 
Hallucination Scale (LSHS; Appendix D), a 16-item questionnaire. The LSHS measures 
predispositions to hallucinations in healthy and clinical populations (Launay & Slade, 1981; 
revised by Morrison, Wells, & Nothard, 2000). Questions were rated on a 4-point scale to 
measure frequency of the hallucinatory event (1 = never, 2 = sometimes, 3 = often, 4 = almost 
always).  
 Further, we asked participants to report changes in mood, concentration, cognition, 
sensory disruption (e.g., visual or hearing changes), as well as headaches, neck pain, or any other 
symptoms following rTMS. Adverse effects were reported on a five-point scale (1 = no 
symptoms/change, 2 = minimal symptoms/change, 3 = slight symptoms/change, 4 = moderate 
symptoms/change, 5 = significant symptoms/change).  
 We repeated all vision assessments and questionnaires at follow-up visits to assess any 
changes with rTMS, and for a more complete representation of longer-term effects of 1 Hz rTMS 
to the visual cortex. 
Magnetic Resonance Imaging  
Anatomical and 1H MRS data were acquired with a 3T Siemens Magnetom® Tim Trio 
magnetic resonance scanner, with a 32-channel high-resolution brain array coil (Siemens, 
Erlangen, Germany). Head motion was minimised with the placement of soft pads holding the 
participant's head in place. Imaging was acquired at rest in a dark room, and participants were 
instructed to keep their eyes closed throughout.  
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 Anatomical images were acquired first to allow placement of the MRS volume-of-interest 
(VOI) using a T1-weighted MPRAGE imaging sequence (number of slices  = 192; in-plane 
resolution = 1 x 1 mm; slice thickness = 1 mm; imaging matrix = 256 x 256; TR = 2300 ms; TE 
= 2.62 ms; TI = 900 ms; flip angle = 9o; FoV = 256 mm; acquisition time = ~5 min). 
 Using the anatomical images, MRS was acquired from a single 2.5 x 2.5 x 2.5 cm3 VOI 
positioned medially in the visual cortex (V1). The VOI was positioned as far back within the 
posterior region of the occipital pole, centred on the calcarine sulcus, and avoided non-brain 
tissue (including cerebrospinal fluid and the sagittal sinus) to minimise macromolecule 
contamination. The lower edge followed the cortical surface and was aligned alongside the 
cerebellar tentorium (Figure 4.1a-b). The VOI position was recorded relative to anatomical 
landmarks in all three dimensions (sagittal, coronal, and transverse) using screenshots, and used 
as a reference for subsequent acquisitions. In two participants, because of a relatively small 
occipital lobe, the VOI had to be placed further supero-anteriorly, and may not have been 
constrained fully to the occipital lobe. The use of a smaller VOI was not desirable since it would 
reduce the signal-to-noise ratio (SNR) (for a review, see Mullins et al., 2014). 1H MR spectra 
were obtained using Mescher-Garwood point resolved spectroscopy (MEGA-PRESS), a J-
coupled difference editing technique (Mescher, Merkle, Kirsch, Garwood, & Gruetter, 1998), 
provided by Siemens as a work-in-progress (WIP) sequence (TR = 1500 ms; TE = 68 ms; 
spectral bandwidth = 1500 Hz; 1024 data points with water suppression yielding 512 averages; 
acquisition time = ~13 min). The MEGA-PRESS sequence provides reliable detection of GABA 
and other brain metabolites (Mullins et al., 2014; Puts & Edden, 2012). Siemens standard 3D 
automated shimming, followed by manual shimming were performed prior to each acquisition. 
During odd-numbered (‘ON resonance’) acquisitions, a frequency selective Gaussian inversion 
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pulse, and a chemical shift selective suppression (CHESS) water suppression band at 4.7 parts 
per million (ppm) of proton frequency were irradiated at 1.9 ppm. During even-numbered (‘OFF 
resonance’) acquisitions, the same pulse was applied symmetrically to the opposite side of the 
water spectrum at 7.5 ppm. The difference between the ‘ON’ and ‘OFF’ edited spectra provides 
a resulting spectrum retaining only peaks affected by the editing pulses: the GABA signal peak 
at 3.02 ppm, a combined glutamate and glutamine (Glx) signal peak at 3.75–3.8 ppm, and 
macromolecular peaks. The difference editing approach separates the GABA spectrum from 
overlapping spectra of more concentrated metabolites, in particular the creatine (Cr; an amino 
acid) peak at 3.0 ppm (Figure 4.1c, blue line). However, the GABA spectrum still contains 
contributions from other macromolecules (Aufhaus et al., 2014; Behar, Rothman, Spencer, & 
Petroff, 1994) and homocarnosine (a GABA derivative inhibitory neuromodulator; Rothman, 
Behar, Prichard, & Petroff, 1997), and is therefore referred to as GABA+ rather than GABA. 
Due to their similar chemical structure and overlapping spectra, glutamate (3.75 ppm) and its 
metabolic intermediate glutamine (3.76 ppm) cannot be differentiated using this method, and are 
therefore referred to as the composite measure Glx. An unsuppressed water reference was also 
acquired (16 averages, acquisition time = ~1 min).   
Transcranial Magnetic Stimulation 
A Magstim Rapid2 Stimulator and a 70 mm diameter figure-of-eight coil (Magstim, 
Whitland, Wales, UK) were used to deliver stimulation pulses to the defined target site.  
Phosphene threshold. Due to large inter-individual variability in visual cortical 
excitability thresholds (Stewart, Walsh, & Rothwell, 2001b), rTMS was delivered to the target 
stimulation site at the individual PT to minimise confounds in excitability and induce as 
consistent effects across participants. PT provides a well-established standard measure of visual 
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cortical excitability (Silvanto & Pascual-Leone, 2008). PT was measured using 1 Hz rTMS (7 s 
inter-pulse interval, 10 pulses) to the occipital lobe, and defined as the lowest stimulator output 
intensity (expressed as a percentage of maximal output) that evoked phosphenes in at least 50% 
of pulses (Elkin-Frankston et al., 2010). Participants were seated in a lit room wearing a 
blindfold with eyes closed and asked to report “yes/no/maybe” to phosphene elicitation 
following each TMS pulse. TMS was initially applied 2 cm lateral to the left of the inion, at an 
initial stimulator output intensity of 60%. The coil handle was held 90o to the left of the inion 
midline. If the participant reported a visual sensation, they were asked to describe the appearance 
(colour, shape, and size) and location to confirm phosphene perception. A “maybe” response was 
considered a negative response. If no visual sensation was reported, the TMS coil was 
repositioned in 1 cm steps above/below/lateral to the original site 2cm lateral to the inion, and 
pulses redelivered, to a maximum of 4 cm lateral and above/below the inion. If phosphenes were 
still not reported, the stimulator output intensity was increased by 5% and the process repeated. 
The process was repeated until a phosphene was perceived, and the stimulator output intensity 
was then refined in 1% steps. Blindfolds were removed every 10–15 min where necessary, for a 
minimum of 2 min, to prevent visual cortical excitability (Boroojerdi et al., 2000a).  
Repetitive transcranial magnetic stimulation. Participants’ anatomical MR images 
were reconstructed to 3D cortical surfaces using Brainsight software (Rogue Research, Montreal, 
QC, Canada). The target stimulation site corresponded to the centre of the MRS VOI (Mdepth ± 
SEM = 38.631 ± 0.74 mm). The stimulation site was mapped on each participant’s corresponding 
anatomical images in Brainsight by matching anatomical landmarks to the MRS VOI screenshots 
obtained at pre-rTMS MRS acquisition. The spatial relationship between the target stimulation 
site and reference points from the participant’s head (tip of nose, nasion, right and left tragus) 
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were co-registered using a Polaris infrared tracking system (Northern Digital Instruments, 
Kitchener, ON, Canada). Movement of the coil with respect to the participant’s head, and 
therefore the stimulation site, was visualised in real time using the infrared image-guided 
stereotaxy to ensure accurate positioning of the coil and targeted disruption of the stimulation 
site throughout rTMS. The TMS coil was held tangential to the surface of the skull to minimise 
coil-to-cortex distance, and to maximise the TMS effect (Ulmer & Jansen, 2010). Participants 
were seated in a comfortable position with an adjustable chin rest to limit head movement and 
provided with earplugs to prevent changes in auditory thresholds during rTMS (Rossi et al., 
2009). Participants underwent 1 Hz rTMS (1 s inter-stimulus interval, 1200 pulses [20 min], 
100% PT) at rest, either in a single 20 min session (n = 8, four male/four female) or five 
accelerated 20 min sessions separated by ~15 min intervals in a single day (n = 8, six male/two 
female). In the accelerated rTMS group, stereotaxic co-registration was assessed immediately 
prior to each new rTMS session and refined if necessary. 
Experimental Procedure 
To minimise diurnal variation of neuromodulators, including those implicated in TMS 
mechanisms (e.g., Ridding & Ziemann, 2010; Sale, Ridding, & Nordstrom, 2007), participants 
underwent testing at approximately the same time of day. We minimised the time difference 
between when the PT was obtained and rTMS was performed, while ensuring that MRI of 
different visits (pre- and post-rTMS) were also acquired at similar times irrespective of group 
allocation. Visit one (baseline/pre-rTMS): all participants initially underwent vision assessments 
and questionnaires to ensure inclusion criteria were met (including normal visual and cognitive 
status), followed by MRI, which commenced at ~13:00. PT was always obtained after pre-rTMS 
MRI, usually on the same day. Visit two (rTMS): offline 1 Hz rTMS was scheduled at least 4 
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days following pre-rTMS measures to prevent any lingering TMS effects from PT interacting 
with the rTMS protocol. rTMS commenced at ~13:40 for participants in the single rTMS session 
group, and at ~11:00 for participants in the accelerated rTMS sessions group. Participants were 
immediately transferred into the MRI scanner after rTMS ceased, and MRI acquisition 
commenced within 5 min of rTMS ending. In both groups, immediate post-rTMS MRI 
commenced at ~14:00. Participants in the single rTMS group underwent a further MRI 1 hr post-
rTMS at ~15:00. We did not perform further follow-up visits in the single rTMS group based on 
previous research demonstrating that effects following ~15–20 min 1 Hz rTMS to the occipital 
cortex recover within 20–40 min (for a review, see Thut & Pasucal-Leone, 2010). We did not 
perform MRI 1 hr post-rTMS in the accelerated rTMS group because of fatigue following a long 
protocol (~5 hr), and since effects were expected to persist for > 24 hrs (for a review, see 
Goldsworthy et al., 2015). Visits three and four (follow-up for the accelerated rTMS group only): 
participants in the accelerated rTMS group were further followed-up at 24 hr, and 1-week post-
rTMS, in both cases at ~1400.  
 MRI, vision assessments, and questionnaires were repeated at follow-up visits. Because 
participants were immediately transferred to the MRI following rTMS cessation, we could not 
perform vision assessments and questionnaires immediately post-rTMS in both groups; instead 
they were performed after immediate post-rTMS MRI acquisition. Therefore, for the single 
rTMS group, vision assessments and questionnaires were only followed up once, in-between 
immediate and 1 hr post-rTMS MRI acquisition. Figure 4.2 shows a diagram of the procedure for 
both rTMS groups. 
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Data Analyses 
Magnetic resonance spectroscopy processing. MEGA-PRESS data were exported in 
RDA file format. Data were processed using the MATLAB-based tool Gannet (v3.0; 
http://www.gabamrs.com; Edden, Puts, Harris, Barker, & Evans, 2014). To filter out spectra of 
interest and improve the SNR, individual acquisitions underwent standard processing including 
frequency and phase correction, fast Fourier transform of time-domain acquired data to 
frequency-domain spectra, exponential line broadening, subtraction of the ‘ON’ and ‘OFF’ 
spectra resulting in the difference edited spectrum, and Gaussian model fitting of the GABA+ 
and Glx signal peaks. The amplitude of the peak for a given metabolite is related to the total 
number of molecules, and therefore represents the total concentration of that metabolite. 
GannetFit estimated the area under the edited GABA+, Glx, and Cr peaks, and the water signal 
from the unsuppressed water spectrum (Figure 4.1c). GannetCoRegister, which calls SPM8 
(Statistical Parametric Mapping, Wellcome Centre for Human Neuroimaging, London, UK; 
http://www.fil.ion.ucl.ac.uk/spm), registered the MRS VOI to the corresponding anatomical 
images by creating a binary mask of the VOI with the same geometric parameters as the 
anatomical image. GannetSegment performed segmentation of the anatomical images, and 
determined tissue fractions (grey and white matter, and cerebrospinal fluid) within the VOI to 
provide cerebrospinal fluid-corrected GABA+ and Glx concentration estimates (in institutional 
units (i.u.)) using SPM8. Lastly, GannetQuantify accounted for tissue-related variance to provide 
tissue-corrected (relaxation- and alpha-corrected, voxel-average-normalised) GABA+ and Glx 
concentration estimates relative to water (i.u.) (Harris, Puts, & Edden, 2015). Gannet uses the 
standard deviation of the fitting residual, expressed as a percentage of the signal height, to 
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determine the fit error of the model, which reflects the SNR. All acquired spectra had a fit error < 
5%.  
Statistical analyses. All statistical analyses were performed using R statistical computing 
software (R Foundation for Statistical Computing, Vienna, Austria; www.R-project.org). Data 
were assessed for statistical assumptions and found to violate assumptions of parametric testing. 
We used multilevel (mixed) modelling and the maximum-likelihood estimation to analyse 
differences across multiple variables since it accounts for the repeated nature of the data, is 
highly flexible in dealing with varying intervals between measurements, and overcomes issues 
where assumptions of analysis of variance (ANOVA) are violated. Akaike’s information 
criterion was used to measure the goodness of a fit of an estimated model, and the appropriate 
covariance structure. Where only two variables were compared, we conducted 
independent/dependent Yuen’s t-tests (YW) for non-normally distributed data with 10% trimmed 
means. Effect sizes for Yuen (ESYW) were calculated using 10% trimmed means, and additionally 
500 bootstrapping samples for independent t-tests. Significance level was chosen as p < .05, and 
p < .1 for trending results, for all analyses. The rTMS groups were analysed separately due to 
different follow-up visit intervals (single rTMS group: pre-rTMS, immediate post-rTMS, 1 hr 
post-rTMS; accelerated rTMS group: pre-rTMS, immediate post-rTMS, 24 hr post-rTMS, 1-
week post-rTMS). 
To ensure consistent MRS VOI positioning in participants across visits, we assessed 
changes in tissue proportions within the VOI between visits using a multilevel model, with 
random effect for participant, and fixed effect for visit, for each rTMS group and for each tissue 
fraction (grey matter, white matter, cerebrospinal fluid) separately. To ensure tissue proportions 
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were consistent between rTMS groups, pre-rTMS tissue fractions were compared using Yuen’s 
independent t-test. 
 The impact of single and accelerated rTMS sessions on visual cortex GABA+ and Glx 
concentrations were analysed using a multilevel model, with random effect for participant, and 
fixed effect for visits, for each metabolite and rTMS group separately. The effects of rTMS on all 
vision assessments and questionnaire responses (MoCA, VVIQ, and LSHS) were determined 
using Yuen’s dependent t-test for the single rTMS group (pre-rTMS and immediate post-rTMS 
visits); and a multilevel model for the accelerated rTMS group (all visits), with random effect for 
participant and fixed effect for visits.  
 The relationship between PT (visual cortical excitability), pre-rTMS GABA+ and Glx 
concentrations, and pre-rTMS questionnaire responses was analysed using Kendall’s tau (τ), a 
non-parametric correlation for non-normally distributed data.  
Results 
Tissue Fraction Analyses 
Analyses of tissue fractions demonstrated consistent VOI positioning across visits. In the 
single rTMS group, there were no significant changes in tissue proportions across visits for white 
matter, F(2, 14) = 2.61, p = .109; and cerebrospinal fluid, F(2, 14) = 1.839, p = .195. Tissue 
proportions for grey matter trended significance across visits, F(2, 14) = 3.147, p = .074. In the 
accelerated rTMS group, there were no significant changes in tissue proportions across visits for 
grey matter, F(3, 18) = .719, p = .554; white matter, F(3, 18) = .529, p = .668; and cerebrospinal 
fluid, F(3, 18) = .747, p = .538. Based on pre-rTMS tissue proportions, there were no significant 
differences between the single and accelerated rTMS groups in grey matter, YW(10.76) = .764, p 
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= .462, ESYW = .322; white matter, YW(10.9) = .442, p = .668, ESYW = .223; and cerebrospinal 
fluid, YW(9.72) = .519, p = .615, ESYW = .189.  
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on GABA+ 
and Glx Concentrations 
In the single rTMS group, there were no significant changes across visits in GABA+ 
concentration, F(2, 14) = .733, p = .498; and Glx concentration, F(2, 14) = .15, p = .862. In the 
accelerated rTMS group, there was a significant change in GABA+ concentration across visits, 
F(3, 21) = 5.446, p = .006. Pre-rTMS GABA+ concentration was significantly greater than 
immediate post-rTMS, b = - .285, t(21) = -2.203, p = .039; and showed a trend towards being 
significantly greater than 24 hr post-rTMS concentration, b = - .229, t(21) = -1.768, p = .092, in 
the accelerated rTMS group. Pre-rTMS GABA+ concentration was comparable with 1-week 
post-rTMS concentration, b = .178, t(21) = 1.372, p = .185. There were no significant changes 
across visits in the accelerated rTMS group for Glx concentration, F(3, 21) = .81, p = .503. 
Results for metabolite concentrations measured at each visit are presented in Figure 4.3. 
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Vision 
Assessments, Cognitive and Imagery Questionnaire Responses 
For vision assessments, in the single rTMS group, there were no significant differences 
across visits for right eye visual acuity, YW(7) = - .424, p = .685, ESYW = .009; left eye visual 
acuity, YW(7) = -1.286, p = .901, ESYW = .002; and stereoacuity, YW(7) = 1, p = .351, ESYW = .11. 
In the accelerated rTMS group, there were no significant differences across visits for right eye 
visual acuity, F(3, 21) = 1.629, p = .213; left eye visual acuity, F(3, 21) = .597, p = .624; and 
stereoacuity, F(3, 21) = 1.355, p = .284. In both rTMS groups, participants correctly identified 
all colour vision plates at all visits.  
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 For questionnaire responses, in the single rTMS group, VVIQ with eyes closed was 
significantly greater at pre-rTMS compared with 1 hr post-rTMS, YW(7) = 2.481, p = .042, ESYW 
= .37. There were no significant differences in the single rTMS group across visits for VVIQ 
with eyes open, YW(7) = 0, p = 1, ESYW = 0; MoCA, YW(7) = - .475, p = .649, ESYW = .14; and 
LSHS, YW(7) = 1.764, p = .121, ESYW = .16. In the accelerated rTMS group, there was a 
significant difference in MoCA across visits, F(3, 21) = 3.117, p = .048; contrasts revealed a 
trend towards significance with a lower score pre-rTMS compared with 1-week post-rTMS, b = 
.875, t(21) = 1.987, p = .06. There were no significant differences in the accelerated rTMS group 
across visits for VVIQ with eyes open, F(3, 21) = .944, p = .437; VVIQ with eyes closed, F(3, 
21) = .232, p = .873; and LSHS, F(3, 21) = .684, p = .572. Mean (± SEM) questionnaire 
measures are reported in Table 4.1. Participants’ self-reported symptoms following rTMS are 
reported in Table 4.2. 
Relationship Between Phosphene Threshold, GABA+, Glx, and Questionnaire 
Responses 
There was a significant positive correlation between pre-rTMS GABA+ and Glx 
concentrations, τ = .68, p < .001. PT was not significantly correlated with pre-rTMS measures of 
GABA+ concentration, τ = - .237, p = .206; Glx concentration, τ = - .245, p = .19; VVIQ with 
eyes open, τ = - .254, p = .175; VVIQ with eyes closed, τ = - .017, p = .928; or LSHS, τ = - .309, 
p = .109. Pre-rTMS GABA+ concentration was not significantly correlated with corresponding 
visit measures of VVIQ with eyes open, τ = - .067, p = .718; VVIQ with eyes closed, τ = - .136, 
p = .47; and LSHS, τ = .219, p = .254. Similarly, pre-rTMS Glx concentration was not 
significantly correlated with corresponding visit measures of VVIQ with eyes open, τ = - .092, p 
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= .62; VVIQ with eyes closed, τ = - .093, p = .619; and LSHS, τ = .174, p = .362. Mean (± SEM) 
PT and questionnaire responses are reported in Table 4.1.  
Discussion 
A single 20 min session of low-frequency (1 Hz) rTMS (100% PT) to the visual cortex 
had no significant change on GABA+ or Glx concentrations compared with pre-rTMS levels. 
However, five accelerated sessions using the same stimulation parameters significantly reduced 
GABA+ concentration immediately following rTMS, with effects lasting up to 24 hr, and 
returning to baseline by 1-week post-rTMS. Despite a positive relationship between pre-rTMS 
GABA+ and Glx concentrations, there was no significant change in Glx concentration following 
accelerated rTMS compared with pre-rTMS levels, highlighting the differential effect of low-
frequency rTMS. 
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Visual 
Cortical GABA+ and Glx Concentrations 
 According to traditional views on frequency-dependent rTMS effects, with a low-
frequency (e.g., 1 Hz) rTMS protocol we may expect an “inhibitory” response (for reviews, see 
Hallett, 2007; Thut & Pascual-Leone, 2010), and accordingly an increase in GABA+ 
concentration following rTMS. We observed no change in GABA+ concentration following a 
single session of rTMS and instead a decrease in concentration following accelerated rTMS. In 
the motor cortex, sub-MT paired-pulse TMS suppresses motor cortex excitability by activating 
intracortical inhibitory circuits, while supra-MT intensity facilitates a response (Nakamura, 
Kitagawa, Kawaguchi, & Tsuji, 1997). Conversely, supra-MT low-frequency rTMS to the motor 
cortex does suppress motor evoked potentials (Chen et al., 1997). Therefore, in addition to the 
frequency, the intensity level relative to the excitability threshold (e.g., MT) influences excitation 
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or inhibition in the cortex. Our results are also in line with our previous patient study in which 
we used rTMS to ameliorate visual hallucinations that occurred as a consequence of occipital 
stroke (Chapter 2; Rafique et al., 2016). Although the rTMS protocol in our previous patient 
study used the classic multiday approach to rTMS, in which the patient underwent a single daily 
session of 1 Hz rTMS to the visual cortex over five consecutive days, we nonetheless observed 
an increase in functional activity at the stimulation site post-rTMS (and a corresponding decrease 
in hallucinations). Following the notion that low-frequency rTMS is simply inhibitory, we would 
expect a decrease in functional activity at the stimulation site in the patient. High doses of short 
trains of 1 Hz rTMS to the prefrontal cortex are reported to excite local and contralateral 
functional activity, with intensity-dependent increases with higher intensities, e g., ≥ 100% MT 
(Nahas et al., 2001). Consequently, sub-PT intensity rTMS in our study may have had the 
converse effect on GABA+ concentration. Similar intensity-dependent rTMS effects are also 
observed in regional cerebral blood flow. Low-frequency rTMS (1–2 Hz) at intensities 
above MT increases cerebral blood flow at the stimulation site in the motor cortex (Bohning et 
al., 1999; Fox et al., 1997), as well as modifying blood flow at local and distal regions with 
increasingly greater modulation observed for higher intensities (Speer et al., 2003). In converse, 
supra-MT high-frequency rTMS (5–10 Hz) decreases cerebral blood flow in the motor cortex 
(Paus et al., 1998; Siebner et al., 2000a).  
 We did not observe significant changes in Glx concentration in the visual cortex 
following low-frequency rTMS. Similarly, Stagg and colleagues (2009b) also report significant 
effects of inhibitory theta burst protocols of rTMS (continuous TBS) on MRS measured GABA 
but not Glx concentration in the motor cortex. Dose-dependent changes in Glx concentration are, 
however, seen with conventional high-frequency rTMS. A single 20 min session of 20 Hz rTMS 
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to the prefrontal cortex decreases Glx concentration. In contrast, single daily sessions of 20 Hz 
rTMS applied over five consecutive days does not affect Glx concentration at the stimulation site 
(prefrontal cortex), although a significant increase in Glx is observed in remote regions. These 
high-frequency rTMS effects are found to be dependent on pre-rTMS Glx levels, with lower 
concentrations pre-rTMS associated with a greater increase in Glx (Michael et al., 2003).  
Relationship Between GABA+, Glx, and Visual Cortical Excitability 
 We observed no significant relationship between pre-rTMS GABA+/Glx concentrations 
and PT (visual cortical excitability) (Figure 4.4a), but a significant positive correlation between 
pre-rTMS GABA+ and Glx concentrations in the visual cortex. Terhune and colleagues (2015) 
report a strong negative correlation between PT and MRS measured glutamate concentration in 
the visual cortex, with lower PT associated with elevated glutamate concentration, and no 
correlation between GABA and glutamate. Although Terhune and colleagues report 
concentrations as ratios relative to Cr (to normalise data), we nonetheless fail to observe these 
relationships in our data using the same standard reference to Cr (Figure 4.4b). Variability in 
results between studies is likely attributed to differences in TMS parameters used to obtain PT, 
and MRS acquisition parameters. Furthermore, Terhune and colleagues measured PT following 
dark adaptation, which increases cortical excitability (Boroojerdi et al., 2000a). In the motor 
cortex at least, a significant positive correlation is also observed between MRS measured GABA 
and Glx relative to Cr (Tremblay et al., 2012). Additionally, as in the visual cortex, no direct 
relationship is observed between MRS measured GABA and TMS measures of cortical 
excitability (GABAA and GABAB receptor activity) in the motor cortex, suggesting that overall 
GABA concentration may not reflect specific synaptic activity, and hence excitability levels 
(Stagg et al., 2011c; Tremblay et al., 2012). Conversely, TMS measures of cortical excitability, 
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specifically GABAB receptor activity, in the motor cortex are positively correlated with MRS 
measured glutamate concentration (Tremblay et al., 2012). GABAB receptor mechanisms are 
instead mediated by glutamatergic activity (Chalifoux & Carter, 2011; Prout & Eisen, 1994), 
whereby a GABAB agonist has significant excitatory rather than inhibitory effects in the visual 
system (Luo, Wang, Su, Wu, & Chen, 2011). Moreover, a linear relationship is suggested 
between neuronal glucose oxidation and glutamate/glutamine cycling (Patel et al., 2004). These 
findings suggest that MRS metrics of glutamate relate to synaptic glutamatergic activity (Stagg 
& Nitsche, 2011). MRS measures of GABA instead are considered to represent the sum of 
inhibitory and excitatory activity (GABAA and GABAB receptor activity, respectively) across all 
cells affected by GABAergic modulation within the VOI (Rae, 2014). Therefore, an 
increase/decrease in MRS measured GABA concentration does not simply imply 
increased/deceased inhibition, respectively. Mechanisms underlying PT are not as well 
understood as MT, but GABAergic mechanisms are repeatedly implicated in PT (e.g., 
Boroojerdi, Prager, Muellbacher, & Cohen, 2000b; Mulleners et al., 2002). The use of a GABAA 
agonist is observed to increase PT, i.e., reduce cortical hyperexcitability in the visual cortex, in 
migraine patients with aura (Mulleners, Chronicle, Vredeveld, & Koehler, 2002). If phosphene 
induction via stimulation occurs via GABAA receptor activity, then collectively based on prior 
work, neither MRS measured GABA or glutamate levels would directly be associated with PT 
(visual cortical excitability).  
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on 
Cognitive and Imagery Responses 
 Following accelerated rTMS, changes in cognitive scores measured with MoCA trended 
towards significance, with greater scores at 1-week post-rTMS compared with pre-rTMS. 
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Although GABA+ concentration did not show a significant change at 1-week post-rTMS, there 
was an increase relative to pre-rTMS, and this change in cognitive effect may be related. Or 
simply, the effect can be attributed to a learning effect—we employed all three MoCA versions, 
however, since there were four visits in the accelerated rTMS protocol, participants were tested 
on version one at pre-rTMS and 1-week post rTMS visits.  
Following a single session of rTMS, VVIQ with eyes closed significantly decreased 1 hr 
post-rTMS compared with pre-rTMS, with no consistent change in GABA+/Glx concentration. It 
is possible that this effect is related to other mechanisms affected by a smaller dose of 1 Hz 
rTMS. Or perhaps, less likely, this effect may be due to mechanisms that only arise 1 hr post-
rTMS since no change was detected immediately post-rTMS. Visual cortex activity and 
vividness of visual imagery show a trend for a positive correlation (Amedi, Malach, & Pascual-
Leone, 2005), and 1 Hz rTMS to the occipital cortex impairs response time of visual imagery and 
perceptual versions of the same tasks (Kosslyn et al., 1999). Remarkably, there was no change in 
VVIQ following accelerated rTMS that may be due to adaptive processes or metaplasticity 
(Bocci et al., 2014; Lang et al., 2004). These findings on VVIQ may have important inferences 
for the differential effects of single and accelerated 1 Hz rTMS sessions. 
Therapeutic Potential of Accelerated Low-Frequency Repetitive Transcranial 
Magnetic Stimulation to the Visual Cortex 
 The effect of accelerated 1 Hz rTMS to the visual cortex on reducing GABA+ 
concentration has valuable implications for cortical plasticity. Retinal and cortical lesions trigger 
visual cortical plasticity necessary for reorganisation and restitution of visual cortical function. 
Reorganisation is dependent on GABAergic modulation and associated LTP that enables nearby 
cells to adopt topographical representation of damaged cells and continued processing of the 
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involved region. There are major biochemical changes in adjacent deafferented synapses 
involving increased glutamatergic NMDA and decreased GABAA and GABAB response in the 
visual cortex (Eysel et al., 1999). Similarly, in stroke, during the acute phase of recovery, peri-
infarct regions show diminished excitability associated with GABAB receptor activity (Clarkson, 
Huang, MacIsaac, Mody, & Carmichael, 2010). In the subacute stages of stroke, downregulation 
of GABA increases neuronal firing (Redecker, Wang, Fritschy, & Witte, 2002), thereby also 
increasing NMDA function that is integral to structural (Lee, Ueno, & Yamashita, 2011) and 
electrophysiological reorganisation, as well as reduced intracortical inhibition (Buchkremer-
Ratzmann & Witte 1997; Liepert, Hamzei, Weiller, 2000b). Subacute GABA inhibition occurs 
not only in peri-infarct regions, but also in the contralesional hemisphere, and is related to 
improved motor skills in the nonparetic forelimb of stroke patients (Luke, Allred, & Jones, 
2004). A continued widespread reduction of GABAA receptor activity, and associated 
excitability, persists for several months following cortical injury and is thought to facilitate 
plasticity changes via LTP and remapping of motor cortical representations (Carmichael, 2003; 
Neumann-Haefelin, Hagemann, & Witte, 1995). This rewiring underlies at least some recovery 
of function seen after stroke and is still maintained in the chronic stages of stroke recovery.  
Pairing rTMS treatment with vision therapies (e.g., vision restoration therapy in visual 
field loss, patching treatment in amblyopia) within a critical window of plasticity (e.g., 24 hr for 
a single day of accelerated 1 Hz rTMS) may lead to more efficient recovery and requires further 
investigation. Adjunct therapies can provide a better method for improving connectivity of 
involved neuronal networks and for increasing synaptic efficiency, which permits changes in 
neuronal excitability and rewiring to restore function with longer-term effects (Liepert et al., 
2000a; Pekna, Pekny, & Nilsson, 2012).  
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The use of 1 Hz rTMS may be preferable to other noninvasive brain stimulation 
techniques that have differing effects on MRS measured GABA/glutamate and likely plasticity. 
For example, continuous TBS (inhibitory TBS) to the motor cortex significantly increases MRS 
measured GABA, with no effect on Glx concentration, which is linked to LTD-like phenomena 
(Stagg et al., 2009b). Different stimulation techniques stimulate different populations or 
components of neurons to variable extents (e.g., Stagg et al., 2009a, 2011a). Further, metabolites 
are influenced by more than one biochemical pathway. Animal studies suggest that dopamine 
directly affects the excitability of GABAergic neurons, but also that modulation of dopamine 
occurs indirectly via GABA-mediated activity (for a review, see Pascual-Leone et al., 1998). 
These distinct effects have implications for the potential therapeutic use of stimulation paradigms 
where it may be clinically beneficial and more effective to use one paradigm over another. It is 
important to highlight that MRS quantifies overall local concentration of metabolites and does 
not provide insight into changes at the synapse/receptor level (for a review, see Stagg, Bachtiar, 
& Johansen-Berg, 2011b). As such, we can only speculate on the nature of changes in GABA+ 
concentration and take these factors into consideration when interpreting LTD/LTP like changes.  
 This study provides preliminary results for clinicians/researchers to determine 
appropriate responses to rTMS to the visual cortex on GABA and glutamate levels at the 
stimulation site by assessing any deviations in effects in patient populations compared with 
controls. Deviations in the expected response in patient populations can provide further valuable 
insight into underlying disease processes, the possibility to develop biomarkers for diagnosis, 
and information on whether the rTMS treatment is likely to be successful. Our results are from 
healthy control participants, and effects will indeed vary in patient populations, e.g., visual 
pathway damage, altered biochemical regulation in underlying medical conditions, interactions 
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with medications, etc. (Maeda, Keenan, Tormos, Topka, & Pasucal-Leone, 2000; Wassermann, 
2002). We also do not expect the same results with accelerated rTMS applied over consecutive 
days as is used in protocols for therapeutic applications (e.g., 2–5 days). Instead, we would 
expect an augmented response in GABA+ concentration with higher doses of accelerated rTMS 
based on previous research (Goldsworthy et al., 2014; Holtzheimer et al., 2010), and perhaps a 
dissimilar effect on Glx concentration. Similarly, our differential results between single and 
accelerated rTMS sessions may be due to dose-dependent effects. It may be that single sessions 
over consecutive days can produce a similar effect, in which case one day of accelerated rTMS 
offers a more efficient protocol, or perhaps an opposite effect is observed with repeated doses of 
single sessions (e..g, Michael et al., 2003). The effect of single session and accelerated rTMS to 
the visual cortex over a greater number of days on GABA and glutamate mechanisms requires 
investigation. Knowledge of differential effects with a variety of protocols will enable 
modulation of a greater number of disorders presenting with variable pathophysiology. With 
longer applications of rTMS, there is greater potential of adverse effects on sensory and 
cognitive processing/responses, or self-reported effects. Adverse effects should be evaluated 
following repeated high doses of rTMS, and due to unpredictability of effects in disease states in 
patient populations. 
Limitations 
The sample size employed in this study is small; however, we minimised possible 
confounds (e.g., employing strict inclusion criteria to limit considerable inter-individual 
variability) to the best of our ability, and we observe significant changes despite a smaller sample 
size. The significant change in GABA+ concentration following accelerated rTMS is unlikely 
due to fluctuations as concentrations in the occipital cortex are consistent throughout the day 
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(Evans, McGonigle, & Edden, 2010), and stable for as much as 7 months (Near, Sandberg, 
Kumaragamage, & Blicher, 2014; O’Gorman, Michels, Edden, Murdoch, & Martin, 2011). It is 
important to note that we did not control for factors such as menstrual cycle effects (Harada, 
Kubo, Nose, Nishitani, & Matsuda, 2011) or cycle-linked disorders, which can cause changes in 
GABA receptors and neuronal function (for a review, see Bäckström et al., 2003; Epperson et al., 
2002). 
 Due to MR set-up time, including VOI positioning and MRS shimming, and acquisition 
of anatomical images, there was a delay of ~20 min between the end of rTMS and the start of 
MRS acquisition that could not be avoided (MRS acquisition took an additional 13 min). 
Therefore, short-lived metabolite changes, especially following single session rTMS, may not be 
measurable. We did not consider the effect of rTMS on other metabolites as they were not 
supported by our acquisition protocols. Consequently, we cannot rule out effects of rTMS on 
other metabolites/biochemical pathways (Pascual-Leone et al., 1998) that may influence our 
results. Moreover, rTMS effects propagate from the stimulation site to remote regions (Rafique 
et al., 2015; Reithler et al., 2011), but because of the single voxel limit, we cannot effectively 
determine remote effects of rTMS on metabolite concentrations. Due to MRS technical 
constraints, acquisition of a second VOI would not commence for ~45 min following cessation 
of rTMS, and immediate or shorter-lasting measurable effects would be lost. Given that we 
cannot accurately localise rTMS effects, the MRS measured effect of rTMS may have been 
dampened by the spread of rTMS to regions outside of the VOI during acquisition, or the effect 
may be diluted from unaffected concentrations within the VOI. 
  The absence of significant rTMS effects on Glx concentration may be ascribed to the 
lower detection sensitivity compared with GABA using the MEGA-PRESS sequence (Henry, 
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Lauriat, Shanahan, Renshaw, & Jensen, 2011; Schubert, Gallinat, Seifert, & Rinneberg, 2004). 
The current sequence also cannot separate glutamate and glutamine spectra, thus, the composite 
value (Glx) may not accurately reflect sensitive changes in glutamate. Regardless, prior work 
suggests that Glx is primarily driven by the glutamate signal, as glutamate is found at ~10 times 
the concentration of glutamine in the brain (Stagg, 2014). There is potential for contamination of 
the edited signal with coedited macromolecular signals with the MEGA-PRESS sequence. 
Approaches to correct for macromolecules have their own significant limitations (Henry, Dautry, 
Hantraye, & Bloch, 2001; Rothman, Petroff, Behar, & Mattson, 1993), and we opted for the most 
common method to overcome macromolecule issues by reporting GABA+ concentrations. 
Nevertheless, variations in macromolecules between individuals are small compared with 
variations in GABA concentration (Hofmann, Slotboom, Boesch, & Kreis, 2001; Kreis, 
Slotboom, Hofmann, & Boesch, 2005; Mader et al., 2002), and so it is unlikely that this 
contamination affects interpretability of our observed effect in GABA+ concentration following 
accelerated rTMS. While GABA+ is also contaminated by homocarnosine, the in vivo 
concentration of homocarnosine is much lower than that of GABA (Govindaraju, Young, & 
Maudsley, 2000), thus, the effect on GABA+ concentration following accelerated rTMS is also 
less likely to be driven by homocarnosine. 
 Determining comparable tissue composition across visits is an indirect measure to 
demonstrate our consistent voxel positioning across visits. GABA concentrations are only 
weakly affected by voxel positioning in the occipital cortex, and as such, perfect voxel 
positioning is not critical (Near et al., 2014). Despite this reassurance, we remained critical in our 
voxel positioning to ensure as consistent positioning as possible between visits. 
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Conclusion 
A single day of accelerated low-frequency (1 Hz) rTMS to the visual cortex at 100% PT 
significantly decreases GABA+ concentration in the visual cortex for at least 24 hours. The 
present approach and longer-term investigation of accelerated rTMS effects to the visual cortex 
has implications for developing treatment protocols in clinical vision applications involving 
altered GABAergic function. These findings have further significance for exploiting visual 
cortical plasticity and provide insight into a critical window of plasticity in which adjunct 
therapy would be most efficient for functional restoration and recovery. Future work should be 
directed at refining protocols and investigating accelerated 1 Hz rTMS protocols on the visual 
cortex in patients with visual-related disorders.  
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Figure 4.1. Proton (1H) MR spectra acquired from the visual cortex. (a-b) Example of typical voxel 
placement in the occipital lobe on T1-weighted images for a single participant shown in sagittal and 
transverse planes, respectively. (c) Sample processing of the MEGA-PRESS difference edited 
spectrum (blue line) from the corresponding voxel using Gaussian fitting (red line) with Gannet 
(v3.0). Example shows typical signal peaks for GABA (3.02 ppm), Glx (3.75–3.8 ppm), Cr (3.0 
ppm), and water (4.7 ppm) for a single participant.  
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Figure 4.2. Diagram of the experimental procedure. All participants took part in procedures in grey, participants undergoing a single rTMS 
session took part in procedures in red, and participants who underwent accelerated rTMS took part in procedures in purple. Pre-rTMS 
(baseline) procedures took longer than follow-up visits as participants were provided with detailed instruction of procedures, and because of 
time involved in determining optimal positioning of the MRS voxel. 
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Figure 4.3. Mean GABA+ and Glx concentrations for all visits for the (a) single rTMS session 
group, and (b) accelerated rTMS sessions group. Error bars represent ± SEM. Triangle symbols 
represent Glx, and circles represent GABA+ concentrations.  
* p < .1. ** p < .05. 
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Figure 4.4. No significant relationship between visual cortical excitability (PT) and visual cortical 
GABA+/Glx expressed as (a) tissue-corrected concentrations (i.u.), and (b) normalised 
concentrations using integral ratios relative to Cr.  
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Table 4.1. 
Group Characteristics and Questionnaire Responses Across Visits 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) rTMS group and visits for which measures are associated with, group age, PT, and questionnaire 
responses. Data are presented as mean (± SEM) values.  
 
 
 
 
 
 
 
 
     VVIQ 
Visit Age (years) PT (%) MoCA LSHS eyes open eyes closed 
Single rTMS group 25.5 ± 2.25 68.625 ± 2.05     
    Pre-rTMS   28.875 ± 0.55 22.38 ± 1.349 61.88 ± 3.34 65.875 ± 3.22 
    Immediate – 1 hr post-rTMS   29.13 ± 0.295 21.38 ± 1.36 61.88 ± 3.303 59.625 ± 4.63 
Accelerated rTMS group 24.75 ± 1.07 73.13 ± 2.75     
    Pre-rTMS   28.875 ± 0.52 21.63 ± 1.511 52.875 ± 2.955 54.625 ± 2.6 
    Immediate – 1 hr post-rTMS   29 ± 0.423 4.93 ± 1.742 50 ± 3.059 53.13 ± 4.147 
    24 hr post-rTMS   28.875 ± 0.61 22.875 ± 2.06 50.875 ± 3.55 54.429 ± 4.38 
    1-week post-rTMS   29.75 ± 0.16 22.875 ± 1.87 50.25 ± 3.56 52.75 ± 3.9 
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Table 4.2. 
Adverse Effects Reported at Post-Stimulation Follow-Up Visits 
 
 
Participant # 
Visit 
Immediate – 1 hr post-rTMS 24 hr post-rTMS 
Single rTMS group   
    2 Headache = 3  
    3 Cognition = 2  
    7 Headache = 2  
    8 Concentration = 2  
Accelerated rTMS group   
    10 Headache = 2 Headache = 4 
    11 Headache = 2  
    12 Neck discomfort = 2  
    13 Concentration = 3.5, hearing  
TMS tapping noises = 3 
Hearing TMS tapping 
noises = 2 
 
Note. The columns list (from left to right) participants (identified numerically) that experienced adverse 
effects following rTMS and their allocated rTMS group, and the post-rTMS follow-up visit at which 
symptoms were experienced. Symptoms were reported as: 1 = no symptoms/change, 2 = minimal 
symptoms/change, 3 = slight symptoms/change, 4 = moderate symptoms/change, 5 = significant 
symptoms/change. Participants reported no significant adverse effects (e.g., pain/discomfort) during or 
after rTMS, even at higher stimulation intensities. The side effects reported are transient and common 
with rTMS (Rossi et al., 2009). 
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CHAPTER 5 
 
MODULATING INTRINSIC FUNCTIONAL NETWORK CONNECTIVITY 
WITH THE VISUAL CORTEX USING LOW-FREQUENCY REPETITIVE 
TRANSCRANIAL MAGNETIC STIMULATION 
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Preface 
Intrinsic network connectivity between functionally interconnected nodes becomes altered in 
pathophysiology. Noninvasive brain stimulation can modulate pathological functional networks 
identified with rsFC and an attempt to restore the disease-driven response. The potential of 
stimulation protocols to target networks associated with the visual cortex for relevance in visual-
related disorders requires investigation. Here we investigated the effects of alternative low-
frequency (1 Hz) rTMS regimes to the visual cortex on modulating functional connectivity with 
the visual network and default mode network (DMN) in healthy controls using multi-echo (ME) 
rsfMRI. We further considered the influence of changes in visual cortex GABA (assessed via 
GABA+) and glutamate (assessed via Glx) concentrations on rsFC following rTMS. A single 20 
min rTMS session to the visual cortex modulated rsFC with cortical and subcortical regions 
within and outside of the visual network and DMN. These rsFC changes were not evident 
immediately post-rTMS but were observed at 1 hr post-rTMS. In contrast, following five 
accelerated 20 min sessions to the visual cortex, absent or rather weak alterations in rsFC 
associated with the visual network and DMN were observed. Acute disruption with a single 
session of rTMS causes widespread reconfiguration of intrinsic rsFC in networks of interest, 
whereas accelerated sessions produce a relatively homeostatic response. GABA+ and Glx were 
differently associated with single and accelerated rTMS sessions and with the visual network and 
DMN. These findings offer insight into neural processes associated with intrinsic functional 
network connectivity with the visual cortex and the potential for 1 Hz rTMS to modulate 
interconnected regions. The differential effects associated with single and accelerated rTMS 
sessions are crucial for furthering the advancement of low-frequency rTMS in treatment 
modalities for visual-related disorders. 
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Examining the human brain as an integrative network of functionally interacting brain 
regions can provide new insights about large-scale neuronal communication in the human brain. 
It allows us to examine how connectivity and information integration relates to human 
behaviour, and how this organisation may be altered in pathophysiological processes or 
following neuromodulation (Bullmore & Sporns, 2009; Greicius, 2008). rsfMRI permits 
investigation of intrinsic connectivity between functionally related brain regions at rest. rsFC 
provides a measure of synchronous fluctuations in BOLD signal among regions to determine 
functional connectivity between interconnected nodes of networks. As such, rsFC provides 
insight into the brain’s functional organisation of multiple systems and baseline neural 
processing (Fox & Raichle, 2007). Disturbances in rsFC are reported for a significant number of 
disease states (for a review, see Fox & Greicius, 2010) and potential biomarkers have been 
identified that show variability in the strength of functional coupling within distinct networks, for 
example, in Alzheimer's disease (Li et al., 2002), depression (Greicius et al., 2007), 
schizophrenia (Liang et al., 2006), and in cases of visual impairment (Dai et al., 2013; Liu et al., 
2007; Yu et al., 2008). In addition, in cortical lesions, abnormal communication between the 
lesion site and remote interconnected regions causes pathophysiological changes locally and 
distal to the site of damage (Chapters 2–3; Guo et al., 2014; Rafique et al., 2016, 2018).  
Noninvasive brain stimulation influences neuronal properties of the stimulated region, an 
accessible network node, which propagates the response transsynaptically to functionally 
interconnected nodes (Fox et al., 2014). A variety of rTMS protocols are capable of modulating 
functional network connectivity associated with the stimulation site (van der Werf, Sanz-Arigita, 
Menning, & van den Heuvel, 2010; Watanabe et al., 2014). The combination of rTMS and rsFC 
offers a promising technique to both diagnose and modulate pathological network interactions 
 133 
for perceptual, behavioural and/or neurochemical gains in conditions associated with altered 
network connectivity (Fox, Halko, Eldaief, & Pascual-Leone, 2012; Grefkes et al., 2010; 
Strafella et al., 2003). The combined application of rsFC and rTMS in visual disorders has 
received little attention. For example, visual hallucinations associated with vision loss are a 
frequent and under-investigated consequence stemming from disorganised functional activity in 
interconnected cortical and subcortical networks (Chapter 2; ffytche et al., 1998; Rafique et al., 
2016). Similarly, widespread alterations in rsFC are observed in amblyopia, suggesting that 
deficits are related to abnormal neural connections across networks (Wang et al., 2014). While 
rTMS can alter functional network connectivity, the effects can be unpredictable, unstable, and 
short lasting, particularly in pathophysiology (Maeda et al., 2000; Ridding & Ziemann, 2010), 
thus, limiting its usefulness. If we wish to selectively increase or decrease functional 
connectivity between specific brain regions in a controlled manner in visual disorders, 
knowledge of effects for different stimulation protocols is necessary in healthy individuals. A 
reference model of expected effects in healthy controls can provide knowledge of underlying 
mechanisms of rTMS, from which therapeutic protocols for visual-related disorders can be 
developed, and patient data can be compared. 
 The purpose of the present study was to explore the efficacy of low-frequency (1 Hz) 
rTMS to the visual cortex on modulating intrinsic functional network connectivity. Two 
alternative rTMS regimes are established in clinical applications (in non-visual disorders): a 
single session of rTMS applied over consecutive days for weeks/months or accelerated sessions 
(multiple sessions within one day) applied over consecutive days for a shorter period than single 
session rTMS. Previous research using accelerated rTMS in patient populations suggests that 
despite the reduced number of days of stimulation compared with single session rTMS, the 
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increased stimulation doses within a single day produce augmented effects (for a review, see 
Goldsworthy et al., 2015). Thus, we explored the effect of these alternative rTMS protocols by 
employing a shorter schedule consisting of a single 20 min session or five accelerated 20 min 
sessions of 1 Hz rTMS to the visual cortex. Further, we assessed whether longer-term changes 
persisted beyond the immediate post-rTMS measured effects. Further details of the two regimes 
are provided in Chapter 4 (pp. 98–99). 
 The effect of these rTMS protocols was investigated on two networks of interest using 
ME rsfMRI. We considered the direct effect of 1 Hz rTMS on nodes of the visual processing 
network interconnected to the stimulation site in the visual cortex (V1) (Beckmann, DeLuca, 
Devlin, & Smith, 2005; Yeo et al., 2011). Additionally, we explored the indirect effect of rTMS 
to the visual cortex on the DMN. The DMN consists of brain regions that show increased levels 
of activity during rest and are engaged in spontaneous and self-generated mental activity in the 
absence of external attentional demands (Gusnard, Akbudak, Shulman, & Raichle, 2001). The 
DMN is functionally and structurally interconnected with a considerable number of cortical and 
subcortical regions (Buckner, Krienen, Castellanos, Diaz, & Yeo, 2011; Hagmann et al., 2008; 
Margulies et al., 2009). We chose to investigate effects on the DMN since it has been suggested 
that dysfunction may arise in the DMN in disorders affecting visual processing (Lewis et al., 
2014). In addition, significant disruption of the DMN, e.g., via stimulation to the visual cortex, 
may also have substantial implications for cognitive and behavioural performance. Data were 
analysed using ME-independent components analysis (ICA) and a whole-brain exploratory seed-
based analysis approach. ME-ICA uses ME fMRI acquisition and TE dependency of resting-state 
BOLD signal to denoise artefactual fluctuations more effectively than other approaches (e.g., 
physiological noise modelling, band-pass filtering) and improves temporal SNR (Kundu, Inati, 
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Evans, Luh, & Bandettini, 2012). ME-ICA addresses the problem of low statistical power in 
fMRI studies by attenuating non-BOLD-related noise, leading to improvement in sensitivity and 
statistical power of fMRI (Kundu et al., 2012). The enhanced sensitivity facilitates detection of 
smaller and more subtle effects in brain regions that are methodologically fraught by other 
denoising methods (for a review, see Kundu et al., 2017; Lombardo et al., 2016).  
 We have previously assessed changes in visual cortical GABA (assessed via GABA+) 
and glutamate (assessed via Glx) concentrations following stimulation of the visual cortex using 
identical rTMS protocols (Chapter 4). The coordination between GABAergic interneurons and 
glutamatergic neurons directly impacts BOLD signal (Logothetis, 2008; Magistretti & Pellerin, 
1999; Smith et al., 2002a). However, the neurochemical basis for variability in rsFC remains 
poorly understood and is to some extent related to GABAergic and glutamatergic systems; 
therefore, we explored the influence of these metabolites on changes in rsFC following rTMS. 
The neurochemical underpinnings of network connectivity will provide a better understanding of 
normal neurophysiological responses and alterations with rTMS associated with 
GABAergic/glutamatergic systems, with translation to therapeutic protocols of noninvasive brain 
stimulation. 
Methods 
This study was approved by York University’s Office of Research Ethics. All individuals 
gave informed written consent. 
Participants 
Sixteen participants took part in the study (Mage ± SEM = 25.15 ± 1.21 years; 10 
males/six females). All participants were right-handed, with normal or corrected-to-normal 
vision (> 0.04 logMAR; stereoacuity ≥ 50”), and no known contraindications to TMS and MRI. 
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Participants presented with no underlying medical conditions, were not taking any medications at 
the time of the study, and had no history of neurological or psychological disorders. All 
participants had also taken part in an MRS study to quantify changes in visual cortex GABA+ 
and Glx concentrations (Chapter 4) following the same experimental procedure as the present 
study. Participant history is provided in more detail in Chapter 4 (see Methods: Participants, p. 
97). Participants received monetary compensation for their participation ($10 CAD/hr).  
Experimental Design Overview 
Participants initially underwent pre-rTMS (baseline) ME rsfMRI. In a separate follow-up 
visit, participants received offline 1 Hz rTMS to the visual cortex (V1) at the individual PT, 
either in a (1) single 20 min session of rTMS, or (2) five accelerated 20 min sessions of rTMS 
(separated by intervals of ~15 min). ME rsfMRI was repeated immediately following cessation 
of rTMS in both groups. ME rsfMRI was further performed (1) 1 hr post-rTMS in the single 
rTMS group, and (2) 24 hr and 1-week post-rTMS in the accelerated rTMS group.  
Magnetic Resonance Imaging  
ME rsfMRI and anatomical data were acquired with a 3T Siemens Magnetom® Tim Trio 
magnetic resonance scanner, with a 32-channel high-resolution brain array coil (Siemens, 
Erlangen, Germany). Head motion was minimised using soft pads surrounding participants’ 
heads. Imaging was acquired in a dark room, and participants were instructed to keep their eyes 
closed and to not think of anything in particular throughout.  
 ME rsfMRI data were acquired first to capture immediate post-rTMS effects using 
whole-brain ME echo-planar imaging with a T2*-weighted sequence (number of contiguous 
axial slices = 43; in-plane resolution = 3.4 x 3.4 mm; slice thickness = 3 mm; imaging matrix = 
64 x 64; TR = 3000 ms; TE = 14, 30, 46 ms; flip angle = 83°; FoV = 216 mm; acquisition time = 
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~10 min). Anatomical images were acquired with a T1-weighted MPRAGE imaging sequence 
(number of slices = 192; in-plane resolution = 1 x 1 mm; slice thickness = 1 mm; imaging matrix 
= 256 x 256; TR = 2300 ms; TE = 2.62 ms; TI = 900 ms; flip angle = 9°; FoV = 256 mm; 
acquisition time = ~5 min).   
Repetitive Transcranial Magnetic Stimulation 
Anatomical MR images were reconstructed to 3D cortical surfaces, and individual 
stimulation sites were mapped to their corresponding reconstructed cortical surface using 
Brainsight software (Rogue Research, Montreal, QC, Canada). Participant target stimulation sites 
in the visual cortex were based on our MRS study (Chapter 4, Methods, pp. 103, 105) from 
which GABA+ and Glx concentrations were extracted. Therefore, target sites in the present 
study and the MRS study were identical to enable a direct relationship between changes in 
metabolites and rsFC following the two rTMS protocols. Anatomical images in native space 
were manually co-registered to MNI coordinate space (see Table 5.1 for individual stimulation 
site MNI coordinates) within Brainsight using a linear transformation (translation, rotation, and 
scaling). Positioning of the coil with respect to the participant’s head and the stimulation site was 
visualised in real time using a Polaris infrared image-guided tracking system (Northern Digital 
Instruments, Kitchener, ON, Canada) to ensure accurate and targeted disruption of the 
stimulation site throughout. Participants were seated in a comfortable position with an adjustable 
chin rest to limit head movement and provided with earplugs to prevent changes in auditory 
thresholds during rTMS (Rossi et al., 2009). A Magstim Rapid2 Stimulator and a 70 mm 
diameter figure-of-eight coil (Magstim, Whitland, Wales, UK) were used to deliver the 
stimulation pulses to the stimulation site. The TMS coil was held tangential to the surface of the 
skull to minimise coil-to-cortex distance and to maximise the TMS effect (Ulmer & Jansen, 
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2010). rTMS was delivered to the stimulation site at the participant’s PT to minimise inter-
individual variability in visual cortical excitability thresholds (Stewart et al., 2001b). Details in 
obtaining the PT are described in Chapter 4 (Methods: Phosphene Threshold, pp. 104–105). 
Participants underwent 1 Hz rTMS (100% PT) at rest either in a single 20 min session (n = 8, 
four male/four female) or five accelerated 20 min sessions separated by ~15 min (n = 8, six 
male/two female) within a single day. Each rTMS session consisted of 1200 pulses (20 min). 
Stereotaxic co-registration was assessed immediately prior to each new rTMS session for 
accelerated sessions and refined where necessary. Details on the choice of rTMS protocols can 
be found in Chapter 4 (pp. 98–99). 
Experimental Procedure 
Participants initially underwent ME rsfMRI which commenced at ~13:00. On a different 
day, participants underwent rTMS to the visual cortex, which commenced at ~13:40 for 
participants in the single rTMS group, and commenced at ~11:00 for participants in the 
accelerated rTMS group. These times for rTMS commencement were chosen so that rTMS 
would cease at the time same of day irrespective of group, and accordingly immediate post-
rTMS rsfMRI would be performed at ~14:00 in both groups to minimise diurnal confounds. 
Following cessation of rTMS, participants were immediately transferred into the MRI scanner 
and acquisition commenced within 5 min of rTMS ending. Participants in the single rTMS group 
underwent further rsfMRI 1 hr post-rTMS at ~15:00. Participants in the accelerated rTMS group 
received further rsfMRI at 24 hr and 1-week post-rTMS, both at ~1400. The procedure was 
identical to that of our MRS study in order to support any correlation between changes in rsFC 
with our previous data on GABA+ and Glx concentrations following rTMS. Full details on MRS 
methods and scheduling choice of follow-up visits is found in Chapter 4 (Methods: Magnetic 
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Resonance Imaging, pp. 102–104; Methods: Experimental Procedure, pp. 106–107). ME rsfMRI 
and MRS were performed in participants within a time period of 1 month.  
Data Analyses 
Preprocessing and denoising. MRI data were manually assessed and showed minimal 
participant movement in the scanner; therefore, all participants and acquisition runs were 
included in subsequent analyses. ME rsfMRI data were initially preprocessed and denoised using 
the AFNI integrated ME-ICA pipeline (v3.2.2; http://afni.nimh.nih.gov; Kundu et al., 2013, 
2012). The first five TRs were removed to achieve steady-state equilibration. MR images were 
skull-stripped and intensity-normalised. Images were deobliqued, slice-timing corrected, 
axialised, and despiked. Motion correction parameters were estimated for each time point by 
aligning the middle TE (30 ms) images to the corresponding first time point image using a rigid 
body (six parameters) alignment procedure. Functional and anatomical images were co-
registered by registering the skull-stripped middle TE image from the first time point to the 
skull-stripped anatomical image using an affine (12 parameters) alignment procedure with the 
local Pearson correlation and T2* weights. Motion correction and anatomical co-registration 
parameters were then applied in one step. Functional and anatomical images additionally 
underwent non-linear warping to standard MNI space (MNI Colin27, 1 x 1 x 1 mm). The three 
TEs provide different BOLD contrasts and are combined to create an optimal combination of 
contrast specific to each voxel therefore, producing a more homogenous contrast-to-noise ratio 
compared with single-echo fMRI (Kundu et al., 2015). The concatenated optimally combined 
functional data underwent principal component analysis (PCA) to distinguish BOLD signal of 
high and low variance components from noise. Denoising in ME-ICA is achieved with spatial 
FastICA, which decomposes and classifies the retained components from PCA into BOLD signal 
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and non-BOLD noise, and effectively removes noise components using linear regression, 
including motion, physiological and scanner artefacts (e.g., draining veins, and in-plane 
acceleration) (Evans, Kundu, Horovitz, & Bandettini, 2015; Kundu et al., 2017). Using non-
BOLD component time courses as noise regressors greatly improves seed-based correlation 
mapping by minimising the influence of high- and low-frequency non-BOLD fluctuations 
(Kundu et al., 2012). ME-ICA denoising retains thermal noise and low variance ICs with high 
degrees of freedom, therefore, increasing sensitivity for determining significant effects (Kundu et 
al., 2015, 2017) and temporal SNR (Kundu et al., 2015).  
 In CONN: functional connectivity toolbox (v17.f; http://www.nitrc.org/projects/conn; 
Whitfield-Gabrieli & Nieto-Castanon, 2012), a Matlab-based cross-platform, ME-ICA denoised 
time series were spatially smoothed using a 6 mm full width at half maximum Gaussian kernel. 
Each participant’s anatomical scan from each visit was segmented into cerebrospinal fluid, grey 
and white matter. These preprocessing steps within the CONN toolbox were implemented using 
SPM8 (Statistical Parametric Mapping, Wellcome Centre for Human Neuroimaging, London, 
UK; http://www.fil.ion.ucl.ac.uk/spm). BOLD signal from white matter and cerebrospinal fluid 
masks were identified using a component-based noise correction (CompCor; Behzadi, Restom, 
Liau, & Liu, 2007) and associated residual confounding effects were linearly regressed with 
PCA (five components each with no additional temporal expansion derivative terms; Chai, 
Castañón, Öngür, & Whitfield-Gabrieli, 2012) to improve (centre) the distribution of 
connectivity values of the data. The CompCor method addresses confounding effects without 
affecting intrinsic functional connectivity (Chai et al., 2012), while improving specificity, 
sensitivity, and validity of subsequent functional connectivity analyses such as false positive 
anticorrelated activity (Whitfield-Gabrieli & Nieto-Castanon, 2012). Data were not band-pass 
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filtered or detrended since they underestimate the effect of non-BOLD fluctuations, remove 
BOLD-related fluctuations, and discard low-frequency components (Evans et al., 2015; Kundu et 
al., 2012) that mediate rsFC and are necessary for the detection of functionally relevant networks 
(Biswal et al., 1995; Fransson, 2005; Greicius, Krasnow, Reiss, & Menon, 2003).  
Functional connectivity. We used exploratory whole-brain seed-based analyses to 
determine the effects of the two rTMS regimes on rsFC using the CONN toolbox. Temporal 
correlations of BOLD signal during rest were computed between a seed region-of-interest (ROI) 
(from which the reference time series were extracted) and all other voxels in the brain, yielding 
seed ROI-specific spatial functional maps (seed-to-voxel analysis; Biswal et al., 1995). Two 
networks were explored: the visual network associated with the stimulation site at the visual 
cortex (V1) and the DMN. A 10 mm radius sphere ROI was centred at the stimulation site and 
positioned closest to the posterior surface of the occipital pole (Brodmann area 17), which 
received the strongest stimulation (i.e., region closest to the TMS coil), and was specific to each 
participant (average MNI coordinates: x = 1, y = -81, z = 15; see Table 5.1 for individual MNI 
coordinates). The DMN seed ROI was selected from the CONN DMN atlas. For the DMN, a 10 
mm radius sphere ROI was placed in the posterior cingulate cortex/precuneus (Brodmann area 
23/31; MNI coordinates: x = -6, y = -52, z = 40; Whitfield-Gabrieli & Nieto-Castanon, 2012) in 
all participants. Overlapping posterior cingulate cortex/precuneus regions are considered a 
critical node in the DMN (Damoiseaux et al., 2006; Grecius et al., 2003; Gusnard et al., 2001) 
and are shown to extract reliable patterns of DMN functional connectivity using seed-based 
analyses (e.g., Fox et al., 2005; Fransson, 2005; Greicius et al., 2003). First-level analyses 
correlated the average BOLD time course between each seed ROI to whole-brain voxels (one 
dimension, no temporal expansion of derivatives, no frequency decomposition) to create rsFC 
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maps for each visit and participant separately using a weighted GLM and bivariate Pearson’s 
correlations (with no haemodynamic response function weighting). The correlation coefficients 
represent the level of association between two time series that reflects the relative degree of 
functional connectivity of each seed and each voxel in the brain. The resulting weighted 
correlation coefficients were converted to normally distributed z-scores using Fisher's 
transformation. The first-level individual rsFC maps were subsequently used for second-level 
GLM analyses to investigate significant changes in seed-to-voxel rsFC between pre-rTMS and 
follow-up visits for each rTMS group and seed ROI, separately. The rTMS groups were analysed 
independently due to different follow-up visit intervals. Paired t-tests were calculated to 
investigate whole-brain differences in rsFC between pre-rTMS and each follow-up visit. The 
number of degrees of freedom from ME-ICA denoised data for each participant and visit were 
entered as a covariate of no interest for subject- and group-level analyses to control for and avoid 
inflated test statistics and false positive results (Kundu et al., 2017). Nonparametric statistics 
(1000 permutations; Pernet, Latinus, Nichols, & Rousselet, 2015) were chosen to control for 
false positive rates and to provide added protection against potential violations of parametric 
assumptions with small sample sizes (Eklund, Nichols, & Knutsson, 2016). Significant clusters 
were investigated with post-hoc simple effects analyses to identify the direction of rsFC effects 
(i.e., increase or decrease) between the pre-rTMS visit and each post-rTMS follow-up visit. The 
resulting rsFC maps were thresholded at a whole-brain uncorrected voxel-level (height) 
threshold of p < .001, cluster-mass (extent) threshold of p < .05 corrected with FDR for multiple 
comparisons, with a minimum cluster size of 25 voxels. These a priori thresholds were chosen in 
accordance with CONN toolbox guidelines for supporting strong focal effects as opposed to 
weaker diffuse effects (e.g., uncorrected voxel-level threshold of p < .01), and to further 
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constrain false positive effects. Positive and negative correlations (two-sided) were examined. 
Regions showing significant changes in rsFC associated with the seed ROIs between pre-rTMS 
and follow-up visits were identified using the Harvard-Oxford cortical and subcortical 
probabilistic (25% probability) anatomical atlases (Desikan et al., 2006), the Automated 
Anatomical Labeling atlas to parcellate cerebellar areas (Tzourio-Mazoyer et al., 2002), and the 
Brodmann Area atlas (Brodmann, 1909, 1910), all implemented within the CONN toolbox.  
 To investigate how changes in rsFC within these networks are influenced by GABA+ and 
Glx concentrations following the two rTMS protocols, we repeated the above procedure with 
multiple regression analyses. The metabolite concentrations obtained from our MRS study 
(Chapter 4) were acquired from the same stimulation site seed ROI used for rsFC and were 
included as a covariate of interest in second-level analyses. We still controlled for the number of 
degrees of freedom from ME-ICA denoised data (covariate of no interest). These analyses 
evaluated the correlation between change in rsFC (difference in connectivity pre- and post-
rTMS) and change in metabolite concentration (difference in GABA+/Glx concentration pre- 
and post-rTMS) in the networks of interest. Analyses compared pre- and post-rTMS for each 
metabolite, seed ROI, and rTMS group, separately. 
Results 
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Resting-
State Functional Connectivity   
Regions demonstrating significant changes in rsFC with the stimulation site (V1) and 
posterior cingulate cortex/precuneus seed ROIs following a single rTMS session are provided in 
Tables 5.2–5.3, respectively. For both seed ROIs, there were no significant changes in rsFC with 
correlated regions immediately following cessation of rTMS compared with pre-rTMS. 
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However, significant changes in rsFC were detected 1 hr after rTMS had ceased compared with 
pre-rTMS. The stimulation site showed significant changes in rsFC with frontal, parietal, 
temporal, and occipital lobe regions, as well as the brainstem, thalamus, and cerebellum (Table 
5.2; Fig 5.1a). The posterior cingulate cortex/precuneus showed significant changes in rsFC with 
frontal and temporal lobe regions, as well as the cingulate gyrus, cerebellum, and basal ganglia 
(putamen, pallidus, accumbens) (Table 5.3; Fig 5.1b).  
 There were no significant changes in rsFC between the stimulation site and correlated 
regions following accelerated rTMS compared with pre-rTMS. Only the middle temporo-
occipital region showed a significant decrease in rsFC with the posterior cingulate 
cortex/precuneus at 1-week post-rTMS compared with pre-rTMS (Brodmann area 22; MNI 
coordinates: x = 54, y = -41, z = 1; voxels = 411 mm; effect size = .21). However, using a less 
conservative voxel-level threshold of p < .01 revealed diffuse weak changes in rsFC between the 
stimulation site and correlated regions only at 24 hr post-rTMS (Table 5.4), and only at 1-week 
post-rTMS for regions correlated with the posterior cingulate cortex/precuneus (Table 5.5).  
 The average difference in connectivity strength between pre- and post-rTMS visits across 
participants for each seed ROI and correlated regions are represented by effect size values in 
Tables 5.2–5.5. 
Influence of GABA+ and Glx on Resting-State Functional Connectivity  
Multiple regression analyses demonstrated a significant correlation between pre- and 
post-rTMS differences in rsFC and metabolite concentrations in networks associated with our 
seed ROIs. These findings suggest that changes in rsFC are related to GABA+ and/or Glx 
changes following 1 Hz rTMS to the visual cortex.  
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 Significant changes in rsFC following a single rTMS session for both seed ROIs, the 
stimulation site (V1) and posterior cingulate cortex/precuneus, are provided in Tables 5.6–5.7, 
respectively. Significant changes in rsFC between the stimulation site and correlated regions 
associated with GABA+/Glx were only apparent 1 hr after rTMS ceased. The stimulation site 
showed significant changes in rsFC with frontal, parietal, and occipital lobe regions, and the 
cerebellum (Table 5.6). However, in the case of the posterior cingulate cortex/precuneus seed, 
significant changes in rsFC with correlated regions were only associated with GABA+ and not 
Glx. Effects with the posterior cingulate cortex/precuneus were detected immediately after rTMS 
ceased and continued until 1 hr post-rTMS. The posterior cingulate cortex/precuneus showed 
significant changes in rsFC with frontal, parietal, occipital, and temporal lobe regions, as well as 
the cingulate gyrus, basal ganglia (caudate), thalamus, and cerebellum (Table 5.7). Notably, the 
effects associated with the posterior cingulate cortex/precuneus were more widespread and not 
stable, showing variable changes in network connectivity at 1 hr compared with immediately 
post-rTMS. 
 Tables 5.8–5.9 show significant changes in rsFC following accelerated rTMS sessions for 
the stimulation site and posterior cingulate cortex/precuneus seed ROIs, respectively. With 
accelerated rTMS, significant changes in rsFC between the seed ROIs and correlated regions 
associated with GABA+ and Glx were apparent immediately after rTMS and continued to 1-
week post-rTMS. Widespread changes in rsFC associated with GABA+/Glx were observed in 
frontal, parietal, occipital, and temporal lobe regions, as well as the cingulate gyrus, basal 
ganglia, thalamus, amygdala, brainstem, and cerebellum. These effects were additionally not 
stable in that they continued to change even at 1-week post-rTMS, as observed from the 
inconsistent involvement of interconnected regions and/or changes in connectivity at the 
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different follow-visits. For example, the left superior lateral occipital cortex shows a decrease in 
rsFC with the stimulation site associated with a change in GABA+ immediately post-rTMS; 
while, an increase in rsFC is observed between these regions at 24 hr post-rTMS (Table 5.8).  
 The effect size values in Tables 5.6–5.9 represent connectivity strength as a ratio of 
change in rsFC between the seed and correlated cluster per unit change in metabolite 
concentration. The average change in metabolite concentration at the stimulation site (average 
pre-rTMS concentration minus post-rTMS concentration) relative to the rTMS protocol is 
provided in the corresponding Table captions. 
Discussion 
We report unexpected differential rsFC changes in nodes associated with the stimulation 
site in the visual cortex and the DMN following two different low-frequency (1 Hz) rTMS 
(100% PT) protocols. A single 20 min session produced delayed strong changes in rsFC across 
cortical and subcortical regions compared with pre-rTMS. Surprisingly, five accelerated 20 min 
sessions of rTMS produced weak and relatively insignificant changes in rsFC. We further 
observed that rsFC was associated with changes in GABA+ and Glx concentrations in both 
rTMS protocols, and these changes to rsFC fluctuated between post-rTMS visits. This study 
demonstrates that 1 Hz rTMS modulates rsFC with regions distal to the site of stimulation and 
with regions that are not usually functionally connected to the seed ROIs pre-rTMS.  
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Intrinsic 
Visual Cortex Functional Connectivity 
The resting-state visual network consists of primary visual and extrastriate cortices, with 
additional functional connectivity with the motor network (van den Heuvel, Mandl, Kahn, 
Hulshoff Pol, & Hilleke, 2009). A single 20 min session of 1 Hz rTMS to the visual cortex 
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modulated rsFC (correlated and anticorrelated) to cortical regions outside the usual visual 
network (Table 5.2), including nodes of the DMN (e.g., precuneus and middle frontal gyrus) and 
subcortical regions (e.g., cerebellum and thalamus). The DMN consists of overlapping posterior 
cingulate cortex/precuneus, anterior cingulate cortex, frontal, parietal, and temporal regions 
(Greicius et al., 2003; Laird et al., 2009). Although we did not directly stimulate nodes of the 
DMN, the posterior cingulate cortex/precuneus also showed modified rsFC to regions outside the 
DMN post-rTMS, e.g., basal ganglia and cerebellum (Table 5.3). Increasing evidence suggests 
that specific cerebellar regions are integral to the DMN (Brissenden, Levin, Osher, Halko, & 
Somers, 2016; Buckner et al., 2011). The cerebellum is rarely reported as a node of the DMN as 
many studies do not acquire whole-brain data or acquisition/analysis methods may be 
insensitive. Identification of subcortical effects in the present study may be attributed to ME-ICA 
sensitivity. These subcortical effects are reported to be unobservable with single-echo rsfMRI at 
the current sample size and with alternative denoising techniques where effects are obscured by 
greater amounts of non-BOLD noise, e.g., low functional contrast-to-noise due to cerebral spinal 
fluid and blood flow pulsatility (Kundu et al., 2012; Lombardo et al., 2016).  
 Notably, for both seed ROIs, effects of single session rTMS did not emerge until 1 hr 
post-rTMS. The delayed changes in rsFC suggest that either effects are too diffuse and weak 
immediately post-rTMS to be detected, or that there is greater inter-individual variability 
immediately post-rTMS, and therefore rsFC changes were not significant. We tested the former 
by using a less conservative voxel-level threshold (p < .01) to investigate weaker effects, yet we 
continued to observe no significant changes in rsFC between pre-rTMS and immediate post-
rTMS visits. Exploring individual-level rsFC maps revealed little change in connectivity values 
for either seed ROI between pre-rTMS and immediately post-rTMS visits. The continued 
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absence of rsFC changes immediately post-rTMS suggests that the latter may be more likely, or 
perhaps a combination of the two has occurred.  
 Further, it is interesting that rsFC changes following a single session of rTMS outlast 
those measured by other neurotechniques that have recorded shorter aftereffects. Our knowledge 
of rTMS aftereffects has relied heavily on EEG recordings. In the case of low-frequency rTMS 
to the visual cortex, EEG recordings following 10–20 min of 1 Hz rTMS have established 
aftereffects lasting in the range of 10–40 min (for a review see, Thut & Pasucal-Leone, 2010). 
Accordingly, we did not expect rsFC changes to persist at 1 hr post-rTMS following a single 
rTMS session and certainly not that these effects would only be reliable at 1 hr post-rTMS. This 
finding critically highlights that our understanding of noninvasive brain stimulation is highly 
dependent on and limited by the tool of measure; specifically, rsfMRI aftereffects persist longer 
than those measured by EEG. In line with our results, Nettekoven and colleagues (2014) 
previously demonstrate that accelerated TBS causes changes in excitability (as measured by 
motor evoked potentials) that are unrelated to changes in motor network rsFC. These findings 
suggest that rsfMRI may not be as sensitive as EEG to immediate post-rTMS effects, but instead 
shows delayed network changes. Alternatively, aftereffects observed using electrophysiological 
measures compared to functional connectivity likely occur via different mechanisms and/or 
dissimilar timeframes. In addition, ME-ICA is considered to be more sensitive to slower 
emerging changes with TMS than previous conventional methods; therefore, we may be unlikely 
to capture these effects using single-echo rsfMRI and alternative denoising techniques (e.g., 
band-pass filtering) (Evans et al., 2015), and perhaps even with EEG.  
 We observed a rather unexpected finding of null effects following five accelerated 20 
min sessions of rTMS on rsFC. We expected either an inversion of effects compared to single 
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rTMS, as had been previously observed with longer trains of stimulation (e.g., Gamboa et al., 
2010), or a strengthening of effects (e.g., Nettekoven et al., 2014). One possible explanation for 
this null finding is the presence of larger inter-individual variability in TMS response (Ridding & 
Ziemann, 2010; Stewart et al., 2001b), which would likely intensify with concentrated doses of 
rTMS such as accelerated sessions. However, investigation of individual-level connectivity 
values following accelerated rTMS showed very little change in rsFC between seed ROIs and 
correlated regions compared with pre-rTMS. Again, to test for weaker effects, we repeated 
analyses with a less conservative uncorrected voxel-level threshold (p < .01) and did in fact 
observe weak and diffuse differences in rsFC following accelerated rTMS (Tables 5.4–5.5). 
These diffuse changes encompassed a large number of brain regions (clusters > 1000 voxels) that 
were detected only at 24 hr post-rTMS for effects associated with the stimulation site, and were 
only observed at 1-week post-rTMS for the posterior cingulate cortex/precuneus seed. The 
continued absence of immediate post-rTMS effects suggests subtle accelerated rTMS effects do 
not become stable and/or arise until at least 24 h, yet these subtle effects persist for at least 1-
week.  
 A consideration for accelerated rTMS effects relates to metaplasticity induced by TMS 
and the ability of functional cortical networks to maintain neuronal activity within a dynamic 
range (Bocci et al., 2014; Lang et al., 2004). It could be, at least in terms of rsFC, that the brain 
becomes resistant to change and the dose-dependent effects of accelerated rTMS throughout the 
day are due to metaplasticity as a compensatory measure to maintain homeostasis in healthy 
control individuals. Support for the presence of this resistant effect comes from the strong 
observed changes in rsFC following just a single session of rTMS that are not seen with 
subsequent stimulation. Gamboa and colleagues (2011, 2010) observe suppression of aftereffects 
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following two accelerated TBS sessions within one day that were dependent on the TBS protocol 
and the timing of the break interval in between sessions. A commonly proposed description of 
these aftereffects with multiple rTMS sessions is the Bienenstock-Cooper-Munro theory 
(Bienenstock, Cooper, & Munro, 1982). Hebbian synaptic plasticity would enable a continuous 
unidirectional change in network excitability following stimulation that would essentially 
destabilise a neural system (Bocci et al., 2014). According to the Bienenstock-Cooper-Munro 
theory, LTP effects induced after stimulation favour the induction of LTD with subsequent 
stimulation, thereby preventing an excessive buildup of LTP or LTD. This mechanism regulates 
intrinsic excitability and ensures stable neuronal activity through dynamic modification of LTP 
and LTD thresholds. Therefore, an increased LTD response will occur following enhanced 
postsynaptic activity from saturation of LTP-induced mechanisms and vice versa. Conversely, a 
strengthened effect is recorded with multiple/accelerated stimulation protocols in patient 
populations (for a review, see Goldsworthy et al., 2014; Rafique et al., 2016) and in healthy 
controls (Bastani & Jaberzadeh, 2014; Kettekoven et al., 2014). The contradictory findings 
between studies across research groups likely pertains to differences in stimulation protocols, 
intervals between multiple stimulation sessions, site of stimulation, and the neurotechnique 
employed to measure aftereffects. We have previously observed a reduction in MRS measured 
GABA+ at the visual cortex with this accelerated rTMS protocol (Chapter 4), suggesting that 
restorative effects with our protocol may only be at the functional network connectivity level. If 
we consider the influence of GABA+/Glx concentration on rsFC changes following accelerated 
rTMS, we observe significant widespread changes to networks associated with both seed ROIs 
(Tables 5.8–5.9). This contrasting finding in rsFC when taking into consideration GABA+ and 
Glx concentrations with accelerated rTMS may indicate that the influence of GABA+ and Glx is 
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greater with accelerated sessions, and these rsFC changes become apparent because much of the 
unexplained variance is accounted for. At least in terms of GABA+ and Glx involvement, we can 
be confident post-accelerated rTMS effects are occurring, and other mechanisms must be 
concerned beyond involvement of these neurotransmitters to produce a restorative effect in rsFC. 
The interaction between GABAergic and glutamatergic systems may be a more appropriate 
indicator of TMS effects since these systems are critical in LTD and LTP. 
Influence of GABA+ and Glx on Intrinsic Visual Cortex Functional Connectivity  
Our previous study investigating changes in GABA+ and Glx concentration at the 
stimulation site using identical rTMS protocols found no significant change in metabolites with a 
single session, and a significant reduction in GABA+ concentration for up to 24 hr following 
accelerated rTMS (Chapter 4). Yet, when we investigate the influence of these GABA+ and Glx 
concentrations on rsFC, we see these metabolite changes influence rsFC immediately after rTMS 
ceased for both stimulation protocols (Tables 5.6–5.9). In addition, these rsFC changes persist 
until at least the last follow-up visits for both protocols. Our distinct findings highlight technique 
sensitivity, namely MRS versus rsfMRI. Functional connectivity is influenced by cortical 
network oscillations in the gamma frequency range (Cabral, Hugues, Sporns, & Deco, 2011), and 
the interaction with GABA-mediated responses (Muthukumaraswamy, Edden, Jones, 
Swettenham, & Singh, 2009). In the visual cortex, gamma frequency oscillations are positively 
related with MRS measured GABA and inversely correlated with the magnitude of BOLD 
response (Muthukumaraswamy et al., 2009). Synchronised neural oscillations in cortical 
networks are particularly mediated by postsynaptic GABAA receptors (for a review, see 
Gonzalez-Burgos & Lewis, 2008). Conversely, MRS is considered insensitive to synaptic 
activity, but instead measures the total concentration of GABAA and GABAB within the MRS 
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voxel, reflecting extrasynaptic GABAergic tone (Stagg et al., 2011c). Lastly, spontaneous 
neurotransmitter release at synapses occurs in the absence of neuronal spikes or action potentials 
(for a review, see Kavalali, 2015). Taken together, the findings suggest that spontaneous 
neurotransmitter release may reflect an important component of spontaneous fluctuations, and it 
may be that measuring rsFC is an indirect measure that is more sensitive to changes in GABA+ 
and Glx than measuring GABA+ and Glx directly with MRS. 
 In these analyses, we observed stronger widespread activity following accelerated rTMS 
than with a single session, which is consistent with our previous finding of a greater effect of 
accelerated rTMS on MRS measured GABA+ (Chapter 4). Differential effects between single 
session and accelerated rTMS were observed for Glx influence on rsFC with the DMN node 
posterior cingulate gyrus/precuneus. Glx concentration was not associated with rsFC changes in 
regions interconnected with the posterior cingulate gyrus/precuneus following a single session of 
rTMS (Table 5.7). However, following accelerated rTMS, both GABA+ and Glx influenced 
rsFC with the posterior cingulate gyrus/precuneus (Table 5.9). Indeed, prior work suggests that 
glutamate and GABA are significantly associated with DMN activity (Hu, Chen, Gu, & Yang, 
2013; Kapogiannis, Reiter, Willette, & Mattson, 2013). In contrast, both GABA+ and Glx 
concentration influenced rsFC associated with the stimulation site following single and 
accelerated rTMS sessions. These findings imply that Glx is not sufficiently altered at the visual 
cortex following a single session of 1 Hz rTMS to influence rsFC between the posterior cingulate 
gyrus/precuneus and interconnected regions. Nonetheless, changes in GABA+ and Glx as 
measured from the stimulation site (V1) were otherwise sufficient to influence direct and indirect 
local and distal changes in rsFC. 
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Implications on Intrinsic Functional Connectivity in Visual-Related Disorders  
Our findings have important implications for understanding the underlying effects of 
low-frequency rTMS to the visual cortex, and for developing therapeutic applications for visual-
related disorders. We do not intend to predict effects in pathophysiology coexisting with 
impaired functional state and altered responsiveness to rTMS (e.g., Antal et al., 2008). We know 
from patient populations that accelerated rTMS has a stronger cumulative effect than 
conventional single sessions applied over consecutive days (for a review, see Goldsworthy et al., 
2015). It is highly plausible that these promising results obtained in patient populations are owed 
to impaired systems (e.g., inability to maintain homeostasis, impaired metaplasticity), and the 
magnitude and direction of neuromodulated effects induced by rTMS will differ considerably 
from healthy subjects. Our intention was to provide a baseline framework for under-investigated 
effects of 1 Hz rTMS to the visual cortex. We nonetheless consider it necessary to investigate the 
response in the absence of pathophysiology in order to develop therapeutic techniques in terms 
of the most efficient protocol that combines optimal effects with minimal stimulation time (e.g., 
stimulation over days rather than weeks to improve patient compliance, etc.). Moreover, 
differences in responses between healthy controls and patient populations can highlight potential 
biomarkers. 
 Although effects were widespread and dependent on the rTMS protocol, it is not within 
the scope of the paper to describe the implication and function of each region functionally 
associated with the seed ROIs in this study. However, the regions implicated must be taken into 
consideration in therapeutic applications, and future studies should probe more detailed 
relationships using ROI-to-ROI analyses. For example, in lesion location mapping, recent studies 
suggest stimulating nodes functionally connected to the lesion since it will propagate to the 
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lesion site (Boes et al., 2015). Therefore, regions displaying aberrant activity close to the lesion 
are not only targeted, but remote nodes interconnected to the damaged tissue are (e.g., Boes et 
al., 2015), thus targeting multiple nodes at once. Alternatively, to target a network region that 
lies outside the stimulation depth parameters of rTMS, one can indirectly target distal nodes that 
are within reach and interconnected to the ROI implicated in specific disorders. Importantly, the 
direction of effect (correlated or anticorrelated) is vital when considering desired stimulation 
effects given that a rTMS protocol may worsen an already aberrant connection between the 
visual cortex and distal nodes. For example, abnormalities in correlated and anticorrelated 
networks are observed in a number of neuropsychiatric disorders (Greicius, 2008; Mulders, van 
Eijndhoven, Schene, Beckmann, & Tendolkar 2015; Whitfield-Gabrieli & Ford, 2012). 
Developing protocols in these instances requires comparative data in healthy controls to 
understand the normal connectivity response to rTMS so as not to worsen the pathology. The 
frequent inverse change from correlated to anticorrelated rsFC post-rTMS in this study is likely 
owed to the inhibitory effect of low-frequency rTMS and should be taken into consideration in 
future clinical applications. In some interconnected regions, we observed a switch from 
anticorrelated to correlated rsFC, possibly to maintain a somewhat dynamic functionally 
organised system. 
 When considering the clinical application of accelerated rTMS in greater doses (e.g., 
across consecutive days), it is crucial to consider inadvertently induced perceptual, 
neurobiochemical and behavioural adverse effects. Insight into rTMS effects on resting-state 
networks provides one such tool. Although we observe significant connectivity changes 
following our protocols of lower rTMS doses compared with those used in patient populations, 
these changes did not cause significant measurable or perceptual deficits in at least visual or 
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cognitive function, nor did participants report significant adverse effects (Chapter 4, pp. 111–
112, 129). Given the widespread effects following our rTMS protocols, and involvement of 
numerous nodes, there is greater potential of adverse effects with greater stimulation doses in 
patients. This area remains to be investigated, despite the frequent therapeutic use of noninvasive 
stimulation in pathology. For example, the DMN is involved in cognitive function associated 
with intrinsic processing and external inputs (Fox et al., 2005) and may become impaired with 
greater rTMS doses. Other regions affected by rTMS in our study are implicated in attention 
(e.g., middle temporal and prefrontal regions; Fox et al., 2005; Laufs et al., 2003), auditory 
function (e.g., planum polare and insular cortex) and executive control (e.g., prefrontal and 
cingulate cortices) (for a review, see Beckman et al., 2005).  
Limitations 
Although a smaller sample size was employed due to high neuroimaging costs with 
repeated visits, we used conservative statistical thresholds and employed non-parametric 
methods to limit false positive findings. Additionally, we used a within-subject design to 
decrease inter-individual variability of rTMS effects and to increase statistical power. Despite the 
small sample size, we observed strong effects with a single session of rTMS and for both rTMS 
protocols when considering the influence of GABA+/Glx concentrations. Lastly, ME-ICA is 
considered to substantially improve effect size estimates and statistical power with traditional 
sample sizes in fMRI studies by specifically addressing problems related to non-BOLD artefact 
variability (Lombardo et al., 2016), while remaining conservative in the cut-off for retaining 
BOLD signal components (Evans et al., 2015). 
 Our understanding of 1 Hz rTMS aftereffects on rsFC is limited by our follow-up visit 
time intervals. We observed changes that likely continue well past our last time points and 
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requires further investigation to determine when rsFC starts to stabilise and/or return to baseline 
following rTMS, but is beyond the scope of the present study. In addition, to accurately 
determine whether accelerated rTMS induces a restorative change (i.e., a relatively homeostatic 
response) in rsFC in healthy controls, rsfMRI would need to be repeated following each 
consecutive session. Moreover, our findings are limited to effects produced by 1 Hz rTMS at 
100% PT to the visual cortex. Previous studies demonstrate that the magnitude and direction of 
effects is highly dependent on the intensity of stimulation (i.e., sub- and supra-PT/MT; Di 
Lazzaro et al., 1998; Ziemann, Rothwell, & Ridding, 1996).  
 Changes in metabolite concentrations were obtained from the stimulation site in the 
visual cortex. Therefore, metabolite changes associated with change in rsFC of the posterior 
cingulate cortex/precuneus seed ROI are in reference to those obtained from the stimulation site. 
Given that the stimulation site shows significant correlation to the precuneus and other nodes in 
the DMN, it is expected that metabolite changes would relay to interconnected nodes including 
the posterior cingulate cortex/precuneus. This indirect measure of metabolite influence when 
considering network effects associated with the posterior cingulate cortex/precuneus is key in 
making inferences. We acknowledge that metabolite concentration changes at the posterior 
cingulate cortex/precuneus seed will indeed be different; however, we can only obtain single 
voxel MRS acquisition. We can of course obtain direct measures in a separate analysis, which 
would require repeating the full experiment with all follow-up visits using an MRS voxel at the 
posterior cingulate cortex/precuneus seed that would add considerable MRI costs. This would 
have the added limitation that the functional state of the individual might be different. 
 For participants who underwent accelerated rTMS, rsfMRI was acquired in the same 
session as MRS (counterbalanced) since this only required an additional 10 min of data 
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acquisition. In the single rTMS group, due to known shorter aftereffects, rsfMRI and MRS were 
acquired on different days (with an otherwise identical experimental protocol) separated by an 
interval of at least 1-week (to prevent residual aftereffects of rTMS between sessions) and no 
more than a month. Therefore, in the accelerated rTMS group, we assessed the association 
between metabolite levels and functional connectivity at the same functional state, but not for the 
single rTMS group. 
Conclusion 
Based on connectivity changes with the seed ROIs, findings from the present study 
suggest that the spatial topography of the visual network and DMN is altered following low-
frequency (1 Hz) rTMS to the visual cortex. These results extend our understanding of how focal 
disruption to early visual cortex using rTMS affects network communication. Accelerated rTMS 
within a single day resulted in a resistant effect, while a single session of rTMS induced 
widespread rsFC changes compared with pre-rTMS. These results have important implications in 
developing therapeutic protocols for visual-related disorders in that a single session of 1 Hz 
rTMS to the visual cortex may be more effective than accelerated rTMS in targeting 
interconnected networks. ME resting-state analysis provides an important tool to investigate 
longer lasting and slower emerging TMS-induced aftereffects across multiple networks over 
conventional methods such as EEG that demonstrate shorter duration aftereffects. 
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Figure 5.1. Resting-state maps of average change in functional connectivity with seeds of interest 
following a single session of 1 Hz rTMS. (a) Regions showing significant change in connectivity 
with the stimulation site seed (white circle). (b) Regions showing significant change in connectivity 
with the posterior cingulate cortex/precuneus seed (light blue circle). Orange/yellow regions show a 
positive change in correlation with the seed (decrease in connectivity at 1 hr post-rTMS), while 
pink/purple regions show a negative change in correlation with the seed (increase in connectivity at 1 
hr post-rTMS). Lightning bolt indicates the stimulation site at the visual cortex. L = left; R = right; S 
= superior; A = anterior.  
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Table 5.1. 
Individual MNI Coordinates for the Stimulation Site at the Visual Cortex 
 
 
 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) each participant (identified numerically) and their associated 
rTMS group, and peak MNI coordinates where 10 mm radius sphere seed ROIs were centred.  
 
  
  MNI coordinates 
Participant #  x y z 
Single rTMS  
group 
    1  1 -83 13 
    2  1 -79 18 
    3  0 -84 16 
    4  0 -84 7 
    5  0 -83 8 
    6  -1 -84 11 
    7  1 -75 23 
    8  4 -82 13 
Accelerated 
rTMS group 
    
    9  -5 -83 9 
    10  2 -79 15 
    11  2 -82 12 
    12  -1 -83 15 
    13  1 -80 20 
    14  1 -76 19 
    15  1 -78 20 
    16  1 -85 14 
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Table 5.2.  
 Average Change in Functional Connectivity Between the Visual Cortex (Stimulation Site) and 
Correlated Regions Following a Single rTMS Session 
 
Note. The columns list (from left to right) regions showing significant differences in rsFC with the 
stimulation site between pre- and post-rTMS visits (uncorrected p < .001; cluster-mass p < .05 FDR 
corrected), the associated Brodmann area, peak MNI coordinates of the cluster, cluster voxel size (≥ 25 
voxels), and effect size. Effect sizes represent the average difference in Fisher-transformed correlation 
coefficients between visits (pre-TMS minus the post-rTMS visit) for the stimulation site (seed) and the 
correlated region. A positive effect size indicates a decrease in rsFC at the post-rTMS visit, while a 
negative effect size indicates an increase in rsFC at the post-rTMS visit. N.S. = no significant difference; 
R = right; L = left. aanticorrelated pre-rTMS; banticorrelated post-rTMS. 
  
 
                        Contrast/ 
 
Brodmann 
MNI 
coordinates 
  
 
  
Effect 
Region area  x y z  Voxels   size 
Pre-rTMS < > immediate post-rTMS          
    N.S.          
Pre-rTMS < > 1 hr post-rTMS          
 R superior parietal lobule 7  29 -46 50  628  .28b 
 L superior parietal lobule 7  -34 -60 53  465  .25b 
 R anterior supramarginal gyrus 40  48 -30 39  183  .25b 
 R posterior supramarginal gyrus  40  59 -46 45  36  .17b 
 L posterior supramarginal gyrus 40  -53 -49 15  54  .14a,b 
 R postcentral gyrus 2  51 -19 37  105  .19b 
 R postcentral gyrus 2  51 -14 50  99  - .18a 
 Precuneus  7  2 -66 48  489  .23 
 R middle frontal gyrus 9  48 16 31  389  .24b 
 R frontal Pole 46  51 43 18  239  .29b 
 L frontal Pole 46  -44 38 12  303  .23b 
 Brainstem   -9 -33 -10  129  - .23a 
 L posterior inferior temporal gyrus 20  -50 -19 -29  111  - .13a 
 R thalamus   7 -27 15  81  - .17a 
 R cerebellum crus 1   40 -76 -23  66  - .22a 
 L fusiform gyrus 19  -31 -74 -7  54  - .18 
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Table 5.3. 
Average Change in Functional Connectivity Between the Posterior Cingulate Cortex/Precuneus 
and Correlated Regions Following a Single rTMS Session 
 
Note. The columns list (from left to right) regions showing significant differences in rsFC with the 
posterior cingulate cortex/precuneus between pre- and post-rTMS visits (uncorrected p < .001; cluster-
mass p < .05 FDR corrected), the associated Brodmann area, peak MNI coordinates of the cluster, cluster 
voxel size (≥ 25 voxels), and effect size. Effect sizes represent the average difference in Fisher-
transformed correlation coefficients between visits (pre-TMS minus the post-rTMS visit) for the posterior 
cingulate cortex/precuneus (seed) and the correlated region. A positive effect size indicates a decrease in 
rsFC at the post-rTMS visit, while a negative effect size indicates an increase in rsFC at the post-rTMS 
visit. N.S. = no significant difference; R = right; L = left. aanticorrelated pre-rTMS. banticorrelated post-
rTMS.  
 
Contrast/   
 
Brodmann 
MNI 
coordinates 
  
 
  
Effect 
Region area  x y z  Voxels  size 
Pre-rTMS < > immediate post-rTMS          
    N.S.           
Pre-rTMS < > 1 hr post-rTMS          
 L insular cortex 13  -42 11 -4  633  .26b 
 R frontal pole 10  -1 65 7  34  - .22a 
 L frontal pole 10  -14 65 9  254  - .25 
 R cerebellum crus 2   37 -74 -45  54  - .27a 
 L cerebellum crus 2   -42 -63 -42  36  - .22a 
 L cerebellum 8   -14 -68 -37  39  .12b 
 L cerebellum 7b   -6 -79 -40  57  .17b 
 L cerebellum 6   -28 -49 -37  81  .19b 
 R putamen   24 13 -10  117  .19a 
 L putamen   -34 -6 1  156  .17b 
 L pallidum   -20 0 -7  81  .24b 
 R accumbens   10 11 -10  45  .20b 
 R posterior superior temporal gyrus 22  51 -11 -10  135  .18b 
 R inferior temporal gyrus 20  65 -22 -29  30  - .20a 
 L planum polare 13  -47 -8 -1  60  .31b 
 L precentral gyrus 6  -39 0 26  120  - .20a 
 L paracingulate gyrus 32  -12 16 34  102  .28b 
 L central opercular cortex 13  -42 -8 12  90  .17b 
 162 
Table 5.4. 
Subtle Diffuse Changes in Functional Connectivity Between the Visual Cortex (Stimulation Site) 
and Correlated Regions Following Accelerated rTMS Sessions 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) regions within the cluster showing significant differences in 
average rsFC with the stimulation site between pre- and post-rTMS visits (uncorrected p < .01; cluster-
mass p < .05 FDR corrected), peak MNI coordinates of the cluster, cluster voxel size (≥ 10 voxels), and 
effect size of the cluster. Effect sizes represent the average difference in Fisher-transformed correlation 
coefficients between visits (pre-TMS minus the post-rTMS visit) for the stimulation site (seed) and the 
correlated region. A positive effect size indicates a decrease in rsFC at the post-rTMS visit. N.S. = no 
significant difference; R = right; L = left. banticorrelated post-rTMS. 
 
 
 
 
  
 
Contrast/   
MNI 
coordinates 
  
 
  
Effect  
Region x y z  Voxels  size 
Pre-rTMS < > immediate post-rTMS        
    N.S.         
Pre-rTMS < > 24 hr post-rTMS        
    Cluster 1 -12 -63 67  3511  .20b 
        Precuneus     1727   
        L superior parietal lobule     491   
        R superior lateral occipital cortex     12   
        L superior lateral occipital cortex     430   
        R postcentral gyrus     10   
        L postcentral gyrus     184   
Pre-rTMS < > 1-week post-rTMS        
    N.S.        
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Table 5.5. 
Subtle Diffuse Changes in Functional Connectivity Between the Posterior Cingulate 
Cortex/Precuneus and Correlated Regions Following Accelerated rTMS Sessions 
 
 
 
 
 
 
 
 
 
 
Note. The columns list (from left to right) regions within the cluster showing significant differences in 
average rsFC with the posterior cingulate cortex/precuneus between pre- and post-rTMS visits 
(uncorrected p < .01; cluster-mass p < .05 FDR corrected), peak MNI coordinates of the cluster, cluster 
voxel size (≥ 10 voxels), and effect size of the cluster. Effect sizes represent the average difference in 
Fisher-transformed correlation coefficients between visits (pre-TMS minus the post-rTMS visit) for the 
posterior cingulate cortex/precuneus (seed) and the correlated region. A positive effect size indicates a 
decrease in rsFC at the post-rTMS visit. N.S. = no significant difference; R = right; L = left. 
banticorrelated post-rTMS. 
 
 
 
  
 
Contrast/   
MNI 
coordinates 
  
 
  
Effect  
Region x y z  Voxels   size 
Pre-rTMS < > immediate post-rTMS        
    N.S.         
Pre-rTMS < > 24 hr post-rTMS        
    N.S.        
Pre-rTMS < > 1-week post-rTMS        
    Cluster 1 54 -41 1  4364  .20 
  R middle temporo-occipital     1597   
  R posterior middle temporal gyrus     159   
  R posterior superior temporal gyrus     136   
  R angular gyrus     715   
  R posterior supramarginal gyrus     207   
  R temporal fusiform cortex     32   
  R superior lateral occipital cortex     15   
  R inferior lateral occipital cortex     10   
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Table 5.6. 
Average Change in Functional Connectivity Between the Visual Cortex (Stimulation Site) and 
Regions Correlated With GABA+ and Glx Following a Single rTMS Session 
 
Note. The columns list (from left to right) regions showing significant differences in rsFC with the 
stimulation site associated with GABA+/Glx concentrations between pre- and post-rTMS visits 
(uncorrected p < .001; cluster-mass p < .05 FDR corrected), the associated Brodmann area, peak MNI 
coordinates of the cluster, cluster voxel size, and effect size. Effect sizes represent Fisher-transformed 
regression coefficients as a ratio of change in rsFC between the stimulation site (seed) and the correlated 
region per unit change in metabolite concentration. A positive effect size indicates a decrease in rsFC at 
the post-rTMS visit, while a negative effect size indicates an increase in rsFC at the post-rTMS visit. 
Average change in GABA+ concentration between pre-rTMS and: immediate post-rTMS = -0.176 i.u.; 1 
hr post-rTMS = -0.057 i.u. Average change in Glx concentration between pre-rTMS and: immediate post-
rTMS = -0.039 i.u.; 1 hr post-rTMS = 0.109 i.u. N.S. = no significant difference; R = right; L = left. 
Metabolite/ 
Contrast/ 
 
Brodmann  
MNI 
coordinates 
  
 
  
Effect  
Region area  x y z  Voxels   size 
GABA+          
    Pre-rTMS < > immediate post-rTMS          
       N.S.           
    Pre-rTMS < > 1 hr post-rTMS          
       R precentral gyrus 4  21 -14 50  147  - .74 
       L precentral gyrus 6  -50 -3 37  36  .74 
       R lingual gyrus 17  18 -96 4  117  1.02 
       L inferior occipital gyrus 18  -30 -99 -3  112  1.21 
       Precuneus    21 -60 26  45  - .74 
       R middle frontal gyrus 6  45 13 48  45  .62 
       R cerebellum 9    13 -46 -59  68  - .68 
       R cerebellum 7b   29 -76 -53  48  - .58 
Glx          
    Pre-rTMS < > immediate post-rTMS          
       N.S.           
    Pre-rTMS < > 1 hr post-rTMS          
       L superior frontal gyrus 6  -12 41 53  102  .28 
       R cerebellum 8   18 -44 -56  72  - .21 
       Precuneus  7  10 -71 48  45  - .23 
       R precentral gyrus   26 -17 75  42  .26 
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Table 5.7. 
Average Change in Functional Connectivity Between the posterior cingulate cortex/precuneus 
and Regions Correlated With GABA+ Following a Single rTMS Session 
 
Contrast/ 
 
Brodmann 
 MNI 
coordinates 
  
 
  
Effect 
Region area  x y z  Voxels   size 
Pre-rTMS < > immediate post-rTMS          
    R superior frontal gyrus 6  18 3 69  126  - .31 
    L superior frontal gyrus  6  -1 8 67  374  - .38 
    R pars opercularis 44/45  56 13 4  90  - .38 
    L inferior frontal gyrus 45  -47 22 7  93  - .30 
    R middle frontal gyrus 8  29 24 34  72  - .34 
    R frontal pole 68  35 38 45  68  - .28 
    L orbitofrontal cortex 47  -20 19 -26  27  .10 
    R caudate   15 16 15  207  .32 
    R precentral gyrus 6  45 5 34  135  - .45 
    R parietal operculum cortex 13  59 -30 23  117  .30 
    R thalamus   18 -25 12  81  .23 
    L cerebellum 9   -20 -52 -45  81  - .22 
    L cerebellum 8    -20 -66 -42  36  - .12 
    L cerebellum 6   -31 -63 -26  27  - .21 
    R cerebellum crus 2   5 -82 -26  45  - .24 
    R cerebellum crus 1   56 -46 -31  50  - .21 
    L cerebellum crus 1   -39 -82 -29  27  - .23 
    L superior lateral occipital cortex   -44 -71 23  63  - .47 
    L inferior lateral occipital cortex   -47 -66 -7  27  - .16 
    Anterior cingulate gyrus 24  -6 3 29  50  - .25 
    R temporal pole   21 8 -48  41  .23 
    L inferior temporal gyrus 37  -47 -55 -15  27  - .11 
    R central opercular cortex 13  43 8 4  30  - .26 
    L central opercular cortex 43  -58 -6 7  36  - .34 
    L cuneus 18  -4 -98 15  30  - .24 
    L insular Cortex  13  -42 0 -4  27  - .22 
    R fusiform gyrus 19  26 -79 -15  27  .09 
Pre-rTMS < > 1 hr post-rTMS          
    R temporal pole 22  56 11 10  229  .84 
    R cerebellum crus 2   51 -63 -45  68  - .86 
    R cerebellum 8   29 -57 -59  30  - .60 
    L cerebellum 8   -20 -52 -59  219  .84 
    L frontal pole 10  -6 68 -1  99  - .96 
    R middle frontal gyrus 8  35 27 34  36  -1.25 
    R anterior superior temporal gyrus 22  65 -6 -1  98  1.21 
    R posterior middle temporal gyrus   59 -14 -23  54  - .61 
    L posterior supramarginal gyrus 40  -50 -46 42  63  - .83 
    L superior parietal lobule 7  -34 -44 67  39  .83 
    Posterior cingulate gyrus 31  -4 -33 39  45  - .77 
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Table 5.7. (continued) 
Note. The columns list (from left to right) regions showing significant differences in rsFC with the 
posterior cingulate cortex/precuneus associated with GABA+ concentrations between pre- and post-rTMS 
visits (uncorrected p < .001; cluster-mass p < .05 FDR corrected), the associated Brodmann area, peak 
MNI coordinates of the cluster, cluster voxel size (≥ 25 voxels), and effect size. Effect sizes represent 
Fisher-transformed regression coefficients as a ratio of change in rsFC between the posterior cingulate 
cortex/precuneus (seed) and the correlated region per unit change in GABA+ concentration. A positive 
effect size indicates a decrease in rsFC at the post-rTMS visit, while a negative effect size indicates an 
increase in rsFC at the post-rTMS visit. Average change in GABA+ concentration between pre-rTMS 
and: immediate post-rTMS = -0.176 i.u.; 1 hr post-rTMS = -0.057 i.u. There were no significant 
differences in rsFC in regions associated with Glx concentrations. R = right; L = left.  
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 Table 5.8. 
Average Change in Functional Connectivity Between the Visual Cortex (Stimulation Site) and 
Regions Correlated With GABA+ and Glx Following Accelerated rTMS Sessions 
Metabolite/ 
Contrast/ 
 
Brodmann 
MNI 
coordinates 
  
 
  
Effect  
Region area  x y z  Voxels   size 
GABA+          
    Pre-rTMS < > immediate post-rTMS          
  R superior frontal gyrus 8  24 38 48  486   .63 
  L pars opercularis 44  -55 13 15  273  - .63 
  L pars triangularis 45  -50 27 4  27  - .60 
  R middle frontal gyrus 9  45 24 34  99  .53 
  Frontal medial cortex 11  -1 41 -37  50  - .45 
  R middle temporal gyrus 21/22  56 -22 -7  72  - .59 
  L lingual gyrus 19  -25 -74 4  141  .52 
  L superior lateral occipital cortex 7  -31 -63 50  27  .56 
  L precentral gyrus 6  -53 0 39  81  .63 
  L postcentral gyrus 40  -53 -30 53  27  .32 
  L angular gyrus 39  -42 -57 39  30  .40 
  R caudate   10 19 4  39  .37 
  Subcallosal cortex 25  -4 19 -23  27  - .34 
    Pre-rTMS < > 24 hr post-rTMS          
  L putamen   -28 8 4  135  .4 
  R cerebellum crus 1   35 -66 -37  123  .78 
  R cerebellum crus 6   24 -57 -31  38  .78 
  R superior lateral occipital cortex   32 -82 20  27  - .69 
  L superior lateral occipital cortex 19  -31 -79 20  81  - .46 
  L superior frontal gyrus 10  -36 57 12  66  .54 
  L frontal medial cortex 10  -6 60 -12  59  - .82 
  L orbitofrontal cortex 47  -17 13 -23  27  .44 
  L anterior middle temporal gyrus 21  -58 -11 -20  56  - .56 
  R precentral gyrus 6  37 -11 67  36  .50 
  R angular gyrus 40  62 -52 37  28  - .39 
  R superior parietal lobule 7  21 -55 53  27  - .39 
  Anterior cingulate 24  -4 -6 34  27  .44 
    Pre-rTMS < > 1-week post-rTMS          
  L orbitofrontal cortex 47  -39 16 -10  210  - .43 
  L superior frontal gyrus 6  -25 27 50  61  .47 
  R pars opercularis 9  45 16 23  27  - .19 
  R superior lateral occipital cortex 19  35 -82 34  36  - .31 
  L superior lateral occipital cortex 19  -36 -82 29  111  .33 
  L angular gyrus 40  -55 -49 23  90  - .32 
  R posterior supramarginal gyrus   45 -44 18  63  - .42 
  L postcentral gyrus 7  -17 -44 56  27  .32 
  L parietal operculum cortex 40  -50 -33 23  27  .34 
  R posterior middle temporal gyrus 21/22  62 -22 -7  54  - .30 
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Table 5.8. (continued) 
Metabolite/ 
Contrast/ 
 
Brodmann  
 MNI 
coordinates 
  
 
  
Effect 
Region area  x y z  Voxels   size 
Glx          
   Pre-rTMS < > immediate post-rTMS          
R angular gyrus 22  62 -57 20  210  .22 
L cerebellum crus 1   -20 -66 -34  117  - .15 
L cerebellum 6   -34 -36 -37  54  - .16 
R superior frontal gyrus 8  18 30 42  108  .22 
R middle frontal gyrus   45 38 -10  27  - .11 
L middle frontal gyrus 6  -39 8 61  53  .19 
R posterior inferior frontal gyrus   43 -25 -26  36  - .13 
R precentral gyrus 9  54 08 18  93  .20 
L postcentral gyrus 40  -53 -33 56  67  .15 
Precuneus  31  15 -63 34  81  .19 
L superior lateral occipital cortex 19  -14 -87 45  86  - .21 
L superior lateral occipital cortex 19  -44 -74 45  67  .24 
R insular cortex 13  29 24 04  63  .17 
R posterior middle temporal gyrus 21  70 -38 -15  62  .22 
R posterior middle temporal gyrus 21  59 -25 -10  27  - .20 
R posterior inferior temporal gyrus 20  62 -25 -26  27  - .09 
R thalamus   10 -30 9  27  - .14 
   Pre-rTMS < > 24 hr post-rTMS          
R inferior lateral occipital cortex 19  51 -66 -4  338  - .30 
L inferior lateral occipital cortex 19  -47 -82 9  258  - .36 
L superior lateral occipital cortex   -47 -71 26  27  - .27 
L middle temporo-occipital 21  -64 -52 7  256  - .35 
R posterior middle temporal gyrus   51 -33 -10  108  - .27 
L posterior middle temporal gyrus 21  -61 -14 -10  225  - .40 
R fusiform gyrus 19  29 -85 -12  156  - .46 
L fusiform gyrus 19  -39 -74 -10  72  - .38 
R temporal fusiform cortex   29 -52 -20  54  - .40 
L temporal fusiform cortex 37  -36 -60 -15  45  - .31 
R superior parietal lobule 7  24 -57 59  149  - .37 
L superior parietal lobule 7  -20 -57 64  72  - .16 
L orbitofrontal cortex   -25 22 -15  99  .34 
L superior frontal gyrus 8  -4 54 34  27  - .25 
L middle frontal gyrus 6  -39 5 42  27  - .13 
R cerebellum 4–5   7 -46 -10  57  - .21 
R amygdala   18 -3 -15  54  .18 
R postcentral gyrus 2  40 -22 39  27  .18 
L postcentral gyrus 7  -14 -41 59  42  .20 
R thalamus   2 -3 4  27  .24 
   Pre-rTMS < > 1-week post-rTMS          
L cerebellum 9   -17 -55 -45  156  - .39 
R temporal fusiform cortex 19/37  26 -55 -10  111  - .40 
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Table 5.8. (continued) 
Note. The columns list (from left to right) regions showing significant differences in rsFC with the 
stimulation site associated with GABA+/Glx concentrations between pre- and post-rTMS visits 
(uncorrected p < .001; cluster-mass p < .05 FDR corrected), the associated Brodmann area, peak MNI 
coordinates of the cluster, cluster voxel size (≥ 25 voxels), and effect size. Effect sizes represent Fisher-
transformed regression coefficients as a ratio of change in rsFC between the stimulation site (seed) and 
the correlated region per unit change in metabolite concentration. A positive effect size indicates a 
decrease in rsFC at the post-rTMS visit, while a negative effect size indicates an increase in rsFC at the 
post-rTMS visit. Average change in GABA+ concentration between pre-rTMS and: immediate post-
rTMS = 0.285 i.u.; 24 hr post-rTMS = 0.229 i.u.; 1-week post-rTMS = -0.1775 i.u. Average change in 
Glx concentration between pre-rTMS and: immediate post-rTMS = 0.294 i.u.; 24 hr post-rTMS = 0.114 
i.u.; 1-week post-rTMS = -0.165 i.u. R = right; L = left.  
 
 
 
  
 170 
Table 5.9. 
Average Change in Functional Connectivity Between the Posterior Cingulate Cortex/Precuneus 
and Regions Correlated With GABA+ and Glx Following Accelerated rTMS Sessions 
 
Metabolite/ 
Contrast/ 
 
Brodmann 
 MNI 
coordinates 
  
 
  
Effect  
Region area  x y z  Voxels   size 
GABA+          
    Pre-rTMS < > immediate post-rTMS          
       R superior frontal gyrus 6  26 0 64  237  - .86 
  L orbitofrontal cortex 47  -44 24 -10  30  .67 
  R superior lateral occipital cortex 7  15 -68 59  168  - .74 
  L cerebellum crus 1   -50 -52 -40  108  - .68 
  L cerebellum crus 2   -25 -68 -40  104  - .44 
  R paracingulate gyrus 8  7 24 42  72  - .81 
  L paracingulate gyrus 9  -9 46 18  66  .70 
  L posterior middle temporal gyrus 21  -66 -33 -7  45  .63 
    Pre-rTMS < > 24 hr post-rTMS          
        R posterior middle temporal gyrus 21  62 -22 -7  27  .42 
        L posterior middle temporal gyrus 21  -66 -22 -10  90  .78 
        R superior temporal gyrus 22  48 -25 -1  30  .38 
        L superior temporal gyrus 38  -50 19 -23  27  - .53 
        L cerebellum crus 1   -47 -49 -29  69  - .80 
        R frontal operculum cortex 13  48 16 -1  48  .72 
        Brainstem   -1 -38 -40  36  - .41 
        R precentral gyrus 6  45 0 45  27  .51 
        L precentral gyrus 6  -36 -8 64  32  - .46 
        L thalamus   -9 -33 4  27  .34 
    Pre-rTMS < > 1-week post-rTMS          
       R cerebellum crus 2   40 -52 -40  54  - .42 
       L cerebellum crus 2   -50 -52 -48  51  - .33 
       L hippocampus 30  -12 -41 1  45  .39 
       R superior frontal gyrus 6  10 24 56  27  - .21 
       L thalamus   -4 -22 9  27  .41 
       R lingual gyrus 30  21 -44 -7  27  - .36 
Glx          
    Pre-rTMS < > immediate post-rTMS          
  R paracingulate gyrus 8  5 27 45  680  - .28 
  L paracingulate gyrus 9  -9 49 18  36  .23 
  R postcingulate gyrus 5  2 -41 72  27  - .15 
  R anterior cingulate gyrus 24  -6 5 29  66  - .21 
  R posterior supramarginal gyrus 40  43 -46 42  105  - .26 
  L precentral gyrus 6  -47 -11 31  27  .09 
  R angular gyrus   40 -55 34  105  - .28 
  R occipital pole 18  24 -96 20  135  .21 
  R inferior lateral occipital cortex 18  32 -87 -7  63  .19 
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Table 5.9. (continued) 
Metabolite/ 
Contrast/ 
 
Brodmann 
MNI 
coordinates 
  
 
  
Effect  
Region area  x y z  Voxels   size 
Glx (continued)          
    Pre-rTMS < > immediate post-rTMS          
  R superior lateral occipital cortex 7  32 -71 56  38  - .22 
  L superior lateral occipital cortex   -44 -68 26  57  - .21 
  R orbitofrontal cortex 45  51 33 -7  60  .25 
  L cerebellum crus 2   -28 -68 -40  36  - .18 
    Pre-rTMS < > 24 hr post-rTMS          
  R fusiform gyrus   18 -79 -18  144  - .35 
  R paracingulate gyrus 32  10 11 39  48  .35 
  L paracingulate gyrus 32  -4 27 34  99  .25 
  R planum polare 13  51 3 -4  87  .31 
  L planum polare 22  -58 -3 -1  36  .32 
  R superior lateral occipital cortex 7  18 -68 59  66  - .17 
  L superior parietal lobule 7  -28 -46 56  63  - .29 
  R superior temporal gyrus 22  51 13 -10  45  .32 
  R inferior temporal gyrus 37  56 -52 -18  27  - .14 
  R posterior middle temporal gyrus 22  62 -22 -4  57  .19 
  Subcallosal cortex   2 13 -4  27  - .17 
    Pre-rTMS < > 1-week post-rTMS          
  R accumbens   10 13 -10  108  .43 
  L cerebellum crus 1 & 2   -47 -49 -40  90  - .42 
  R superior lateral occipital cortex 7  35 -66 59  72  - .39 
  R lingual gyrus 18  10 -90 -10  54  .21 
  R inferior temporo-occipital 37  62 -52 -18  54  - .22 
  R anterior supramarginal gyrus 2  59 -22 31  54  - .37 
  L frontal pole 10  -17 63 -18  28  - .31 
  L middle frontal gyrus 8  -42 35 34  27  .40 
  Anterior cingulate gyrus 32  2 38 15  27  .14 
  L fusiform gyrus   -31 -66 -15  27  - .27 
 
Note. The columns list (from left to right) regions showing significant differences in rsFC with the 
posterior cingulate cortex/precuneus associated with GABA+/Glx concentrations between pre- and post-
rTMS visits (uncorrected p < .001; cluster-mass p < .05 FDR corrected), the associated Brodmann area, 
peak MNI coordinates of the cluster, cluster voxel size (≥ 25 voxels), and effect size. Effect sizes 
represent Fisher-transformed regression coefficients as a ratio of change in rsFC between the posterior 
cingulate cortex/precuneus (seed) and the correlated region per unit change in metabolite concentration. A 
positive effect size indicates a decrease in rsFC at the post-rTMS visit, while a negative effect size 
indicates an increase in rsFC at the post-rTMS visit. Average change in GABA+ concentration between 
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pre-rTMS and: immediate post-rTMS = 0.285 i.u.; 24 hr post-rTMS = 0.229 i.u.; 1-week post-rTMS = -
0.1775 i.u. Average change in Glx concentration between pre-rTMS and: immediate post-rTMS = 0.294 
i.u.; 24 hr post-rTMS = 0.114 i.u.; 1-week post-rTMS = -0.165 i.u. R = right; L = left. 
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CHAPTER 6 
 
GENERAL DISCUSSION 
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Summary 
 In Chapter 2, I investigated the efficacy of 1 Hz rTMS in mitigating visual hallucinations 
that are prevalent following visual pathway damage. Multiday rTMS of 30 min sessions was 
applied to the visual cortex in a patient who experienced disruptive and continuous phosphene 
hallucinations for more than 2 years following occipital stroke. rTMS significantly attenuated the 
perception of hallucinations and the effect outlasted stimulation. However, despite repeated 
doses, the therapeutic effect of rTMS only persisted for a few days following rTMS cessation. In 
the only other study that has investigated rTMS to alleviate visual hallucinations in visual 
pathway damage, a single 30 min session of rTMS was sufficient to cease intermittent 
hallucinations for two weeks (Merabet et al., 2003). Further, in another sensory domain, 1 Hz 
rTMS has shown promise in alleviating auditory hallucinations (Lee et al., 2005; Vercammen et 
al., 2010). Although rTMS substantially redistributed the imbalanced and aberrant functional 
activity in our patient to more closely resemble that of controls, and this attempt at 
“renormalisation” was reflected in the attenuation of hallucinations, I sought to determine why 
the positive impact of rTMS had not been as enduring in this patient as it is in other cases. 
Therefore, in Chapter 3, I investigated white matter structural connectivity to determine whether 
more persistent changes in connectivity that are not as malleable to neuromodulation may 
provide insight. I observed that more permanent and maladaptive structural changes had indeed 
occurred. Diffusion imaging showed regeneration of optic radiations that deviated from their 
regular pathway, as well as a combination of greater and reduced structural tracts between the 
visual cortices and frontal, temporal, and parietal regions. The extent of structural changes likely 
offer explanation as to why the patient was not as responsive as expected. In the presence of 
longer-term structural reorganisation, transient neuromodulation effects on functional activity are 
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insufficient to overcome more permanent aberrant structural changes with sustained effects. 
However, it is promising that despite these extensive structural changes, we were nonetheless 
able to modify functional activity and significantly decrease the perception of hallucinations 
providing substantial relief for the patient, even if it was only for a week. rTMS still holds 
promise, and longer repeated application of rTMS will have a more sustained response. Longer-
term functional changes may in turn lead to longer-term structural changes and better functional 
outcome. The combination of fMRI and DTI is invaluable as it provides insight into neural 
mechanisms underlying pathophysiology (e.g., in this case visual hallucinations) and changes 
with rTMS, as well as information on barriers for better prognosis (e.g., significant structural 
changes).  
 In Chapter 2, I also observed that despite the significant reduction in perception of visual 
hallucinations with rTMS and the corresponding rebalance of functional activity across 
hemispheres post-rTMS in the patient, the stimulation site showed an overall increase in 
functional activity with a 1 Hz rTMS “inhibitory” paradigm. As discussed previously, numerous 
studies suggest that low-frequency “inhibitory” effects depend on numerous factors including 
stimulation intensity relative to cortical excitability thresholds. We nonetheless had predicted a 
reduction in functional activity at the stimulation site. This expectation was based on the view 
that visual hallucinations are thought to arise from dysfunctional persistent neuronal firing in 
peri-infarct regions (De Haan et al., 2007; Kasten et al., 1998; Manford & Andermann, 1998; 
Rijntjes et al., 1994); therefore, one would expect that if rTMS decreases the perception of 
hallucinations, it also decreases the increased neuronal firing (i.e., BOLD signal) around the 
lesion (rTMS target site). This unexpected finding suggested that either the rTMS response 
deviated from the typical response because of pathophysiology in the patient, or that we simply 
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do not know enough about multiday 1 Hz rTMS effects in the visual cortex, and accordingly, 
cannot predict changes in BOLD signal post-rTMS. The unexpected finding of increased 
functional activity at the stimulation target site (lesion) also suggested that the alleviation of 
symptoms (perception of hallucinations) occurred via mechanisms of which BOLD signal may 
be a poor indicator. It could also be that the alleviation of symptoms occurred via alterations in 
BOLD signal downstream from the rTMS target site as well as a rebalancing of BOLD signal at 
the target site. For these reasons, it was clear that I had to investigate rTMS effects in healthy 
control participants and determine the expected response in the absence of pathophysiology in 
order to guide development of therapeutic protocols. Investigation in the absence of dysfunction 
would highlight which mechanisms rTMS can target and is capable of altering, and therefore, 
which visual disorders it would be suitable for. Furthermore, obtaining more complete 
representation of neural substrates of rTMS can prevent inadvertently induced adverse effects in 
patient populations. Lastly, knowledge of rTMS effects in healthy controls and deviation from 
these effects in patients can highlight mechanisms underlying pathophysiology and offer insight 
into the pathology that we may not already know. 
 To address limitations of the patient study and gain insight into neural mechanisms of 1 
Hz rTMS to the visual cortex, in Chapter 4 I investigated rTMS effects on GABA and glutamate 
neurotransmitters that are key in plasticity. In addition, in Chapter 5, I investigated the effects of 
rTMS on intrinsic functional connectivity between the visual cortex and remote regions. To 
refine parameters and find the most efficient rTMS protocol for clinical application, I also 
compared single session and accelerated rTMS regimes, two alternative approaches that are used 
in clinical applications in non-visual disorders (Goldsworthy et al., 2015). I observed that 1 Hz 
rTMS targets MRS measured GABA but not Glx activity in the visual cortex, and that overall 
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GABA concentration (consisting of inhibitory GABAA and excitatory GABAB concentrations) 
decreased with accelerated 1 Hz rTMS sessions but not with a single session. On the other hand, 
single session rTMS induced strong diffuse widespread changes in rsFC, whereas accelerated 
rTMS produced weak subtle changes. Moreover, rsFC changes were associated with changes in 
GABA and Glx activity. These findings highlight that the choice of regimen would largely be 
based on the mechanism you wish to alter. Specifically, single session rTMS may have a better 
response on altering dysfunctional connectivity between nodes, whereas accelerated rTMS may 
be better suited to modulating GABA concentrations at the visual cortex.  
Collectively, these studies were intended to advance our knowledge of low-frequency 
rTMS on the visual cortex, with a specific interesting in developing therapeutic protocols 
relevant to visual disorders. 
Limitations  
Limitations associated with each of the experimental studies are discussed within the 
appropriate chapters. Other general limitations are discussed here.  
With regards to experimental design, in hindsight, rsfMRI and MRS in our patient pre- 
and post-rTMS would have been extremely valuable. Unfortunately, due to limited availability of 
the patient because she resides in a different country, refinement of parameters and further 
investigation have not been possible. In Chapters 4–5, inconsistent follow-up time points were 
used between single session and accelerated rTMS regimes. We chose these time points based on 
previous research on known rTMS aftereffect durations (for a review, see Thut & Pasucal-Leone, 
2010) to minimise high MRI costs and fatigue effects in individuals who underwent a rather long 
protocol with accelerated rTMS (4–5 hr session). However, based on the present findings on 
rsfMRI that indicate aftereffects persist for much longer than the chosen timepoints, it would be 
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important to continue follow-up visits for longer periods that are consistent across regimes for 
better comparison and for a fuller determination of the duration of rTMS effects.  
A difficulty arises with TMS coil orientation when stimulating visual areas depending on 
individual anatomy such as the proximity of the target stimulation site with external anatomy 
such as the neck. The bulk of the coil and coil cable can result in restricted positioning depending 
on the curvature of the back of the head and location of the neck and shoulders. The main 
concern is that the TMS coil is tangential to the target stimulation site to ensure minimal coil-to-
target stimulation distance (Ulmer & Jansen, 2010) as dictated by image-guided stereotaxy. 
Therefore, if needed, the coil may be rotated in order to obtain the optimal position, which may 
not be a consistent orientation across individuals. The direction of the current in the TMS coil is 
opposite to the direction of the induced current immediately underneath the coil. The direction of 
the induced current can significantly influence mechanisms of neuronal activation, including the 
type of neurons recruited (e.g., interneuron versus pyramidal) and the site of the neuronal 
depolarisation (e.g., soma versus axon hillock) (Fox et al., 2004; Thielscher, Opitz, & Windhoff, 
2011; Wagner et al., 2004). The effect of coil orientation on TMS induced effects has primarily 
been examined in the motor cortex. For instance, posterior–anterior, anterior–posterior, and 
lateral–medial induced currents in the brain produce different patterns of corticospinal volleys 
(Di Lazzaro et al., 2012). Therefore, coil rotation with occipital stimulation may have had a large 
impact on stimulation effects across individuals, but without investigation of TMS coil 
orientation on the visual cortex, it is difficult to ascertain. Moreover, inter-individual variability 
in TMS-induced responses may be partly related to differences in the coil-to-cortex distance and 
physiological variability. The coil-to-cortex distance is not homogenous across cortical and 
subcortical layers nor across individuals. Layers of neural tissue located underneath the TMS 
 179 
coil, e.g., skull, cerebrospinal fluid, grey and white matter, all have distinct electrical properties. 
The inconsistency in tissue leads to an inhomogeneous dispersion of the electrical field in each 
layer and a buildup of electrostatic charge at the boundaries (Rotenberg et al., 2014), and these 
physiological-specific differences are further influenced by coil orientation (Opitz et al., 2013). 
Moreover, there are individual state-dependency effects of underlying neuronal activity that 
affect the TMS response (Pasley et al., 2009; Perini et al., 2012). 
There are limitations associated with interpretation of TMS-induced changes. TMS 
stimulates neuronal tissue externally and artificially, thus, changes revealed by TMS may be 
different from those following physiological processes. Remote changes observed in response to 
TMS with neuroimaging may reflect other factors besides propagation of activity along cortical 
connections and TMS-induced plasticity, consequently complicating interpretation. These 
confounds include effects induced from the tapping or clicking sensation from the coil, e.g., 
intensity of tapping sensation, coil clicking noise, or muscle twitching to stimulation, all of 
which increase with greater stimulation intensity. There are also behavioural or cognitive 
consequences of TMS leading to changes in neuronal activity, or neuronal adaptation to the TMS 
perturbation. These confounds are accounted for to some extent in a repeated measures design 
(as employed in the present studies). A placebo rTMS condition (e.g., sham rTMS or rTMS to 
the vertex) was not employed in Chapters 4–5 in addition to the baseline/no rTMS condition due 
to the already extremely high MRI costs. There are also issues associated with these rTMS 
control conditions. rTMS to the vertex induces significant network changes across the brain (e.g., 
via DMN), and sham stimulation can induce changes in neural activity via clicking noises or the 
tapping sensation (Duecker & Sack, 2015; Jung, Bungert, Bowtell, & Jackson, 2016). 
Additionally, with sham rTMS, participants are usually aware the stimulation sensation and 
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clicking noise is different to real stimulation. No single control condition can satisfy the potential 
confounds induced by rTMS unless we account for them all, which was financially not possible. 
We are also limited by the noninvasive techniques available to determine underlying 
neural mechanisms in humans, including limitations of spatial and temporal resolution. We can 
obtain indirect measures, e.g., fMRI BOLD signal, rather than directly measuring neuronal 
activity to infer changes (Logothetis & Wandell, 2004). It is not possible in the human brain to 
noninvasively investigate at the level of individual neurons and synapses, or at the level of 
neuronal groups and populations, but we can obtain information on neural networks using rsFC. 
We also cannot measure precise neurotransmitter receptor activity, but only measure overall 
concentrations extrasynaptically using MRS. Despite these limitations, we can obtain vast 
knowledge using a combination of techniques to gain as much understanding as possible.  
Future Directions – What Next? 
The work in this dissertation barely scratches the surface in determining effects of rTMS 
to the visual cortex and translation to therapeutic intervention. A considerable amount of 
research on rTMS still needs to be conducted to determine a complete representation of 
underlying neural substrates, longer-term effects, adverse effects with repeated application, and 
determining the most efficient stimulation protocols. I will begin by mentioning some immediate 
future areas of work that can contribute valuably to the field. These future directions are not 
exhaustive. There are, of course, undoubtedly many future areas of research with regards to 
developing therapeutic noninvasive brain stimulation techniques for visual disorders that are yet 
to be investigated. 
First, a variety of stimulation parameters need to be investigated. This includes testing the 
effects of high-frequency rTMS to the visual cortex, but also exploring different low-frequency 
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protocols, e.g., 1 Hz versus 3 Hz, to determine the most efficient protocol and to create a wide 
array of parameters suitable for a range of disorders. Moreover, other rTMS parameters also need 
to be manipulated including sub-PT versus supra-PT intensity. A different response is expected 
with sub- and supra-PT rTMS (e.g., Di Lazzaro et al., 1998; Ziemann et al., 1996) that can target 
different mechanisms compared with rTMS applied at PT intensity. The interval time between 
accelerated sessions, as well the length of a session, are important factors to consider that may 
substantially affect results. It is important to identify intervals that are optimal for inducing long-
lasting and stable neuroplastic change, and these will likely change for different cortical targets. 
Although this has been done to a greater extent for tDCS and the motor cortex, it is very unlikely 
that the same spacing interval will be optimal for all noninvasive brain stimulation techniques 
(Goldsworthy et al., 2015). The relevance of intervals during conventional rTMS impacts the 
direction of aftereffects irrespective of the frequency (i.e., low- versus high-frequency) (Monte-
Silva et al., 2010; Rothkegel, Sommer, & Paulus, 2010). It has also been shown that simply 
prolonging stimulation duration for enhancing the efficacy of a TBS protocol without spaced 
intervals results in a reversal of aftereffects on cortical excitability (Gamboa et al., 2010). We 
have previously observed different effects on object and scene processing with 20 min compared 
with 30 min of 1 Hz rTMS to occipital regions (Mullin & Steeves, 2013; Rafique et al., 2015). 
Ultimately, it will be important to ascertain the minimal stimulation time that produces the most 
efficient sustained response. And then, most importantly, we must consider how these results 
with different parameters translate to different clinical populations. 
There is also the essential consideration of other noninvasive brain stimulation 
techniques. TBS allows for much shorter application time and longer-lasting cortical excitability 
effects than conventional rTMS (Chistyakov, Rubicsek, Kaplan, Zaaroor, & Klein, 2010; Huang 
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et al., 2009; Ishikawa et al., 2007). Can we then replicate findings of low- and high-frequency 
rTMS with TBS and significantly shorter application times? Or, will TBS parameters produce 
vastly different effects and therefore be better suited to different visual disorders than those 
suited to rTMS? How do effects change with a variety of TBS parameters to the visual cortex? 
Varying effects on GABA/glutamate concentrations are observed depending on the type of 
noninvasive brain stimulation. Continuous TBS to motor cortex increases MRS measured GABA 
(Stagg et al., 2009b) consistent with the known inhibitory neurophysiological effects of 
continuous TBS. However, pharmacological studies have shown that the aftereffects of 
continuous TBS are mediated to an extent by glutamatergic mechanisms (Huang, Chen, 
Rothwell, & Wen, 2007) to which MRS may not be sensitive. Anodal (facilitatory) tDCS to 
motor cortex decreases GABA (Stagg et al., 2009a), while increasing Glx in the parietal lobe 
(Clark, Coffman, Trumbo, & Gasparovic, 2011). Cathodal (inhibitory) tDCS leads to a 
significant decrease in Glx and a correlated decrease in GABA in the motor cortex (Stagg et al., 
2009b). Continuous TBS and cathodal tDCS have very similar neurophysiological effects, yet 
have markedly different effects on neurotransmitters (Stagg, 2014). The LTP-like and LTD-like 
effects of rTMS rely on NMDA receptor-mediated glutamatergic and GABAergic function, and 
rTMS is capable of inducing action potentials in nearby stimulated neuronal tissue. tDCS on the 
other hand is considered to induce a modulatory effect via biasing cortical excitability (Nitsche 
& Paulus, 2000). More specifically, animal studies have established that anodal tDCS increases 
neuronal excitability and spontaneous firing rate by depolarising resting membrane potentials, 
whereas cathodal tDCS hyperpolarises membrane potentials, leading to decreased neuronal firing 
rate and excitability (for a review, see Dayan et al., 2013). Different stimulation techniques may 
therefore also stimulate populations of neurons to different extents that has important 
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implications for the therapeutic use of stimulation paradigms where it may be clinically 
beneficial to preferentially stimulate one group of neurons. Accordingly, one paradigm may be 
more effective than another.  
While rTMS does alter functional connectivity, it appears to do so in unpredictable ways 
across individuals, and between unexpected regions. If the goal is to selectively increase or 
decrease connectivity between specific brain regions in a controlled manner, advances in our 
understanding of rTMS or alternative approaches is needed. One alternative approach that may 
help address this issue is to precondition the stimulation and modify connectivity in a more 
controlled manner. Preconditioning with a session of tDCS can be used to shape the conditioning 
effect of subsequent rTMS (Siebner et al., 2004). “Facilitatory” preconditioning with anodal 
tDCS followed by subsequent 1 Hz rTMS reduces corticospinal excitability to below baseline 
levels for more than 20 min. Conversely, “inhibitory” preconditioning with cathodal tDCS 
followed by subsequent 1 Hz rTMS increases corticospinal excitability for at least 20 min. This 
preconditioning pattern is interpreted in the context of homeostatic plasticity. Although activity-
dependent synaptic plasticity is required for modification of network properties, homeostatic 
mechanisms ensure that plastic changes only occur within a physiologically useful range and 
allow for network stability (Turrigiano & Nelson, 2004). The variable aftereffects may be due to 
different excitability levels in participants at the time of rTMS conditioning (i.e., state-
dependency; Pasley et al., 2009). Therefore, the preconditioning approach might be effective in 
enhancing the therapeutic efficacy of rTMS in patients and may produce more consistent 
aftereffects as well as limit inter-individual variability. 
There are a variety of other noninvasive techniques that can be used to determine the 
effects of stimulation on other neurophysiological parameters in the visual cortex, e.g., PET, or 
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assessing changes on other neurometabolites. A valuable measure would be to assess BDNF 
concentration. BDNF regulates cell growth, survival, proliferation, and protects against oxidative 
stressors (Müller et al., 2000; Post et al., 1999). BDNF also modulates LTP and LTD 
mechanisms (Figurov, Pozzo-Miller, Olafsson, Wang, & Lu, 1996; Gottman, Mittmann, & 
Lessmann, 2009; Woo et al., 2005). With regards to the visual cortex, acceleration of BDNF 
promotes visual cortical development and plasticity (Berardi, Pizzorusso, Ratto, & Maffei, 2003; 
Huang et al., 1999; McAllister, Katz, & Lo, 1999). Notably, rTMS is shown to upregulate BDNF 
and improve aberrant visual cortical topography (Makowiecki, Harvey, Sherrard, & Rodger, 
2014). Modulation of BDNF with noninvasive brain stimulation is therefore ideal in clinical 
applications. Furthermore, individuals expressing polymorphism in BDNF show impaired 
responses to noninvasive brain stimulation (Antal et al., 2010; Cheeran et al., 2008). This has 
critical value in clinical applications as it can determine the efficacy of treatment with regards to 
plasticity and resistance to treatment. Suitably, BDNF quantification has been suggested as a 
biological marker to characterise rTMS effects (Brunoni, Boggio, & Fregni, 2008). In humans, 
BDNF can be quantified noninvasively using salivary or blood samples (Saruta, Fujino, To, & 
Tsukinoki, 2012; Trajkovska et al., 2007; Vrijen, Schenk, Hartman, & Oldehinkel, 2017). 
The diffusion tensor is only capable of representing a single fibre orientation per voxel. 
Therefore, in circumstances of complex fibre architecture (e.g., bending, crossing and kissing 
fibres, contamination between adjacent fibre populations), the diffusion tensor is a poor 
representation of the underlying structure that can lead to errors in the estimation of fibre 
orientations and associated errors in the reconstruction of fibre pathways (Smith, Tournier, 
Calamante, & Connelly, 2012). More sophisticated diffusion imaging techniques and analyses 
have been proposed. For example, high angular resolution diffusion imaging (HARDI) has better 
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angular and spatial resolution, demonstrating greater detection of crossing fibres in cases where 
DTI is inaccurate (Jansons & Alexander, 2003). Accordingly, HARDI has better discrimination 
of pathways and produces more fibres; therefore, it demonstrates better detection in disease 
states affecting white mater structure (Berman, Lanza, Blaskey, Edgar, & Roberts, 2013; Wang 
et al., 2016). A novel combination of processing, reconstruction, and tractography methods 
termed high definition fibre tracking (HDFT) have been developed using a high angular 
resolution-based approach (Fernández-Miranda et al., 2012). HDFT leverages high directional 
sampling of diffusion imaging space to get better resolution of underlying white matter geometry 
for tractography (Yeh, Wedeen, & Tseng, 2010). Studies demonstrate that HDFT provides 
accurate replication of complex known neuroanatomical features where DTI fails (Fernández-
Miranda et al., 2015; Wang et al., 2013; Wu, Sun, Wang, Wang, & Ou, 2016). Furthermore, 
HDFT is proven to allow tracing from one cortical region to other cortical or subcortical regions 
through complex crossings areas, providing detailed evidence of the cortical site of origin or 
termination of fibres without the need for approximation as with DTI (Fernández-Miranda et al., 
2015; Wu et al., 2016).  
The information from a seed-based rsFC map is limited to the functional connections of 
the selected seed region, making it difficult to examine functional connectivity patterns on a 
whole-brain scale. Model-free methods exist to examine whole-brain connectivity patterns 
without the need of defining an a priori seed region. In contrast to seed-based methods, model-
free methods look for general patterns of (unique) connectivity across brain regions. ICA-based 
methods are perhaps the most popular and powerful model-free technique (Beckmann et al., 
2005; Calhoun, Adali, Pearlson, & Pekar, 2001; De Luca, Beckmann, De Stefano, Matthews, & 
Smith, 2006; van de Ven, Formisano, Prvulovic, Roeder, & Linden, 2004) and show a high level 
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of consistency (Damoiseaux et al., 2006). ICA methods search for a mixture of underlying 
sources that can explain resting-state patterns and look for the presence of spatial sources of 
resting-state signals that are maximally independent from each other. A possible disadvantage of 
ICA methods is that the ICs are often perceived as more difficult to understand than traditional 
seed-based rsFC maps since they contain a more complex representation of the data. ICA data 
may therefore complicate the translation of between-group results to clinical relevance (Fox & 
Raichle, 2007). Lastly, there are important limitations to measuring connectivity with rsfMRI. 
Because participants are not performing a specific task, there is no clear measure of performance 
or mental state. In this case, task-based fMRI can provide valuable information where rsfMRI 
fails. Moreover, rsfMRI is a correlational measure only, and not a causal measure, limiting the 
conclusions that can be drawn. Further research in patient populations would also benefit from 
effective connectivity models to investigate the causal influence of implicated regions on 
interconnected regions (Friston, 1994). For example, in the case of visual hallucinations in our 
patient, the causal influence of peri-infarct regions at the lingual gyrus (considered the main 
source of hallucinations) on interconnected regions with aberrant activity can confirm/refute 
which regions are the cause and which are involved as a secondary effect to the hallucinations.  
In the pathological brain, restoring a normal pattern of activity within a given neural 
network may not be the most effective way to suppress symptoms and encourage rehabilitation. 
Instead, it may be more beneficial to induce changes that prove behaviourally more adaptive. 
Because increasing cortical excitability can facilitate learning, adjunct therapies or online 
stimulation protocols may have a greater impact in restorative neurology and rehabilitation (e.g., 
stimulation combined with visual tasks or vision restoration therapy). In this respect, findings 
from the learning literature suggest that the optimal interval spacing between training sessions is 
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influenced by numerous key factors, including the nature of the task being learned (for a review, 
see Donovan & Radosevich, 1999). The same principles may apply with different forms of 
noninvasive brain stimulation in addition to the spacing of intervals between stimulation sessions 
and the length of stimulation. 
Shorter schedules of rTMS application were used in healthy controls and in our patient 
due to limited knowledge of aftereffects on the visual cortex (e.g., adverse effects) and 
associated ethical considerations. The repeated consecutive application of rTMS was well 
tolerated by controls and the patient. One would likely observe different results with prolonged 
application over consecutive weeks, as would be used in clinical applications, and this warrants 
further investigation now that I have established a safe starting point. With longer applications of 
stimulation, the likelihood of adverse effects increases. Although longitudinal studies are 
difficult to achieve due to high attrition rates and high financial costs, longer-term investigation 
over periods of months is necessary to rule out long-term side effects of rTMS. At present, 
longitudinal noninvasive brain stimulation studies are significantly lacking, particularly with 
follow-ups using neuroimaging. Current studies that have investigated long-term effects have 
done so using subjective or behavioural measures only (e.g., Dunner et al., 2014; Liepert et al., 
2000a). Along with long-term follow-up with neuroimaging, more clinical trials in visual 
disorders are needed, and with much larger sample sizes. Longitudinal studies are particularly 
critical, as individual differences in brain plasticity are quite large (Maeda et al., 2000), and 
understanding factors that condition individual differences will offer unique and novel targets to 
promote individual brain recovery and restoration long-term with minimal adverse effects. 
Important factors to consider that likely contribute to differences in mechanisms of plasticity 
across individuals include genetic mechanisms (e.g., polymorphisms, genetic expression), 
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hormonal factors (e.g., gender, menstrual cycle), impact of systemic conditions (e.g. diabetes, 
cancer, or infections), and general day-to-day factors influencing health (e.g., exposure to toxins, 
stress, sleep deprivation, substance abuse, poor nutrition, etc.). 
Relevance to Non-Visual Disorders 
Visual hallucinations can be provoked by a variety pathophysiological processes, 
including cell death (e.g., visual pathway damage), psychological disorders (e.g., schizophrenia), 
drug substances, or neurodegenerative conditions (e.g., dementia with Lewy bodies, Parkinson’s 
disease, Alzheimer’s disease) (for a review, see Onofrj et al., 2015). The prevalence of visual 
hallucinations in Parkinson’s disease for example is relatively high (Barnes, Boubert, Harris, 
Lee, & David, 2003; Williams & Lees, 2005). In Parkinson’s disease, visual hallucinations can 
be accompanied by paranoia and, in comparison with other consequences such as motor 
disability and dementia, hallucinations are more important as a risk factor for nursing home 
placement and its associated mortality. The frequency and morbidity associated with visual 
hallucinations in Parkinson’s disease underscores the need for understanding their 
pathophysiology and treatment (Diederich, Goetz, & Stebbins, 2005). The present work is not 
only relevant to visual hallucinations, but to general visual disorders and non-visual disorders 
that present with secondary visual complications. For instance, patients with Parkinson’s disease 
also have impairments in contrast sensitivity, and rTMS has previously been shown to improve 
contrast sensitivity (Clavagnier et al., 2013; Thompson et al., 2008). In addition to visual 
hallucinations, patients with Alzheimer’s and Parkinson’s disease present with impaired object 
and face perception (Barnes et al., 2003; Tippet, Blackwood, & Farah, 2003). From previous 
research, we know that TMS can influence the processing of faces and objects (Mullin & 
Steeves, 2013; Rafique et al., 2015; Solomon-Harris et al., 2016). Therefore, noninvasive brain 
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stimulation to visual areas holds tremendous promise in improving visual-related symptoms in a 
variety of pathophysiology, and is applicable to any condition with impaired mechanisms that we 
know rTMS can target. It is then quite surprising that the application of noninvasive brain 
stimulation to visual cortices has received considerably less interest in developing relevant 
therapeutic protocols.  
Final Thoughts 
There are substantially more questions and areas that remain to be investigated. Although 
time-consuming and costly, it is vital that we explore effects of different noninvasive brain 
stimulation techniques and stimulation parameters to create optimal protocols with therapeutic 
relevance. A variety of optimal parameters will enable targeting of a diverse range of pathologies 
and neural mechanisms in visual-related disorders. The use of consecutive brain stimulation and 
neuroimaging techniques that are differentially sensitive to neural mechanisms, and thus 
complementary, is imperative. Effects of stimulation should continue to be explored in healthy 
controls as well as patient populations to gain valuable insight into neural mechanisms 
underlying rTMS and disease processes.  
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Appendix A: Probabilistic Tractography for Controls 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex to the inferior frontal gyrus (white 
mask) for all control participants (C1–C7). Results for C1 are also presented in Figure 3.2a (Chapter 3) as a representative comparison to the 
patient’s probabilistic fibre tractography. L = left; R = right. 
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Figure A2. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex to the precentral gyrus (lime green 
mask) for all control participants (C1–C7). Results for C1 are also presented in Figure 3.2b (Chapter 3) as a representative comparison to the 
patient’s probabilistic fibre tractography. L = left; R = right. 
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Figure A3. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex to the superior temporal gyrus (yellow 
mask) for all control participants (C1–C7). Results for C1 are also presented in Figure 3.3a (Chapter 3) as a representative comparison to the 
patient’s probabilistic fibre tractography. L = left; R = right. 
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Figure A4. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex to the middle temporo-occipital gyrus 
(peach mask) for all control participants (C1–C7). Results for C1 are also presented in Figure 3.3b (Chapter 3) as a representative 
comparison to the patient’s probabilistic fibre tractography. L = left; R = right. 
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Figure A5. Probabilistic fibre tractography for intrahemispheric tracts seeded from the visual cortex to the lateral geniculate body (pink 
mask) for all control participants (C1–C7). Results for C1 are also presented in Figure 3.3c (Chapter 3) as a representative comparison to the 
patient’s probabilistic fibre tractography. L = left; R = right. 
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Figure A6. Probabilistic fibre tractography for intrahemispheric tracts seeded from the lateral geniculate body to the visual cortex (red mask) 
for all control participants (C1–C7). Results for C1 are also presented in Figure 3.4 (Chapter 3) as a representative comparison to the 
patient’s probabilistic fibre tractography. L = left; R = right. 
 260 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A7. Probabilistic fibre tractography of interhemispheric tracts between visual cortices for all control participants (C1–C7). Results 
for C1 are also presented in Figure 3.5 (Chapter 3) as a representative comparison to the patient’s probabilistic fibre tractography. L = left; 
R = right.
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Appendix B: Example of Montreal Cognitive Assessment  
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Appendix C: Vividness of Visual Imagery Questionnaire 
Visual imagery refers to the ability to visualise, that is, the ability to form mental pictures, or to 
"see in the mind’s eye". Marked individual differences have been found in the strength and 
clarity of reported visual imagery and these differences are of considerable psychological 
interest.  
The aim of this test is to determine the vividness of your visual imagery. The items of the test 
will possibly bring certain images to your mind. You are asked to rate the vividness of each 
image by reference to the 5-point scale given below. For example, if your image is "vague and 
dim" then give it a rating of 2. After each item write the appropriate number in the sheet 
provided. The first sheet is for images obtained with your eyes open and the second sheet is for 
images obtained with your eyes closed. Before you turn to the items on the next page, familiarise 
yourself with the different categories on the rating scale. Throughout the test, refer to the rating 
scale when judging the vividness of each image. Try to do each item separately, independent of 
how you may have done other items.  
Complete all items for images obtained with the eyes open and then return to the beginning of 
the questionnaire and rate the image obtained for each item with your eyes closed. Try and give 
your "eyes closed" rating independently of the "eyes open" rating. The two ratings for a given 
item may not in all cases be the same. Use the same images for eyes open and closed. 
 
RATING SCALE  
The image aroused by an item might be: 
No image at all, you only "know" that 
you are thinking of an object 
rating 1 
Vague and dim   rating 2 
Moderately clear and vivid     rating 3 
Clear and reasonably vivid rating 4 
Perfectly clear and as vivid as normal 
vision 
rating 5 
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.................................................................................................... 
In answering items 1 to 4, think of some relative or friend whom you frequently see (but who is 
not with you at present) and consider carefully the picture that comes before your mind’s eye.  
1  
The exact contour of face, head, shoulders and 
body.  
2    
Characteristic poses of head, attitudes of body, 
etc.   
3  
The precise carriage, length of step, etc., in 
walking.   
4 
The different colours worn in some familiar 
clothes.   
.................................................................................................... 
Visualise the rising sun. Consider carefully the picture that comes before your mind’s eye. 
5  
The sun is rising above the horizon into a hazy 
sky.    
6    
The sky clears and surrounds the sun with 
blueness.   
7  
Clouds. A storm blows up, with flashes of 
lightening.  
8 A rainbow appears. 
.................................................................................................... 
Think of the front of a shop which you often go to. Consider the picture that comes before your 
mind’s eye.  
9   
The overall appearance of the shop from the opposite side 
of the road.     
10 
A window display including colours, shape and details of 
individual items for sale.     
11 
You are near the entrance. The colour, shape and details of 
the door.     
12 
You enter the shop and go to the counter. The counter 
assistant serves you. Money changes hands.    
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.................................................................................................... 
Finally, think of a country scene which involves trees, mountains and a lake. Consider the picture 
that comes before your mind’s eye.  
13   The contours of the landscape.     
14    The colour and shape of the trees.     
15  The colour and shape of the lake. 
16 
A strong wind blows on the tree and on the lake 
causing waves. 
.................................................................................................... 
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Appendix D: Revised Launay-Slade Hallucination Scale 
 
Rating scale: 
1 = never, 2 = sometimes, 3 = often, 4 = almost always 
 
Questions: 
1. A passing thought will seem so real that it frightens me 
2. My thoughts seem as real as actual events in my life 
3. No matter how much I try to concentrate on my work unrelated thoughts always creep into 
my mind. 
4.  I have had the experience of hearing a person’s voice and then found that there was no one 
there. 
5. The sounds I hear in my daydreams are generally clear and distinct. 
6. The people in my daydreams seem so true to life that I think they are real. 
7. In my daydreams I can hear the sound of a tune almost as clearly as if I were actually 
listening to it. 
8. I hear a voice speaking my thoughts aloud.  
9. I have been troubled by hearing voices in my head.  
10. I have seen a person’s face in front of me when no one was there. 
11. I have heard the voice of God speaking to me.  
12. When I look at things they appear strange to me.  
13. I see shadows and shapes when there is nothing there.  
14. When I look at things they look unreal to me.  
15. When I look at myself in the mirror I look different. 
 
